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Tissue assembly is a fundamental biological process that arises from complex cell-cell 
and cell-extracellular matrix interactions.  Angiogenesis is the process of capillary 
formation that enables normal physiological responses like wound healing and 
mediates disease states like tumorigenesis.  During angiogenesis, capillary endothelial 
cells degrade the basement membrane, proliferate, migrate, and assemble a new 
vascular network.  While there is much focus on growth factor signaling cascades that 
enable angiogenesis, less attention has been paid to the role of mechanics in capillary 
formation.  Notably, capillary network assembly has been demonstrated on compliant, 
but not stiff, substrates suggesting that the mechanical microenvironment also 
mediates angiogenesis.  However, it is unknown whether, or how, substrate stiffness 
regulates capillary network assembly. 
 
Herein, we demonstrate that substrate stiffness regulates capillary network assembly 
and mediates endothelial cell behaviors that enable assembly.  Compliant (E<1 kPa), 
but not stiff (E>1 kPa), substrates promote the self-assembly of endothelial cell 
networks that result from a balance of cell-cell and cell-matrix adhesion.  Substrate 
stiffness alters the localization of VE-cadherin and focal adhesions, mediators of 
endothelial cell-cell and cell-matrix adhesion, respectively.  Endothelial network 
assembly also requires polymerization of the matrix protein fibronectin that stabilizes 
cell-cell interactions.  Analogously, we demonstrate that mammary cell network 
 assembly is also sensitive to substrate stiffness and requires the deposition of laminin.  
Our findings indicate that compliant substrates foster network assembly by promoting 
cell-cell adhesion, cell-matrix interactions, and reducing cell-matrix adhesion. 
   
We further investigate the role of substrate stiffness in mediating changes in cell shape 
and contractility.  We determine that substrate stiffness and ligand density alter cell 
area, and that both stiffness and cell area are significant predictors of traction force 
generation in endothelial cells during cell-cell contact.  In addition, we demonstrate 
that substrate stiffness alters the synthesis and deposition of fibronectin and extra 
domain B-fibronectin, an isoform preferentially localized to neovasculature, by 
modulating cell shape and the directionality of traction forces in endothelial cells.  
 
Taken together, these data demonstrate that substrate stiffness regulates capillary 
network assembly by altering endothelial cell behaviors that facilitate assembly.  
These findings contribute to the understanding of how the mechanical 
microenvironment regulates capillary network assembly and enable approaches to 
control angiogenesis for therapeutic use.   
 
 
 
 
 iii 
BIOGRAPHICAL SKETCH 
 
Joseph Peter Califano was born in Albany, New York to Antonio and Donna in the 
spring of 1984, and grew up with his older brother Anthony in Colonie, New York.  
He attended Colonie Central High School with keen interests in music, biology, and 
chemistry, and graduated in 2002.  Joe attended Rensselaer Polytechnic Institute as a 
Math and Science Medal scholarship recipient, and majored in Biomedical 
Engineering with a minor in Social Psychology.  He graduated summa cum laude with 
a B.S. in Biomedical Engineering in May 2006.  In August 2006, Joe entered the 
Ph.D. program in Biomedical Engineering at Cornell University and joined the lab of 
Cynthia A. Reinhart-King.  At Cornell, Joe's thesis work was focused on 
understanding the role of the mechanical and chemical microenvironment in blood 
vessel development.  He received an M.S. in Biomedical Engineering in 2009, was 
awarded a National Science Foundation GK-12 Fellowship in 2010, and completed his 
Ph.D. in the spring of 2012.  In addition to practicing science, Joe enjoys running, 
reading, cooking, and eating.   
 
 
 
 
 
 
 
 
 
 
 iv 
 
 
 
 
 
 
 
 
 
 
 
 
For my Family and Friends
 v 
ACKNOWLEDGMENTS 
 
My name appears at the top of this dissertation, but there are many people who made 
this work possible.   
 
I would first like to acknowledge and thank my advisor Dr. Cynthia A. Reinhart-King.  
I am sincerely grateful to Cindy for her advice, encouragement, support, and for 
giving me the independence and guidance to direct the course of my research.  I am 
grateful for her mentorship in communicating science effectively, and for trusting me 
to help set up her lab, an incredible and unique learning experience.  I am indebted to 
Cindy for teaching me how to be a successful scientist, and it was my pleasure to work 
with her.   
 
I would like to recognize and thank my committee members, Dr. Lawrence Bonassar 
and Dr. Thomas Sato for their support and supervision of this work. 
 
I am sincerely grateful for the opportunity to work with collaborators within and 
outside of the Reinhart-King lab.  I want to acknowledge John Huynh, Brooke Mason, 
Casey Kraning-Rush, Jon Charest, and Shawn Carey for terrific collaborations in 
original research and book chapters.  I would like to thank Dr. Nozomi Nishimura, Dr. 
Chris Schaffer, Dr. Kuldeep Rana, and Dr. Michael King, Emily Brooks and Dr. 
Claudia Fischbach, Abdurrahman Gumus and Dr. George Malliaras, Dr. Paraskevi 
Giannakakou, and Dr. Brian DeRubertis and Dr. Angela Vouyouka for their 
collaboration on challenging and exciting research projects.  I would like to also thank 
Dr. Micah Dembo, Dr. Jane Sottile, Dr. Harold Erickson, and Dr. Tomoo Ohashi for 
graciously providing tools and advice necessary for the completion of this work. 
 vi 
I gratefully thank the funding sources that have supported this work, including a 
Sigma Xi Grant-In-Aid of Research, and a National Science Foundation GK-12 
Fellowship.  
 
I would like to thank Dr. Michael Shuler who graciously provided me with a home in 
his laboratory and a place to present my early work at his group meetings.  His 
questions challenged me to think about my work in a variety of contexts.  I am 
indebted to Paula Miller who taught me cell culture and tips on lab management and 
organization.  I am thankful for discussions and advice about research from the 
students in the Shuler lab during my time there.    
 
Thanks to Dr. Chris Schaffer, Dr. Shivaun Archer, Kevin Dilley, and Nev Singhota for 
their advice and mentorship about teaching, GK-12 education, and outreach.  I want to 
acknowledge and thank Mrs. Jackie Henkel, Mr. Mike McNall, and the students in 7th 
grade science at Eagle Hill Middle School for a fantastic teaching experience and for 
helping and allowing me to implement my curriculum.  Thanks also to Dr. Angela 
Vouyouka for her mentorship and allowing me to follow her through the ORs of Weill 
Cornell Medical College—it was an amazing experience I'll never forget.   
 
I am indebted to my fellow graduate students in the Reinhart-King (CRK) lab.  John 
Huynh, Brooke Mason, and Casey Kraning-Rush (not to mention their counterparts 
Joanna, Blake, and Jason) served as my lab family, and I am forever grateful for their 
friendship, encouragement, and insights about science.  They could all be counted on 
for good company, good advice, and good meals, and it was my privilege to work with 
them.  I would also like to thank Jon Charest, Shawn Carey, Courtney Faber, Na 
Young Kim, Abdurrahman Gumus, and Josie Bodle for their collaborations, scientific 
 vii 
expertise, and friendship.  Thanks to all other members of the CRK lab including the 
undergrads that I was fortunate to mentor.  Tracy Cheung, Alina Starchenko, and 
Kelly McBride served as devoted worker-bees and friends, and I am certain they will 
all find success in their future endeavors.    
 
Special thanks to Dr. Christine Montague and Dr. Libin Yuan.  This work could not 
have been completed without their collaboration, and insights and expertise in 
molecular biology.  Their patience and helpful discussions about science and life 
outside of science were truly appreciated.  
 
Thanks to John Nguyen who served as a colleague, roommate, and West Coast liaison.  
I am grateful for his friendship, advice, and insights about science and life.  I’m also 
grateful to John Huynh for his excellent roommate-ship—fun times were had on 
Miller St.   
    
I am grateful for the friendship of my fellow graduate classmates, Emily Brooks, Janet 
Shen, Gilda Shayan, and Phil Buskohl.  We started this journey together and I am 
thankful for their continued friendship and encouragement.  Thanks also to Michelle 
Martinez for her friendship and accompaniment as we explored the eateries of Ithaca 
together.   
 
I would be remiss to not acknowledge the excellent teachers who inspired my interest 
in science and engineering.  From RPI, I want to thank Dr. Deepak Vashishth and Dr. 
Rena Bizios for their instruction, their enthusiasm about BME and research, and their 
continued encouragement and support.  I would not have ended up in graduate school 
without their mentorship.  At CCHS, my interest in science was awakened by Mrs. 
 viii 
Villa and Mr. Diana.  I am undoubtedly on this path because of their pedagogical 
excellence. 
 
Thanks to my RPI “brother” Barret LaGrave (Gravester) for his friendship both in and 
out of the Poly.  I’m also grateful for the continued friendship and encouragement of 
Dara Farber.  Her wisdom and uncanny ability to teach me things about myself helps 
keep everything in perspective.    
 
Lastly, but most importantly, I must acknowledge and thank my family including my 
parents, Antonio and Donna, and my brother, Anthony.  Their unconditional love, 
support, and encouragement serves as a beacon in the night throughout this journey 
called life.  Ti saluto! 
 ix 
TABLE OF CONTENTS 
 
Biographical Sketch            iii 
Dedication             iv 
Acknowledgements             v 
Table of Contents             ix 
List of Figures             xi 
List of Tables           xvi 
List of Abbreviations                    xvii 
List of Symbols                   xviii  
Preface           xix 
 
Chapter 1 Introduction            1 
 
Chapter 2 A Balance of Substrate Mechanics and Matrix Chemistry Regulates 
  Endothelial Cell Network Assembly 
  
 2.1 Abstract           12 
 2.2 Introduction           13 
 2.3 Materials and Methods         15 
 2.4 Results           18 
 2.5 Discussion           32 
  
Chapter 3 Substrate Stiffness Alters Cell-Cell and Cell-Matrix Interactions that 
  Regulate Network Assembly 
  
 3.1 Abstract           36 
 3.2 Introduction           37 
 3.3 Materials and Methods         38 
 3.4 Results           42 
 3.5 Discussion           66 
  
Chapter 4 Substrate Stiffness and Cell Area Predict Cellular Traction Stresses in 
  Single  Cells and Cells in Contact 
  
 4.1 Abstract           70 
 4.2 Introduction           71 
 4.3 Materials and Methods         73 
 4.4 Results           76 
 4.5 Discussion           85 
  
Chapter 5 Substrate Stiffness Alters Fibronectin Synthesis and Deposition 
   
 5.1 Abstract           89 
 5.2 Introduction           90 
 5.3 Materials and Methods         91 
 x 
 5.4 Results         100 
 5.5 Discussion         127 
  
Chapter 6 Conclusions and Future Directions 
  
 6.1 Conclusions         130 
 6.2 Future Directions        134 
 
Chapter 7 Bringing Polymer Science to the Classroom 
  
 7.1 Abstract         136 
 7.2 Introduction         136 
 7.3 The Role of Substrate Stiffness in Mediating Cell Proliferation  137 
 7.4 The Approach         138 
 7.5 The Lessons        
  7.5a Introduction to Polymers      139 
  7.5b Mechanical Testing of Polymers     141 
  7.5c Polymer Stiffness and Cell Proliferation    144 
 7.6 Conclusion         145 
 7.7 Science Scope Article        145
   
Appendix A Protocol for Coverslip Activation      157 
 
Appendix B Protocol for Polyacrylamide Gel Synthesis     159 
 
Appendix C Advanced Methods for Polyacrylamide Gel Synthesis: 
  Double Gels and Micropatterned Gels     162 
 
Appendix D Protocol for N6 Linker Synthesis      164 
 
Appendix E Protocol for Mechanical Testing of Polyacrylamide Gels   168 
 
Appendix F Protocol for Immunofluorescence Staining of Cells 
  on Polyacrylamide Gels       171 
 
Appendix G Protocol for BrdU Incorporation for Cells 
  on Polyacrylamide Gels       173 
 
Appendix H Protocol for Harvesting Cells from Polyacrylamide Gels 
  for SDS-PAGE/Western Blot or qPCR Analysis    174 
 
Appendix I Protocol for Transfection of Endothelial Cells    176 
 
Appendix J GK12 Module Teaching Materials      178 
 
References           198 
 xi 
LIST OF FIGURES 
 
CHAPTER 2 
Figure 2.1: Compliant substrates derivatized with collagen promote 
 EC network assembly.         19 
Figure 2.2: Compliant substrates derivatized with FN promote 
 EC network assembly.         20 
Figure 2.3: Compliant substrates derivatized with RGD promote 
 EC network assembly.         21 
Figure 2.4: Network development over time.        22 
Figure 2.5: Cell network assembly is induced on stiff substrates by 
 decreasing collagen concentration.       23 
Figure 2.6: Network assembly is induced on stiff substrates by decreasing 
 FN concentration.         24 
Figure 2.7: Cell-cell adhesion is induced on stiff substrates by 
 decreasing RGD concentration.        24 
Figure 2.8: Ratio of area to perimeter predicts EC network assembly.    26 
Figure 2.9: Substrate stiffness and ligand concentration alter EC proliferation.   27 
Figure 2.10: FN colocalizes with EC network assembly.      28 
Figure 2.11: ECs do not require exogenous FN to assemble into   
 network-like structures.         29 
Figure 2.12: EC network assembly on compliant substrates requires 
 FN polymerization.         31 
Figure 2.13: Inhibiting FN polymerization disrupts the balance between 
 cell-cell and cell-substrate adhesivity.       32 
       
 xii 
CHAPTER 3 
Figure 3.1: Substrate stiffness alters the localization of VE-cadherin in ECs.   44 
Figure 3.2: EGTA treatment prevents EC network assembly.     46 
Figure 3.3: EGTA disrupts VE-cadherin localization at cell-cell junctions.    47 
Figure 3.4: Treatment with a VE-cadherin blocking antibody prevents 
  EC network assembly.         48 
Figure 3.5: Substrate stiffness alters focal adhesion localization and 
                   cell-substrate adhesion.         50 
Figure 3.6: Compliant substrates promote mammary cell network assembly 
  colocalized with laminin and reduced cell-substrate adhesion.      52 
Figure 3.7: Laminin 3 is requisite for mammary cell network assembly.    53 
Figure 3.8: Networks of mammary epithelial cells are associated 
 with fibronectin.          54 
Figure 3.9: Compliant substrates support mesenchymal cell network assembly 
 colocalized with FN.         55 
Figure 3.10: Compliant substrates support SMC network assembly 
 associated with collagen.        56 
Figure 3.11: Laminin-deficient mammary cells fail to assemble networks 
 on compliant substrates.         58 
Figure 3.12: Lung cells fail to assemble networks and do not exhibit 
 a reduction in cell-substrate adhesion on compliant substrates.   59 
Figure 3.13: Metastatic lung carcinoma cells fail to assemble networks 
 on compliant substrates.        60 
Figure 3.14: Mammary and lung tissue-derived cells that do not assemble 
 networks are not associated with FN.       61    
 
 xiii 
Figure 3.15: Substrate stiffness alters the localization of E-cadherin in  
 mammary cells that assemble networks.       62 
Figure 3.16: Exogenous laminin induces network assembly in laminin-deficient 
 mammary cells.           64 
Figure 3.17: Compliant substrates derivatized with laminin induce E-cadherin 
 mediated cell-cell interactions in mammary cells.     65 
 
CHAPTER 4 
Figure 4.1: Proposed interplay between substrate stiffness, cell area, 
 and traction force in ECs.         72 
Figure 4.2: Representative images of EC morphology and traction stresses 
 on variably compliant substrates.        77 
Figure 4.3: Traction force magnitude and cell area increase with increasing 
 substrate stiffness.          77 
Figure 4.4: Plot of traction force magnitude vs. cell area fit with  
 linear regression lines.         79 
Figure 4.5: Traction force magnitude, cell area, and regression modeling 
 for substrates of variable collagen concentration.     81 
Figure 4.6: EC area increases with increasing fibronectin concentration.    82 
Figure 4.7: Representative images of cell morphology and traction stresses  
 for two ECs in contact.         83 
Figure 4.8: Traction force magnitude increases when ECs are in contact.    84 
 
CHAPTER 5 
Figure 5.1: Substrate stiffness alters fibronectin deposition.     101 
Figure 5.2: Substrate stiffness alters FN localization.     103 
 xiv 
Figure 5.3: ECs on RGD-derivatized substrates assemble networks 
 atop fibrillar assembled FN.       104 
Figure 5.4: Substrate stiffness alters the dynamics and quality of FN deposition.  105 
Figure 5.5: Substrate stiffness mediates the expression and deposition 
 of EDB-fibronectin.        107 
Figure 5.6: FN controls.         108 
Figure 5.7: FN orientation correlates with actin cytoskeletal polarity.   110 
Figure 5.8: Substrate stiffness alters traction force polarization.    112 
Figure 5.9: FN deposition is directed by enforcing cell polarity.    114 
Figure 5.10: Enforcing an elongated cell morphology reduces traction force 
 magnitude on stiff substrates.       115 
Figure 5.11: Inhibiting ROCK or myosin light chain kinase reduces 
 traction force magnitude.       116 
Figure 5.12: ROCK-mediated contractility mediates FN deposition (Y27).   117 
Figure 5.13: ROCK-mediated contractility mediates FN deposition (siRNA).  118 
Figure 5.14: ROCK-mediated contractility and cell area mediate 
 EDB-FN deposition.        119 
Figure 5.15: Constitutively active Rho reduces assembled FN deposition 
 on stiff substrates.        121 
Figure 5.16: Disrupted fibronectin deposition or polymerization does not alter 
 traction force magnitude.       123 
Figure 5.17: Inhibiting FN polymerization does not alter cell displacement.  124 
Figure 5.18: Substrate stiffness mediates laminin deposition in epithelial cells.  126  
 
CHAPTER 7 
Figure 7.1: EC proliferation increases with increasing substrate stiffness.   138 
 xv 
Figure 7.2: "Introduction to Polymers" quiz scores.      141 
Figure 7.3: Mechanical testing apparatus.        143 
Figure 7.4: "Mechanical Testing of Polymers" quiz scores.     144
 Science Scope Article         
 Figure 7S.1: Polymer synthesis in the classroom.     149 
 Figure 7S.2: Cell growth increases with increasing polymer 
 substrate stiffness.       152 
 Figure 7S.3: Cells stained and imaged with fluorescence microscopy.  153 
 Worksheet: Polymer Synthesis       155 
 Worksheet: Substrate Stiffness and Cell Proliferation    156
   
 
 xvi 
LIST OF TABLES 
 
CHAPTER 4 
Table 4.1: List of p-values for significance of predictors E and Area on |F|.   80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xvii 
LIST OF ABBREVIATIONS 
 
ANOVA Analysis of variance 
BAEC Bovine aortic endothelial cell 
BSA Bovine serum albumin 
DAPI 4’,6-diamidino-2-phenylindole 
DOC Deoxycholate 
EC Endothelial cell 
EGTA Ethylene glycol tetraacetic acid 
FITC Fluorescein isothiocyanate 
FN Fibronectin 
GFP Green fluorescent protein 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HUVEC Human umbilical vein endothelial cell 
MEC Mammary epithelial cell 
N6 N-6-((acryloyl)amino) hexanoic acid, succinimidyl ester 
PA Poly(acrylamide) 
PBS Phosphate-buffered saline 
RGD Arginine-glycine-aspartic acid 
RT Room temperature 
SMC Smooth muscle cell 
TBS Tris-buffered saline 
TFM Traction force microscopy 
Triton Octyl phenol ethoxylate 
Tween Polyoxyethylene 20 sorbitan monolaurate 
YFP Yellow fluorescent protein
 xviii 
LIST OF SYMBOLS 
Symbol          Description    Units 
°C           Degree Celsius    Degree 
E           Young’s Modulus   Pa=N/m2 
F           Traction Force    N
           Poisson’s Ratio    --- 
 
 xix 
PREFACE 
 
Well, here it is.  The work presented herein is the result of a six-year journey that 
included two lab relocations, thousands of synthesized polymer substrates, and 
countless hours spent analyzing and interpreting data.  More importantly, it is the 
result of fantastic collaborations and friendships with esteemed colleagues whose 
influence extends well beyond the scope of this document. 
 
In the final analysis, my hope is that we have made a significant contribution to the 
understanding of capillary network assembly.  Perhaps one day our findings will be 
used to help treat disease.  As a student of BME, this would be the most rewarding 
outcome possible.  While this dissertation is the culmination of my work at Cornell, it 
is just the beginning of things to come.  Enjoy!  
 
JPC 
Ithaca, NY 
March 2012
 1 
CHAPTER 1 
 
INTRODUCTION 
 
Tissue assembly is a fundamental biological process that results from complex 
interactions between cells and the extracellular matrix (ECM) [1,2].  In the 
vasculature, angiogenesis is the process of new blood vessel formation from existing 
vessels.  During angiogenesis, normally quiescent endothelial cells (EC) degrade the 
basement membrane, proliferate, migrate, and assemble into new capillary networks 
[3].  While angiogenesis is critical during development and in normal physiological 
responses like wound healing, it is exploited in disease states like cancer.  
 
Research in angiogenesis grew out of early observations of vascularization in tumors 
[4,5] suggesting that tumors stimulate capillary formation [6] enabling their growth 
[7].  By the early 1970s, based on observation in the 1960s that solid tumors were 
incapable of growth beyond a critical size (3-4 mm) without new blood vessel 
ingrowth [8,9], Dr. Judah Folkman postulated his pioneering hypothesis that 
angiogenesis could be targeted to inhibit solid tumor growth [10].  Continued work in 
this field lead Folkman to publish Angiogenesis In Vitro in December 1980 [11] .  This 
seminal work was the first demonstration of angiogenesis in vitro and indicated that 
ECs possess the blueprints required to assemble capillary networks [11].   
 
Since then, research in angiogenesis has focused primarily on understanding the 
molecular pathways that govern the angiogenic response in disease.  For example, 
vascular endothelial growth factor (VEGF) has emerged as a critical stimulus of EC 
proliferation, migration [12], and angiogenesis in the tumor microenvironment [13].  
 2 
In several disease states, an increase in tissue stiffness is associated with altered 
angiogenesis, i.e. new vessel formation that exhibits differences in function and 
structure compared to vessels in healthy tissue.  In diabetic wounds, where collagen 
glycation increases tissue stiffness [14], wound healing is impaired by deficient 
angiogenesis [15].  Moreover, in tumor growth, where tumors are associated with an 
increase in ECM stiffness [16], angiogenic vessels are tortuous and leaky [17].  These 
findings suggest that, in addition to the biochemical microenvironment, the 
biomechanical microenvironment plays a role in mediating capillary network 
assembly in disease.   
 
A hallmark of angiogenesis in vitro is the assembly of EC networks, a response where 
ECs self-organize into ring-like networks with a morphology reminiscent of capillary 
beds found in vivo [11,18].  Several studies suggest that EC network formation is 
sensitive to the stiffness of the microenvironment.  For example, while ECs assemble 
networks on compliant 2D fibrin and matrigel substrates, ECs decrease network 
formation on stiff fibrin gels [19] and on matrigel rigidified by polymerization with 
collagen I [20] or glycation [21].  Similarly, ECs exhibit a decrease in network 
formation on collagen gels made stiffer by increased collagen concentration [22] or by 
glycation [23].  In 3D, ECs seeded within fibrin or collagen gels decrease network 
assembly with increasing gel stiffness [24,25].  While these findings suggest that 
network assembly is associated with compliant, but not stiff, substrates, the role of 
matrix mechanics as a mediator of angiogenesis has not been fully described; it is 
unclear whether, or how, substrate stiffness regulates EC network assembly. 
 
Previous work indicating that EC network assembly is associated with compliant, but 
not stiff, matrices have been performed with protein substrates where the mechanical 
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properties are varied by changing protein concentration [19,22,26].  However, this 
approach may change the number or availability of cell-matrix binding sites that 
fundamentally alter EC behaviors [27], and makes it difficult to decouple the relative 
contributions of mechanics and chemistry in these systems.  To overcome these 
challenges, we have utilized polyacrylamide (PA) substrates, a system that allows 
independent variation of matrix stiffness and chemistry [26,28-31].  While PA 
substrates are typically inert to EC adhesion, they can be functionalized to display a 
protein at the substrate surface [32] that enables cell adhesion and allows for the 
independent variation of mechanical properties and surface chemistry [33].   
 
Understanding how substrate stiffness regulates EC network assembly is crucial for 
the control of angiogenesis.  This is an important consideration for the clinical 
prevention of angiogenesis in disease states that are associated with an increase in 
tissue stiffness, like tumorigenesis [16] and diabetes [34], or to promote angiogenesis 
to vascularize engineering constructs for replacement tissues. 
 
Mechanisms of Stiffness Sensing 
The control of capillary network assembly by the mechanical microenvironment 
requires that cells are aware of, and can respond to, matrix stiffness.  Adherent cells 
are capable of probing the stiffness of the local microenvironment [35], and “stiffness 
sensing” has been demonstrated in a variety of cell types including endothelial 
[20,30,36], smooth muscle [29,37], and transformed cells [38,39].  Substrate stiffness 
engages the mediators of cellular contractility that ultimately effect changes in cell 
behaviors that enable EC network assembly such as adhesion, spreading, and cell-cell 
interactions.  
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Substrate adhesion is enabled by integrins, heterodimeric transmembrane 
glycoproteins that mechanically link the cell to the ECM [40,41].  Integrins cluster 
into focal adhesions that anchor actin stress fibers, through a variety of adaptor 
proteins [42], to the plasma membrane.  Integrins thus serve as force transducers that 
can sense substrate stiffness, mediate cellular contractility, and enable 
mechanotransduction [43-48].   
 
Within cells, contractility is regulated in part by the Rho family of GTPases.  In 
general, Rho-Kinase (ROCK) is activated by Rho-GTP and alters the activity of 
myosin light chain kinase, an activator of myosin motor proteins [49].  Myosin motors 
interact with and tense actin stress fibers [50-52] that create cellular contraction that 
may be transmitted by integrins [53] to the ECM as traction forces [54].  In ECs, Rho-
mediated signaling is thought to facilitate stiffness sensing that enables angiogenic 
network assembly [55]. 
 
The Measurement of Cellular Traction Forces 
Cellular traction forces were first observed in seminal experiments as wrinkles or 
strains in flexible silicone rubber substrates [56].  Since then, several methods have 
been developed to quantify traction forces generated by adherent cells, including 
microfabricated post array detectors [57,58] or cantilevers [59], and micropatterned 
silicone elastomeric substrates [60]. 
 
In our own work, we have utilized a technique developed by Dembo and colleagues 
known as traction force microscopy (TFM) [61,62].  TFM is a tool that maps the 
magnitude, direction, and spatial orientation of traction stresses exerted by an adherent 
cell on a deformable substrate (PA gels).  This is done by tracking the displacement of 
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fiduciary markers (fluorescent beads) embedded within the deformable substrate with 
optical flow algorithms [62].  The displacements are translated into a strain field and 
traction stresses are computed using Bayesian statistics that determine the most likely 
traction fields that explain a given strain field [63].  In isolated ECs, the magnitude of 
traction stresses approaches 10 kPa [30]. 
 
The measurement of traction forces has elucidated the complex relationship between 
cell size, cell adhesion, and force generation.  In a variety of cell types, including ECs, 
there is a positive correlation between the magnitude of traction force and cell size 
[30,64].  As ECs spread, there is an increase in focal adhesion assembly [27], a 
response that requires cytoskeletal tension [65].  While focal adhesion size is 
dependent on the actin cytoskeleton [60], small nascent adhesions are capable of 
exerting large traction forces [31] that enable cell migration [66].   
 
Traction forces have been implicated in mediating cell-cell interactions and EC 
network assembly.  EC attachment to flexible ECM networks enables the development 
of traction forces and network assembly [67] that can be disrupted by inhibiting 
traction forces [22].  These traction force-mediated cell-matrix interactions are thought 
to create tension-based "guidance pathways" that allow ECs to sense each other at a 
distance and organize into multicellular structures [68].  It has been demonstrated that 
ECs sense and respond to the traction stresses exerted by adjacent cells causing 
alterations in cell migration and cell clustering [36].  These findings suggest that EC 
network assembly results in part from cellular contractility and traction forces that 
mediate cell adhesion, spreading, migration, and cell-ECM interactions; however these 
relationships are not well characterized. 
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Substrate Stiffness Mediates Cellular Responses that Enable Tissue Assembly 
Substrate stiffness has emerged as an important mediator of cellular responses like 
adhesion, spreading, and migration that are requisite for tissue assembly.  Stiff 
substrates promote an increase in focal adhesion organization [29,69-72] and support 
increases in cell spreading and actin stress fiber formation [26,71].  In addition, EC 
shape alters cell-cycle dynamics [73-77] that are critical determinants of growth 
[78,79]. 
 
Substrate stiffness and cell shape alter the polarization and alignment of actin stress 
fibers in cells [80,81].  The actin cytoskeleton is a critical determinant of cell shape, 
where the removal of a single actin stress fiber results in rearrangements in shape and 
cytoskeletal organization throughout the cell [51].  Importantly, EC shape alters the 
availability of Rho GTPase activating proteins [82] implicated in capillary formation 
in vitro and retinal angiogenesis in vivo [83].  These findings demonstrate crosstalk 
between substrate stiffness, actin cytoskeletal organization, and cell shape that 
facilitate cellular force balance [45], and suggest that substrate stiffness alters and 
enables capillary formation. 
 
Substrate stiffness has been shown to alter cellular traction forces and cell migration 
[37,84,85].  In fibroblasts, traction force generation increases with increasing substrate 
stiffness [70,86], and cells exhibit durotaxis, migration toward substrates of increasing 
stiffness [86].  In ECs, it is established that force increases linearly with cell area in 
response to changes in ligand density [30,31].  However, the relationship between 
substrate stiffness, cell area, and traction force generation is not well understood.  
Moreover, much of the work investigating EC traction forces has been performed on 
isolated cells, and traction force profiles, as well as the role of substrate stiffness in 
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mediating force profiles, of cells in contact are undefined. 
 
Substrate Stiffness Alters Preferences for Cell-Cell vs. Cell-Substrate Adhesion 
In addition to behaviors like adhesion, spreading, growth, and migration, preferences 
for cell-cell and cell-substrate interactions also enable tissue assembly.  Seminal work 
by Guo et al. hypothesized that substrate stiffness mediates a balance between cell-cell 
and cell-matrix adhesion that governs tissue assembly [87].  When tissue explants 
were plated on stiff substrates, cells from the explant migrated out of the tissue to 
cover the substrate.  In contrast, explants plated on compliant substrates did not exhibit 
the migration of cells out of the tissue.  It was proposed that these differences were 
due to preferences for cell-matrix vs. cell-cell adhesion that responded to substrate 
stiffness in order to optimize mechanical input.  For example, when cells sense a stiff 
substrate (where the substrate resistance to deformation is increased) cells prefer cell-
matrix interactions that provide a more optimal mechanical signal than cell-cell 
interactions.  In contrast, when cells sense a compliant substrate (where the substrate 
resistance to deformation is decreased), cells seek out cell-cell contacts that bolster 
mechanical input and thus prefer cell-cell rather than cell-matrix interactions. 
 
These findings suggest that, like integrins, the mediators of cell-cell interactions are 
capable of transmitting force.  Cell-cell adhesion is mediated in part by cadherins, 
transmembrane, calcium-dependent, intercellular adhesion proteins [88].  It has been 
demonstrated that cadherins are capable of transmitting traction forces [89,90], and 
that these forces require actomyosin activity [91].  Importantly, significant crosstalk 
exists between cadherins and integrins [92] that serve as mechanosensors during tissue 
morphogenesis [93].  In ECs, cell-cell adhesion is mediated in part by vascular 
endothelial (VE)-cadherin [94].  VE-cadherin-mediated cell-cell interactions alter 
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cytoskeletal tension [95], cell spreading, focal adhesion formation [96], and require 
actin cytoskeletal assembly and myosin activity [91].  In turn, changes in Rho-
mediated contractility influence cell-cell contacts [97].  These data suggest that 
cellular contractility is involved in feedback mechanisms that relate cell-cell and cell-
substrate adhesions. 
 
Taken together, these findings suggest that EC network assembly results from 
alterations in substrate stiffness-mediated preferences for cell-cell vs. cell-matrix 
interactions; however, it is not clear how substrate stiffness contributes to these 
interactions in capillary network assembly.    
 
Fibronectin Assembly is Requisite for Capillary Network Assembly 
EC network assembly is thought to be guided in part by the ECM [67].  During 
network assembly in 3D fibrin matrices, ECs require fibronectin (FN) matrix 
fibrillogenesis to promote cytoskeletal organization and actomyosin-dependent tension 
[98].  These findings implicate ECM FN as an important mediator of capillary 
network assembly.    
 
FN is a dimeric glycoprotein found in the ECM and basement membranes that is 
required for embryonic development [99] and cardiovascular tissue morphogenesis 
[100].  During FN matrix assembly, or polymerization, FN dimers are converted into 
an insoluble fibrillar matrix [101].  FN is assembled into fibrils by cells [102] through 
cell-generated forces that stretch and unfold dimer arms [103].  It is thought that Rho-
mediated contractility enables FN assembly by exposing cryptic self-assembly sites 
[104] in FN type III repeats, homology domains containing a β-sandwich structure that 
can be unfolded to a mechanically stable state [105]. 
 9 
In tissues, FN may contain extra domain B (EDB), a type-III homology domain 
resulting from differential exon splicing [106]. While essentially undetectable in 
normal adult tissues [107], EDB-FN is a specific marker for angiogenic blood vessels 
[108] and may be an important clinical target for localizing tumor vasculature [109].  
This has ramifications in cancer, where solid tumors are associated with an increase in 
tissue stiffness [16], alterations in local vasculature [110], and growth requiring 
neovascularization [111]. 
 
These data implicate EC traction forces in mediating FN assembly; however the 
relationship between ECs and FN deposition is unknown.  Furthermore, these data 
indicate that FN matrix assembly mediates capillary network assembly, and suggest 
that substrate stiffness alters EC-FN interactions that enable EC network assembly; 
however, the role of substrate stiffness in mediating EC-FN interactions unknown. 
 
Dissertation Organization 
The goal of this work is to investigate the role of substrate stiffness in regulating 
capillary network assembly.  We demonstrate that substrate stiffness regulates 
capillary network assembly and alters EC behaviors that enable network formation.  In 
Chapter 2, we determine that network assembly is controlled by plating cells on 
substrates that minimize cell-substrate adhesion.  Compliant (E<1 kPa), but not stiff 
(E>1 kPa), substrates promote the self-assembly of EC networks.  This work 
demonstrates that EC network assembly requires the polymerization of ECM FN that 
stabilizes cell-cell interactions.  This work is the first demonstration that substrate 
stiffness regulates capillary network assembly.      
 
In Chapter 3, we investigate the role of substrate stiffness in mediating cell-cell and 
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cell-matrix adhesion in ECs.  We determine that substrate stiffness alters the 
localization of VE-cadherin-mediated cell-cell adhesions and focal adhesion 
organization.  In addition, we determine that the response to stiffness during network 
assembly is not unique to ECs.  Analogous to ECs, mammary cells assemble into 
networks on compliant substrates and require laminin deposition.  Moreover, laminin-
deficient mammary cells are induced to assemble networks in the presence of 
exogenous laminin indicating that the ECM is a crucial regulator of tissue assembly.  
We determine that vascular, mammary, and mesenchymal cell network assembly on 
compliant substrates is associated with ECM colocalization and a reduction in cell-
matrix adhesion.  This work is the first demonstration that compliant substrates 
promote network assembly in a variety of cell types by altering cell-cell and cell-
matrix adhesion, and cell-matrix colocalization.  
 
In Chapter 4, we investigate the relationship between substrate stiffness, cell area, and 
traction force generation in ECs.  We determine that substrate stiffness and cell area 
are both significant predictors of traction force generation during cell-cell contact.  
This work is the first demonstration that substrate stiffness contributes to force 
generation during endothelial cell-cell interaction.        
 
In Chapter 5, we investigate the role of substrate stiffness in mediating FN deposition.  
We determine that substrate stiffness alters the deposition of FN through changes in 
cell shape and ROCK-mediated traction forces.  Furthermore, we determine that 
substrate stiffness alters the synthesis and deposition of EDB-FN, an FN isoform 
specific to neovasculature.  This work is the first demonstration that the mechanical 
microenvironment plays a role in mediating EC-FN interactions. 
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In Chapter 6, conclusions and future directions are presented.  Chapter 7 overviews 
my experience as an NSF STEM Fellow in GK-12 Education, where we developed 
laboratory activities and taught a science curriculum to local middle school students 
that focused on polymer science.  
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CHAPTER 2 
 
A BALANCE OF SUBSTRATE MECHANICS AND MATRIX CHEMISTRY 
REGULATES ENDOTHELIAL CELL NETWORK ASSEMBLY  
 
Published in Cellular and Molecular Bioengineering [112]
1
. 
Selected as an Outstanding Paper from the 2008 Biomedical Engineering Society 
(BMES) Annual Meeting [113]. 
 
2.1 Abstract 
Driven by specific extracellular matrix cues, endothelial cells can spontaneously 
assemble into networks.  Cell assembly is, in part, dictated by both substrate stiffness 
and extracellular matrix chemistry; however, the balance between substrate mechanics 
and matrix chemistry in promoting cell assembly is not well understood.  Because 
both mechanics and chemistry can alter cell-substrate and cell-cell adhesion, we 
hypothesized that cell assembly can be promoted on substrates that minimize cell-
substrate adhesivity while promoting cell-cell connections.  To investigate these 
hypotheses, bovine aortic endothelial cells (EC) were seeded on variably compliant 
polyacrylamide (PA) substrates derivatized with type I collagen and observed over 
time.  Our results indicate that cell assembly can be induced on substrates that are 
sufficiently compliant (E=200 Pa) and present significant amounts of substrate-bound 
ligand, and on substrates that are stiffer (E=10000 Pa) but which present less adhesive 
ligand.  In both of these cases, cell-substrate adhesivity is decreased, which may 
enhance cell-cell adhesivity.  Moreover, our data indicate that fibronectin 
polymerization stabilizes cell-cell contacts and is necessary for network formation to 
                                                 
1
 Figure 2.9 contributed by Tracy Cheung.  
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occur regardless of substrate compliance or the density of substrate-bound ligand.  
These data demonstrate the balance between substrate mechanics and chemistry in 
directing cell assembly. 
 
2.2 Introduction 
Angiogenesis is the process of new blood vessel formation.  Regulated by factors 
including shear stress, growth factors, and cytokines, endothelial cells (EC) migrate 
from pre-existing vessels, proliferate, and differentiate to form new blood vessels [3].  
The extracellular matrix (ECM), which includes collagen and fibronectin (FN) 
[114,115], provides ECs with chemical and mechanical cues that drive migration and 
invasion [116], events integral to new vessel formation.  While these events occur in 
vivo, ECs can be induced to assemble into capillary-like networks that mimic 
angiogenesis in vitro [117] under the appropriate conditions.  Because vascularization 
is critical to most successful tissue engineering, understanding and controlling these 
conditions may be critical to the in vitro development of transplantable organs.   
 
Cell assembly has been shown to be influenced by ECM protein type [118,119], ECM 
concentration [120,121] and substrate stiffness [122,123] through their effects on cell 
shape [124], motility, and differentiation [125].  Tissue formation may arise from the 
optimization of mechanical and chemical input from both cell-cell cohesivity and cell-
substrate adhesivity [126,127].  Recent evidence suggests that cellular organization 
may be directed in part by substrate mechanics; in contrast to compliant substrates, 
rigid gel substrates promote cytoskeletal and focal adhesion organization and cell 
spreading [128].  On compliant substrates, cells tend to aggregate rather than migrate 
away from each other.  Substrate mechanics may have a direct effect on EC sorting 
and subsequent in vitro organization.  Recent data from our lab suggests that ECs on 
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compliant substrates prefer cell-cell connections and cluster while those on stiff 
substrates prefer cell-substrate connections and migrate away from each other [36].  
ECs exhibit an increase in projected area and the appearance of actin stress fibers with 
increasing substrate stiffness [129], and others have suggested that EC capillary 
morphogenesis may be modulated by a balance between substrate stiffness and 
traction force generation [123].  Taken together, these data indicate that substrate 
compliance can directly affect cell organization. 
 
Endothelial cell assembly is further influenced by ECM concentration.  EC attachment 
increases with increasing collagen concentration and promotes the formation of 
capillary networks at intermediate adhesivity [120].  It has been suggested that FN 
may control EC assembly by supporting tension-dependent cell shape changes [130].  
While it is well accepted that both matrix chemistry and mechanics affect endothelial 
network formation, the balance between substrate mechanics and matrix chemistry in 
promoting EC assembly is not well understood. 
 
In this study, the effects of substrate mechanics and matrix chemistry on EC adhesion 
were investigated to understand the integration of mechanical and chemical signals 
that mediate cell assembly and network formation.  Bovine aortic ECs were seeded on 
variably compliant polyacrylamide (PA) substrates derivatized with type I collagen.  
Our results indicate that cell assembly occurs on compliant substrates and not on stiff 
substrates at a high concentration of matrix collagen, that cell assembly is induced on 
stiff substrates by lowering the concentration of collagen, and that overall cell 
assembly is dependent on the ability of ECs to polymerize FN.  These results indicate 
that ECs may integrate mechanical and chemical cues to achieve a balance in cell-cell 
vs. cell-substrate adhesion; when cell-substrate adhesivity is low, cell-cell connectivity 
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is increased, and conversely, when cells are firmly adherent to a substrate, they are 
less likely to assemble. 
 
2.3 Materials and Methods 
Coverslip Activation 
Coverslips were prepared as previously described [131,132].  Square glass coverslips 
(No. 2, 22 x 22mm, VWR, West Chester, PA) were passed through the flame of a 
Bunsen burner, coated with 0.1 N NaOH (Sigma-Aldrich, St. Louis, MO), and allowed 
to dry.  The coverslips were coated with 3-aminopropyl-trimethoxysilane (Sigma-
Aldrich, St. Louis, MO), washed in 18.2 MΩcm purified deionized water, and 
incubated with a coating of a 0.5% solution of glutaraldehyde (70% aqueous stock 
solution, Sigma-Aldrich, St. Louis, MO) in phosphate-buffered saline ((PBS), 
Invitrogen, Carlsbad, CA) at room temperature for 30 minutes.  The coverslips were 
washed with 18.2 MΩcm purified deionized water and allowed to dry overnight. 
 
Poly(acrylamide) Gel Synthesis 
Gels of various Young’s Moduli (E=200, 1000, 2500, 5000, and 10000 Pascals) were 
synthesized by varying the ratio of acrylamide to bis-acrylamide in the gel solution 
mixture [129].  Gel mixtures were prepared with 3-7.5% acrylamide (40% w/v 
solution), 0.04-0.35% N,N’-methylene-bis-acrylamide (2% w/v solution), 0.05% 
N,N,N,N-tetramethylethylenediamine (Bio-Rad, Hercules, CA), and 30 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid ((HEPES), pH 6.0, Sigma-Aldrich, St. 
Louis, MO).  The solutions were adjusted to pH 6.0 with 2N HCl (Sigma-Aldrich, St. 
Louis, MO) and degassed for 30 minutes.  Additional solution components were 20 
µmol/ml N-6-((acryloyl)amido)hexanoic acid ((N-6), synthesized in our lab according 
to the method of Pless et al. [133]) dissolved in ethanol (Sigma-Aldrich, St. Louis, 
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MO), and 2% 0.5 µm diameter fluorescent beads (Molecular Probes, Carlsbad, CA). 
Polymerization was initiated by the addition of a 0.1% ammonium persulfate (Bio-
Rad, Hercules, CA) solution in water to the acrylamide mixture.  20 µl of the mixture 
was pipetted onto an activated coverslip and a circular coverslip (No. 2, 18 mm 
diameter, VWR, West Chester PA) was used to flatten the drop.  Polymerization was 
allowed to occur for 30 minutes at room temperature.  The circular coverslip was 
removed, and the gel was incubated with 1, 5, 10, 50, or 100 µg/ml of type I rat-tail 
collagen (Becton Dickinson, Franklin Lakes, NJ) in HEPES (pH 8.0, Sigma-Aldrich, 
St. Louis, MO) for two hours at 4°C.  The un-reacted N-6 linker was capped with 
0.1% ethanolamine (Sigma-Aldrich, St. Louis, MO) in HEPES (pH 8.0, Sigma-
Aldrich, St. Louis, MO).  Gels were washed with sterile PBS and stored in six-well 
plates. 
     
Cell Culture 
Bovine aortic ECs were maintained at 37°C and 5% CO2 in Medium 199 (Invitrogen, 
Carlsbad, CA) supplemented with 10% FetalClone III (HyClone, Logan, UT), and 1% 
each of penicillin-streptomycin, MEM amino acids (Invitrogen, Carlsbad, CA), and 
MEM vitamins (Mediatech, Manassas, VA).  ECs were used from passages 8-12. 
 
Fibronectin Inhibitor and Control 
Fibronectin polymerization was inhibited by adding 500 nM pUR4B (a kind gift from 
Dr. Jane Sottile) to the EC suspension just prior to gel plating.  500 nM III-11C was 
added to the EC suspension to serve as a control to pUR4B [134,135] (also a kind gift 
from Dr. Sottile).   
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EC Network Assembly, Area, and Perimeter Studies 
ECs were plated on gels of various Young’s Moduli (200-10000 Pa) at a density of 
100,000 or 200,000 cells per well of a six-well plate for cell-assembly studies and 
50,000 cells per well for area and perimeter studies.  10X magnification images of 
cells were captured with an Olympus IMT-2 inverted phase contrast microscope with 
a QImaging Retiga 1300 camera or a Zeiss Axio Observer D1m inverted phase 
contrast microscope with an AxioCam camera for the duration of the experiment.  
Media were replenished every other day. 
 
For cell-assembly studies, aspect ratios of ECs within a network morphology were 
measured with ImageJ (version 1.37, available from the National Institutes of Health, 
Bethesda, MD, at http://rsb.info.nih.gov/ij/).  The aspect ratio was defined as the ratio 
of straight line-segment lengths drawn onto images of ECs corresponding to the long 
and short axis of the cells.  Aspect ratio measurements were constrained to ECs that 
were in contact with at least two additional cells.  Data were measured and pooled into 
two groups (n = 150 for each condition) representing the presence or absence of cell 
assembly across multiple experiments and time points.  For area and perimeter studies, 
ImageJ was used to outline and quantify cells.  Area and perimeter measurements 
were constrained to ECs that were not in contact with any other cells in pre-network, 
sub-confluent cultures.  Data were measured (n = 50 for each gel compliance) across 
multiple experiments at 24 hours after plating. 
 
Statistical Analysis of Assembly, Area, and Perimeter Measurements 
The natural log of aspect ratios, cell area, and cell perimeter measurements were taken 
to ensure normality of the data.  Data were compared with analysis of variance and 
Tukey’s Honestly Significantly Different test or Student’s t test (Figure 2.8D only) in 
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JMP software (v.7, SAS, Cary, NC).   
 
Immuno- and Fluorescent Staining for Fibronectin Localization 
ECs on PA gels were fixed in 3.7% formaldehyde (Mallinckrodt Baker, Phillipsburg, 
NJ) at 4°C overnight and washed with PBS as described elsewhere [136].  Samples 
were incubated with 1% Triton in PBS and 0.02% Tween (Mallinckrodt Baker, 
Phillipsburg, NJ)/1% bovine serum albumin ((BSA), Sigma-Aldrich, St. Louis, MO) 
in PBS for one hour.  Gels were incubated 1:50 with a mouse monoclonal fibronectin 
primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA) in PBS/3% BSA in a 
humidified chamber at 4°C overnight.  A 1:200 fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse secondary antibody (Santa Cruz Biotechnology, Santa 
Cruz, CA) in PBS/3% BSA was applied to the samples for one hour at room 
temperature.  EC filamentous actin was stained with Alexa Fluor 546 phalloidin 
(Molecular Probes, Carlsbad, CA) 1:25 in PBS and nuclei were stained with 4',6-
diamidino-2-phenylindole ((DAPI), Sigma-Aldrich, St. Louis, MO) 1:10 in 18.2 
MΩcm purified deionized water.  Fluorescent localization was visualized with a Zeiss 
Axio Observer Z1m with a Hamamatsu ORCA-ER camera.  Images were pseudo-
colored with Axiovision software v. 4.6. 
 
2.4 Results  
Compliant Substrates Promote EC Network Assembly 
Previous data suggest that compliant substrates promote cell assembly of a variety of 
cell types [118,126], including ECs [122,123].  However, in EC network formation, 
the relative contributions of matrix mechanics and chemistry are unclear.  PA gels 
permit the independent manipulation of the substrate stiffness and matrix chemistry to 
study the effects of mechanics and chemistry on cell assembly [126,128].  Here, PA 
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gels were synthesized with Young’s Moduli of 200, 1000, 2500, 5000, and 10000 Pa, 
derivatized with 100 μg/ml of type I collagen, and seeded with ECs.  On 200 and 1000 
Pa gels, ECs organized into two-dimensional (2D) network structures characterized by 
cords and looping-cell morphologies (Figures 2.1A and 2.1B, respectively), often seen 
in tube formation assays.  Cords and loops of ECs presented as early as 24 hours after 
plating and endured for the duration of the experiment.  On stiffer gels (2500, 5000, 
and 10000 Pa), ECs failed to assemble into cords or loops and appeared uniformly 
distributed throughout the course of observation (Figures 2.1C-2.1E, respectively). 
 
Figure 2.1.  Compliant substrates derivatized with collagen promote EC network 
assembly. 
(A and B) Phase contrast images of ECs on PA gels derivatized with 100 g/mL of 
collagen I assemble into networks on 200 and 1000 Pa substrates, respectively.  This 
phenotype was characterized by cords of cells and ring-like morphologies.  (C–E) 
This organization was not present when substrate stiffness was increased to 2500, 
5000, and 10,000 Pa, respectively.  Scale bars are 50 m. 
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In addition to collagen, we investigated the role of substrate stiffness in mediating 
network assembly on substrates derivatized with FN (Figure 2.2) and an RGD 
sequence-containing peptide (Figure 2.3).  These data indicate that compliant 
substrates promote network assembly independent of ligand type.   
 
 
Figure 2.2.  Compliant substrates derivatized with FN promote EC network 
assembly. 
ECs were plated on variably compliant (E=0.2-10 kPa) substrates derivatized with 100 
g/mL fibronectin (FN).  After 24 hours, ECs on 0.2-1 kPa substrates began to form 
cords and lacunae, hallmarks of developing networks.  Networks continued to develop 
over 48-96 hours after plating.  In contrast, cells on 2.5-10 kPa substrates did not 
assemble networks but were instead uniformly distributed.  Scale bars are 100 m.  
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Figure 2.3.  Compliant substrates derivatized with RGD promote EC network 
assembly. 
ECs were plated on compliant (E=0.2 kPa) and stiff (E=10 kPa) substrates derivatized 
with 100 g/mL of an RGD sequence-containing peptide (NH2-YAVTGRGDS-OH, 
ChemPep, Wellington, FL).  The RGD sequence is found in FN and mediates integrin-
FN attachment [137].  (A) Similar to collagen-derivatized substrates, ECs self-
assembled into networks characterized by clusters (*) and cords (arrow head) of cells 
on compliant substrates.  (B) On stiff substrates, networks did not form and cells were 
uniformly distributed across the substrate.  Scale bars are 100 m.  
 
Time lapse microscopy of cell assembly on compliant gels indicated that early cords 
or line segments of processional ECs branched between nodes of cells and matured 
into closed-loop ring patterns of cells over time.  Cells were observed to sprout from 
cords to create additional connections (Figure 2.4). 
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Figure 2.4.  Network development over time. 
Time-lapse images of EC network development over an 18 hour period.  T = 0 
corresponded to 96 hours after PA gel seeding.  Networks developed as cords of cells 
that joined together to form 2D ring-like morphologies over time.  Circled regions 
highlight ECs that formed an additional connection (arrow) by sprouting from existing 
cords.  Time in hours.  Scale bar is 50 m. 
 
Cell Network Assembly is Induced on Stiff Substrates by Decreasing Collagen I 
Concentration  
Because ECs tended to form networks on compliant gels where cells are also less 
spread and adherent, we hypothesized that a decrease in cell-substrate adhesivity 
enhances cell assembly.  To test this hypothesis, PA gels of varying stiffness were 
synthesized and conjugated with decreased collagen (1 μg/ml) to decrease cell-
substrate adhesivity relative to substrates conjugated with 100 μg/ml of collagen.  
Notably, lowering the concentration of collagen I shifted cell assembly to gels of 
2500, 5000, and 10000 Pa (Figures 2.5B-2.5D, respectively), where it was not seen 
 23 
previously on gels with increased collagen (see Figures 2.1C-2.1E).  Cord 
development occurred on 2500 and 5000 Pa gels as well (Figures 2.5B and 2.5C, 
respectively) but qualitatively did not develop into looping morphologies as complete 
as those on 10000 Pa gels (Figure 2.5D).  On 200 and 1000 Pa gels, ECs were 
adherent to the gel but retained a rounded morphology (Figure 2.5A), and thus were 
unable to form loops.  It should be noted that while decreasing the substrate adhesivity 
on a stiff gel increased network assembly, cell assembly on stiffer gels derivatized 
with 1 μg/ml of collagen I were less extensive than assemblies formed at 100 μg/ml on 
compliant gels. 
 
Figure 2.5.  Cell network assembly is induced on stiff substrates by decreasing 
collagen concentration. 
(A) ECs on PA gels derivatized with 1 g/mL of collagen I showed limited spreading 
and an inability to organize into networks but remained adherent to the gel.  (B–D) 
Cell network assembly was shifted to 2500, 5000, and 10,000 Pa gels, respectively, in 
comparison to cells on gels derivatized with 100 g/mL collagen.  Scale bar is 50 m. 
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Similar to decreased collagen concentration, network assembly was induced on stiff 
substrates by decreasing concentrations of FN (Figure 2.6) and an RGD-containing 
peptide (Figure 2.7).   
 
Figure 2.6.  Network assembly is induced on stiff substrates by decreasing FN 
concentration. 
ECs were plated on variably compliant (E=0.2-10 kPa) substrates derivatized with 1 
g/mL FN.  On 0.2-2.5 kPa substrates, network assembly did not occur but cells 
instead formed aggregates over 96 hours.  Similar to results found with collagen, 
network assembly was induced on stiffer 5-10 kPa substrates.  Scale bars are 100 m.  
 
 
Figure 2.7.  Cell-cell adhesion is induced on stiff substrates by decreasing RGD 
concentration. 
ECs were plated on variably compliant (E=0.2-2.5 kPa) substrates derivatized with 1 
mg/mL of an RGD-sequence containing peptide (NH2-YAVTGRGDS-OH).  After 96 
hours, cells on 0.2 kPa substrates were not well spread.  On 1 kPa substrates, cells 
began to form clusters and formed network-like cords on 2.5 kPa substrates.  Scale bar 
is 100 m.  
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Taken together, these data indicate that compliant substrates foster network assembly 
regardless of matrix ligand type, and that network assembly results from a balance of 
substrate stiffness and matrix chemistry. 
 
Ratio of Area to Perimeter Correlates with EC Assembly 
To explore the mechanism of cell assembly, we measured changes in cell morphology 
as a function of gel modulus and ligand density.  Area and perimeter measurements 
were limited to ECs that were not in contact with any other cells in pre-network, sub-
confluent cultures.  Cell area (Figure 2.8A, white bars) and perimeter (Figure 2.8B, 
white bars) increased with increasing substrate stiffness.  When the collagen 
concentration was decreased to 1 μg/ml, the cell area (Figure 2.8A, black bars) and 
perimeter (Figure 2.8B, black bars) decreased.  Cell adhesion and spreading were 
insufficient to measure on 200 and 1000 Pa gels derivatized with only 1 μg/ml 
collagen.  Notably, area and perimeter alone were not necessarily predictors of cell 
assembly as cell areas of statistical similarity were observed in cases of both the 
presence and absence of cell assembly (e.g. Figure 2.8B, compare the statistically 
similar 2500 Pa gel white bar, where networks did not form, to the 5000 Pa gel black 
bar, where networks did form).  However, it was determined that the ratio of EC area 
to perimeter did correlate with cell assembly.  Sub-confluent ECs with a significantly 
lower ratio of area to perimeter developed into network structures (Figure 2.8C, below 
the dashed line), whereas those with a higher ratio typically did not form network 
structures (Figure 2.8C, above the dashed line).  Therefore, the ratio of area to 
perimeter appeared to be a predictor of future EC assembly, where rounder cells were 
less likely to form spontaneous networks. 
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Assembled ECs have an Increased Aspect Ratio 
To quantify cell assembly, observed in Figures 2.1 and 2.4, the aspect ratio of ECs in 
cell assemblies was measured (Figure 2.8D).  The aspect ratio was defined as the ratio 
of the long axis to the short axis of ECs making at least two cell-cell contacts.  The 
aspect ratio of ECs assembled in cords or loops (Figure 2.8D, starred (+) bar) was 
significantly different than the aspect ratios of ECs not arranged in networks (Figure 
2.8D, (-) bar).  Cell assembly was not quantified by more traditional methods 
including skeletonizing the micrographs [123] or measuring lengths of cords [138], 
because in our samples cell assembly was most extensive approximately four days 
after plating when cells on stiffer substrates were 100% confluent, and these 
measurements could not be done.  
 
 
 
Figure 2.8.  Ratio of area to perimeter 
predicts EC network assembly. 
(A and B) Cell area and perimeter increase on 
PA gels derivatized with 100 g/mL of type I 
collagen with an increase in substrate stiffness 
(white bars).  Cell area and perimeter was 
reduced by lowering the collagen I 
concentration to 1 g/mL but still increased 
with substrate stiffness (black bars; insufficient 
spreading to measure on 200 and 1000 Pa gels).  
(C) Measurements of ratios of EC area to 
perimeter showed statistical significance 
between the occurrence (bars below dashed 
line) and absence (bars above dashed line) of 
cell network assembly.  Note that the 
occurrence and absence of cell network 
assembly show statistical similarity within each 
group.  (D) Aspect ratios showed statistical 
significance between the occurrence (+) and 
absence (-) of cell network assembly.  ‘‘*’’ 
Indicates p<0.001, +/- indicates the presence or 
absence of cell network assembly, respectively.  
Mean + SEM. 
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With the help of Tracy Cheung, we also characterized the role of substrate stiffness in 
mediating EC proliferation (Figure 2.9).  Our data indicate that proliferation increases 
with increasing substrate stiffness over time, and that proliferation rate is dependent on 
ligand concentration.   
 
Figure 2.9.  Substrate stiffness and ligand concentration alter EC proliferation. 
ECs were plated on variably compliant (E=0.2-10 kPa) substrates derivatized with 100 
or 1 g/mL collagen I.  To measure proliferation, Tracy Cheung painstakingly imaged 
the entire substrate and counted cells at each time point.  (A) On substrates derivatized 
with 100 mg/mL collagen, cell proliferation increased with time and with substrate 
stiffness.  (B) On substrates derivatized with 1 g/mL collagen, cells failed to 
proliferate on 0.2-10 kPa substrate.  On 2.5-10 kPa substrates, proliferation increased 
over time and was greatest on 5 kPa substrates, but was less than proliferation 
observed on  substrates derivatized with 100 g/mL collagen. 
 
FN Fibers Colocalize with EC Network Assembly 
Recent data suggest that FN is required for EC assembly in 3D [139].  While it is 
known that cell spreading and FN polymerization are linked [140], and spreading 
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increases with matrix stiffness [129], it is unclear how matrix stiffness affects FN 
polymerization during cell assembly.  To assay for the presence of FN in networks 
formed on 2D compliant gels, ECs on PA gels of varying compliance were stained 
with a FITC-conjugated anti-fibronectin antibody.  FN fibrils colocalized with ECs 
organized into networks (Figure 2.10A) whereas FN was uniformly distributed in 
samples where networks did not form (Figure 2.10B).  Interestingly, FN also 
colocalized with networks formed on gels conjugated with decreased collagen, 
however the FN appeared more web-like (Figure 2.10C) in comparison to the FN 
fibrils formed by cells in networks on compliant gels. 
 
Figure 2.10.  FN colocalizes with EC network assembly. 
PA gels of 200, 1000, 2500, 5000, and 10,000 Pa were derivatized with 100 g/mL of 
type I collagen and plated with ECs. Samples were fixed and stained with a FITC-
conjugated anti-fibronectin antibody.  (A) ECs assembled into cords and loops that 
were colocalized with FN.  (B) FN was uniformly distributed in samples where 
networks did not form.  (C) FN signal appeared web-like on 10,000 Pa gels when the 
collagen I concentration was lowered to 5 or 10 g/mL.  Scale bar is 50 m. 
 
ECs Do Not Require Exogenous FN to Assemble into Network-like Structures  
Because EC assembly was associated with FN (see Figure 2.10A), and others’ data 
suggest that cell assembly proceeds independently of exogenous layers of ECM [118], 
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we sought to determine whether serum-derived FN was necessary for 2D cell 
assembly on compliant substrates.  ECs were seeded on variably compliant PA gels 
derivatized with collagen, either in the presence of media with fibronectin-free serum 
(experimental condition) or in the presence of media with complete serum (control).  
FN-free media appeared to have no effect on cell assembly at a high collagen I 
concentration (100 μg/ml, as depicted in Figure 2.1), however cell assembly on stiff 
10000 Pa gels derivatized with low amounts of collagen was shifted to gels derivatized 
with 5 and 10 μg/ml of collagen I where it was previously seen at 1 g/ml.  Despite 
the lack of exogenous FN in the media, FN staining still colocalized with networks of 
cells, indicating cells were secreting and polymerizing their own FN (Figure 2.11). 
 
 
 
 
 
 
Figure 2.11.  ECs do not require exogenous FN to 
assemble into network-like structures. 
ECs were seeded on PA gels and derivatized with 
collagen I in media with FN-free serum (a gift from 
Dr. Jane Sottile; experimental condition) or in media 
with complete serum (control).  Samples were 
seeded with ECs and stained with a FITC-
conjugated anti-FN antibody.  In the presence of 
media containing FN-free serum, cell network 
assembly occurred on 200 and 1000 Pa gels and was 
associated with FN staining.  Scale bar is 50 m. 
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EC Assembly on Compliant Substrates Requires FN Polymerization 
Our data indicate that EC assembly is associated with FN deposition (Figure 2.10) and 
yet is independent of exogenous FN from serum (Figure 2.11).  To determine whether 
FN polymerization is requisite for cell assembly, 500 nM pUR4B, a fibronectin 
polymerization inhibitor, or a control peptide, III-11C [134,135], was added to 
cultures on variably compliant PA gels. 
 
In the presence of the FN polymerization inhibitor, no networks formed on any type of 
gel, whereas in the presence of the control peptide, networks formed under the same 
conditions where they formed previously.  On 200 Pa gels, where EC networks 
typically form, EC assembly was very transient in the presence of pUR4B (Figure 
2.12A).  Cells were adherent and appeared to form small cords, but ECs in this 
configuration were not seamlessly well connected and were generally rounded in 
shape, unlike those observed on 200 Pa gels without the inhibitor.  Time lapse images 
revealed that ECs on 200 Pa gels treated with pUR4B appeared more motile than 
control cells in networks (data not shown) and failed to develop stable assemblies of 
cords or loops; instead, transient cell-cell connections formed that disassembled over 
time (Figure 2.12A).   
 
Immunostaining of cells treated with FN inhibitor revealed a punctuate distribution of 
FN surrounding the cells (Figure 2.12B).  This was in stark contrast to the fibrils 
formed between cells when the inhibitor was not added (see Figure 2.10). 
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Figure 2.12.  EC network assembly on compliant substrates requires FN 
polymerization. 
(A) ECs were seeded on PA gels with media containing 500 nM pUR4B FN 
polymerization inhibitor or 500 nM III-11C control peptide (gifts from Dr. Jane 
Sottile).  On 200 Pa gels in the presence of pUR4B, EC network assembly was 
disrupted with regions of transient assembly.  Time-lapse images over a 17 hour 
period revealed that ECs treated with pUR4B failed to develop complete network 
structures; instead, cell clusters made transient cell–cell connections that disassembled 
over time.  T = 0 corresponded to 48 hours after plating.  Time in hours.  (B) On 1000 
and 10,000 (1 g/mL of collagen I) Pa gels, cell network assembly was ablated in the 
presence of pUR4B.  FN surrounding cells treated with pUR4B appeared punctate.  
Scale bars are 50 m. 
 
Interestingly, individual, subconfluent cells on stiffer, 2500 and 10000 Pa gels 
conjugated with 100 μg/ml of collagen, that normally would not form networks, when 
treated with FN polymerization inhibitor, displayed a morphology that was typically 
indicative of future cell assembly (Figure 2.13).  Cells were more elongated and 
spindle-shaped.  However, despite this pre-network-like morphology, these cells did 
not form networks.  Time-lapse microscopy of cells on these substrates in the presence 
of FN inhibitor indicated that cells formed connections and elongated, but upon 
elongation, the connection between cell tethers either broke or one of the cells released 
from the substrate and rounded up (Figure 2.13).  In the presence of FN inhibitor, 
these cells displayed impaired cell-cell and cell-substrate adhesion, perhaps attributed 
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to their cell shape change and inability to form stable cell-cell connections. 
 
 
Figure 2.13.  Inhibiting FN polymerization disrupts the balance between cell–cell 
and cell–substrate adhesivity. 
ECs were seeded on 10,000 Pa gels conjugated with 100 g/mL of collagen I in the 
presence of FN polymerization inhibitor and recorded using time-lapse microscopy.  
When FN polymerization is inhibited, cells appear more elongated and spindle-shaped 
with long cell–cell connections (arrows) which are typical of cells prior to network 
formation.  However networks do not form; cell–cell connections are transient and 
tend to break and/or result in cells rounding and releasing from the substrate (asterisk).  
Time in minutes.  Scale bar is 50 m. 
 
2.5 Discussion 
To investigate the balance of substrate mechanics and matrix chemistry in mediating 
EC assembly, variably compliant PA gels were synthesized and derivatized with two 
(high and low) concentrations of type I collagen.  Cell assembly occurred on 200 and 
1000 Pa gels, and not on 2500, 5000, or 10000 Pa gels when the collagen 
concentration was 100 μg/ml.  Cell assembly was shifted to stiffer gels (2500, 5000, 
and 10000 Pa) when the concentration of collagen was lowered to 1 μg/ml.  We 
hypothesize that EC assembly results from a balance between cell-cell and cell-matrix 
interactions as modulated by substrate stiffness and ECM matrix chemistry, and that 
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cell assembly results from an optimization of mechanical input [126]. 
 
The formation of cell assemblies due to substrate stiffness may be due to an alteration 
of associated focal adhesion and cytoskeletal proteins that mediate cell-substrate 
interactions through a tactile-sensing feedback mechanism linked to adhesion and net 
contractile forces [35].  It is well established that focal adhesion size and number and 
stress fibers are reduced on compliant substrates [129] and substrates with less ligand 
available to bind [128].  Cell assembly is disrupted when traction forces are inhibited 
[119], and it has been shown that a decrease in substrate rigidity, through a decrease in 
collagen content, induces EC cord-like morphologies with associated decreased 
concentrations of actin, talin, and vinculin [122].  Additionally, type I collagen 
mediates capillary cell assembly via β1 integrin-activated Src and Rho activation that 
disrupts VE-cadherin interactions at the cell-cell junctions and induces actin stress 
fibers [141].  Changes in these cell-cell-, cell-substrate-, and cytoskeletal-associated 
proteins may affect cell-generated tensile forces based on ECM density; high ECM 
density promotes cell spreading while lower concentrations permit EC shape changes 
that promote capillary tube formation [124].  Changing the density of ECM attachment 
sites causes cell shape changes that can affect differentiation of capillary cells [73,130] 
resulting in enhanced tube formation [142].  These results suggest that on a high 
collagen concentration-derivatized compliant substrate, and on a low collagen 
concentration-derivatized stiff substrate (conditions that promoted EC assembly), 
inadequate mechanical input, as mediated by substrate stiffness and matrix ligand 
concentration, drove ECs to prefer cell-cell contacts that increased mechanical input 
and fostered cell assembly. 
 
FN polymerization colocalizes with EC networks.  It was shown previously that tube 
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formation was associated with FN [143,144] and that ECs form networks of cords 
independent of exogenous layers of ECM [118].  Cell assembly on PA gels was 
associated with FN deposition and independent of exogenous soluble FN.  On stiff 
10000 Pa gels, a low collagen concentration resulted in cell assembly with or without 
FN-containing serum used in the media.  This result suggests that a decreased 
adhesivity (due to a decreased collagen concentration), and not soluble ECM, induced 
cell assembly.  The inhibitor pUR4B is a 49-mer peptide that binds to, and inhibits, 
FN matrix polymerization [134] by interfering with the interaction of FN and 
molecules at cell-surface assembly sites [145].  It has been suggested that FN 
polymerization is integral to maintaining ECM FN [146], and it has been shown to 
regulate neovessel formation by supporting cytoskeletal organization and the 
development of actomyosin-dependent tension [139].  Our data further show that EC 
2D cell assembly requires FN polymerization.  Figure 2.12A indicates that EC plated 
on 200 Pa gels, where networks normally form, when treated with pUR4B form 
transient assemblies characterized by rounded cells.  Time lapse images revealed that 
these ECs appeared more motile, and made transient cell-cell connections compared 
with control cells in networks.  These results suggest that ECs require FN 
polymerization to stabilize cell-cell interactions that promote cell assembly.  While 
pericellular FN polymerization plays a role in 3D neovascularization [139] that may 
occur during angiogenesis, both the combination of a compliant substrate that drives 
EC proximity, and FN polymerization which stabilizes cell-cell contacts, facilitate EC 
2D assembly.   
 
Our data also indicate that FN polymerization plays a key role in the balance between 
cell-cell and cell-substrate adhesion that drives network assembly.  When ECs are 
unable to polymerize FN, their ability to spread is impaired [140], therefore the cells 
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are generally smaller, appear more spindle-shaped and appear to be less adherent to 
the substrate.  When cell-substrate adhesion is decreased, cells typically shift the 
balance to cell-cell adhesion [127],  and increased cell assembly and aggregation.  So 
we might expect that by inhibiting FN polymerization, cell assembly might increase 
due to a decrease in cell spreading and cell-substrate adhesion.  However, FN 
polymerization also appears to reinforce cell-cell connections (Figure 2.12).  
Therefore, when FN fibril formation is inhibited, cell-cell adhesions are unstable and 
transient.  Clearly, there exists a balance where FN polymerization supports and 
strengthens the formation of stable cell-cell contacts without enhancing cell spreading 
to the extent that cell-cell contact is no longer preferred over cell-substrate adhesion. 
 
Together, these data indicate that substrate mechanics or decreased cell-substrate 
adhesivity through changes in matrix density can drive cells into a network-like 
assembly, and FN polymerization is required to form stable cell-cell contacts.  These 
results should help further guide the design of biomaterials intended to foster 
angiogenesis. 
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CHAPTER 3 
 
SUBSTRATE STIFFNESS ALTERS CELL-CELL AND CELL-MATRIX 
INTERACTIONS THAT REGULATE NETWORK ASSEMBLY  
 
Portions of this chapter are in preparation for submission.
1,2
 
 
3.1 Abstract 
Tissue formation arises from a complex interaction between cells and their 
extracellular matrix, and is thought to result from a balance of cell-cell and cell-matrix 
adhesivity.  In our previous work, we demonstrate that substrate stiffness mediates 
capillary network formation, the self-assembly of endothelial cell networks on 
compliant, but not stiff, substrates.  While it is known that substrate stiffness alters cell 
aggregation, the role of substrate stiffness in mediating cell-cell and cell-matrix 
interactions that give rise to capillary network assembly are not well described.  
Herein, we demonstrate that substrate stiffness alters the expression and spatial 
localization of vascular-endothelial (VE) cadherin, a prominent mediator of 
endothelial cell-cell adhesion.  Our data indicate that compliant substrates promote 
cell-cell interactions characterized by tight and mature VE-cadherin-mediated cell-cell 
junctions.  Endothelial cells on compliant substrates exhibit a reduction in cell-
substrate adhesion suggesting a preference for cell-cell vs. cell-substrate adhesion.  In 
addition, we demonstrate the sensitivity of network assembly to substrate stiffness in 
mammary and mesenchymal tissue-derived cells and show that network assembly on 
compliant substrates is associated with i) extracellular matrix colocalization and/or ii) 
                                                 
1
 Figure 3.1E-F contributed by Dr. Christine Montague. 
2
 Figure 3.5C contributed by Alina Starchenko. 
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a reduction in cell-substrate adhesion.  These findings demonstrate that network 
assembly results from a balance between cell-cell and cell-matrix adhesion, and 
suggest that substrate stiffness is a critical regulator of network assembly.   
 
3.2 Introduction 
Tissue formation is a fundamental biological process that involves a complex 
interaction between cells and the extracellular matrix (ECM), and is thought to arise 
from a balance of cell-cell and cell-matrix adhesive forces [147].  When cell-matrix 
adhesion is reduced, cells are prone to cluster (prefer cell-cell interactions).  In 
contrast, when cell-cell adhesion is reduced, cells tend to disperse (prefer cell-
substrate interactions).  This response is also recapitulated by altering the mechanical 
environment of cells.  On compliant substrates, cells prefer cell-cell interactions and 
cluster, while those on stiff substrates tend to disperse [87].  These findings suggest 
that substrate stiffness plays a role in mediating cell-cell and cell-matrix adhesion 
events that enable tissue assembly; however these relationships are poorly understood.  
 
In our previous work, we have demonstrated that compliant, but not stiff, substrates 
promote capillary network assembly [112].  This response is characterized by the self-
assembly of endothelial cells (EC) into clusters and cords of cells that form 
interconnected ring-like networks reminiscent of capillary beds [11].  While we have 
established that ECs prefer cell-cell contacts on compliant substrates [36,112], the 
mechanisms mediating these preferences are unknown.  
 
Endothelial cell-cell adhesion is largely mediated by vascular endothelial (VE)-
cadherin, a major transmembrane receptor governing intercellular adhesion [148].  
Cell-matrix adhesion is mediated by focal adhesions, clusters of integrins that act as 
 38 
mechanosensors and link the ECM to the cytoskeleton [43].  In addition, ECM 
proteins play a prominent role in mediating cell-cell adhesion.  We have shown 
previously that the assembly of ECM fibronectin (FN) stabilizes cell-cell interactions 
and is requisite for capillary network assembly [112].  These findings suggest that 
substrate stiffness promotes capillary network assembly by altering VE-cadherin and 
focal adhesion-mediated cell-cell and cell-substrate interactions in ECs; however these 
interactions are not well described.   
  
In this study, we examined the role of substrate stiffness in altering the mediators of 
cell-cell and cell-matrix interactions that regulate capillary network assembly.  Our 
data indicate that substrate stiffness alters the localization of VE-cadherin in ECs.  
Compliant substrates reduce cell-substrate adhesivity and promote network assembly 
characterized by tight and mature VE-cadherin-mediated cell-cell junctions.  We 
extend these findings to other cell types and demonstrate that network assembly on 
compliant substrates is not unique to ECs.  Cells derived from mammary and 
mesenchymal tissue are induced to assemble networks on compliant substrates and 
exhibit ECM colocalization and a reduction in cell-substrate adhesion.  In contrast, 
cells lacking strong cell-ECM associations and exhibiting insensitivity to alterations in 
cell-substrate adhesion did not assemble networks.  Together, these data suggest that 
substrate stiffness alters cell-cell and cell-substrate interactions that regulate network 
assembly.  
 
3.3 Materials & Methods 
Cell Culture 
Bovine aortic endothelial cells (VEC Technologies, Rensselaer, NY) were maintained 
as described previously [112,149].  MCF-10A mammary epithelial cells (American 
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Type Culture Collection, Rockville, MD, CRL-10317) were maintained in DMEM 
supplemented with 5% (v/v) horse serum, 20 ng/mL EGF (Invitrogen), 10 g/mL 
insulin, 0.5 g/mL hydrocortisone, 100 ng/mL cholera toxin (Sigma-Aldrich, St. 
Louis, MO), and 1% (v/v) penicillin-streptomycin (Invitrogen) [150].  MDA-MB-231 
highly metastatic breast adenocarcinoma cells (ATCC, HTB-26) were maintained in 
Minimum Essential Medium supplemented with 10% (v/v) FBS, and 1% (v/v) 
penicillin-streptomycin (Invitrogen).  C3H/10T1/2 mouse mesenchymal progenitor 
cells (ATCC) were maintained in BME media supplemented with 10% (v/v) heat-
inactivated FBS and 1% (v/v) L-glutamine (Invitrogen).  After passage 5, cells were 
maintained in DMEM supplemented with 10% (v/v) FBS, 1% (v/v) L-glutamine, and 
1% (v/v) penicillin-streptomycin (Invitrogen) according to ATCC protocol.  A7r5 rat 
smooth muscle cells were maintained in DMEM supplemented with 10% (v/v) FBS 
and 1% (v/v) penicillin-streptomycin (Invitrogen). BEAS-2B bronchial epithelial cells 
(ATCC, CRL-9609) were maintained in BECB Medium supplemented with 
SingleQuots (Lonza) according to ATCC protocols, and 1% (v/v) penicillin-
streptomycin (Invitrogen).  A549 metastatic lung carcinoma cells (ATCC, CCL-185) 
were a kind gift from Dr. Paraskevi Giannakakou (Weill Cornell Medical College) and 
were maintained in RPMI 1640 supplemented with 10% (v/v) FBS and 1% (v/v) 
penicillin-streptomycin (Invitrogen).  All cells were cultured at 37
o
C and 5% CO2. 
Live cell imaging was performed in a custom temperature, humidity, and CO2- 
controlled stage of a Zeiss Axio Observer Z1m inverted phase contrast microscope 
with a Hamamatsu ORCA-ER camera. 
 
Polyacrylamide Substrates and Stiffness Characterization 
Variably compliant poly(acrylamide) (PA) gels were prepared as described previously 
[28,112,149] and derivatized with an applied type I collagen (BD, Franklin Lakes, NJ) 
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concentration of 100 µg/ml, or a mixture of 10%:90% collagen to laminin (Sigma) for 
Figures 3.16-3.17.  Matrigel substrates (Figure 3.16A-B) were prepared in well-plates 
according to the manufacturer's instructions.  PA substrates were synthesized with 
Young’s Moduli (E) of 0.2-10 kPa to mimic physiologically relevant tissue stiffness 
[151].  Substrate stiffness was confirmed by measuring E at the gel surface using 
Hertz theory as described previously [30,149]. 
 
Western Blot for VE-Cadherin  
Subconfluent ECs on PA (E=0.2-10 kPa) substrates or polystyrene were lysed with 
buffers to separate Triton-soluble and Triton-insoluble proteins [152].  Triton-soluble 
fractions were extracted with 1% (w/v) NP-40 and 1% (v/v) Triton in Tris-buffered 
saline (TBS; 10 mM Tris-HCl, 150 mM NaCl) with 2 mM CaCl2 (JT Baker, 
Phillipsburg, NJ) pH 7.5, and protease inhibitor cocktail (1:500, Sigma-Aldrich, St. 
Louis, MO).  The Triton-insoluble fractions were extracted with 0.5% (w/v) sodium 
dodecyl sulfate and 1% (w/v) NP-40 (JT Baker) in TBS.  The supernatants were 
analyzed with a protein assay (Bio-Rad, Hercules, CA) and subjected to gel 
electrophoresis (15 g per sample; 8% acrylamide gel) and Western blot.  Antibodies 
to VE-cadherin (C-19, Santa Cruz Biotechnology, Santa Cruz, CA), and to -actin 
(AC-15, Sigma) were detected by chemiluminescence on a Bio-Rad ChemiDoc 
imaging system.  Densitometry of VE-cadherin was performed with Quantity One (v. 
4.6.5; Bio-Rad) and expressed as a ratio to -actin.  Total cell VE-Cadherin was 
calculated by adding the VE-Cadherin/-Actin ratios for Triton-soluble and Triton-
insoluble fractions and the VE-Cadherin in each fraction was determined as a percent 
of the total VE-Cadherin.  Results are the average of three independent experiments. 
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Centrifugation Assay 
A centrifugation assay was performed as described previously by Guo et al. [87].  
Cells were plated on variably compliant (E=0.5-10 kPa) PA gels and allowed to 
adhere for 25 minutes.  A chamber was assembled by the addition of a silicone o-ring 
and top coverslip, inverted, and centrifuged at 500 xg for 10 minutes. Substrates were 
imaged and cells were counted with ImageJ [153].  The percentage of adherent cells 
was determined as the ratio of adherent cells after centrifugation to the number of cells 
from static controls.  For ECs, (Figure 3.5C), ratios were normalized to the 10 kPa 
substrate and fit with a logistic equation (modified from [154]) of the form  
f=1/(1+exp(-b[E-p]), where f is the adherent cell fraction, b and p are the fitted slope 
and inflection point, respectively, and E is the substrate Young’s Modulus in kPa.  
Data were the average of three independent experiments. 
 
Fluorescent Localization  
Cells on PA gels were processed for fluorescence imaging as described previously 
[112].  Briefly, samples were fixed in 3.7% (w/v) formaldehyde for 30 minutes, 
permeabilized with 1% (w/v) Triton, washed with 0.2% (v/v) Tween in PBS, blocked 
with 3% (w/v) BSA in 0.2% (v/v) Tween in PBS for one hour, and incubated 
overnight at 4°C 1:50 in 1% BSA (w/v) in PBS with either an anti-VE-cadherin (C19), 
E-cadherin (H-108), fibronectin (A17), laminin (GB3) (SCBT), or collagen (755P; 
Millipore) primary antibody.  For paxillin staining, samples were blocked with 40% 
(v/v) heat-denatured FBS in PBS for one hour, and incubated with an anti-paxillin 
primary antibody (177; BD) overnight.  Samples were incubated with Alexa Fluor 
secondary antibodies, or Alexa Fluor-labeled phalloidin for one hour, stained with 
DAPI to localize cell nuclei, and imaged with a Zeiss Axio Observer Z1m or Zeiss 
700 LSM confocal microscope with a Hamamatsu ORCA-ER camera.      
 42 
EGTA and VE-Cadherin Blocking  
To disrupt cell-cell interactions, ECs were plated in the presence of 5 mM ethylene 
glycol tetraacetic acid (EGTA) in complete media or vehicle control.  To specifically 
block VE-cadherin engagement, ECs were plated in the presence of 5 g/mL VE-
cadherin blocking antibody [155] (BV9; SCBT) in complete media or vehicle control. 
VE-cadherin was stained and imaged as described above. 
  
Laminin Knockdown  
To knockdown laminin expression, MCF-10A cells were transfected with siRNA 
against laminin-5 chains 3, 3, or 2, or a control siRNA (SCBT) by incubation in 
Lipofectamine 2000 (Invitrogen).  Cells were plated on compliant (E=0.2 kPa) 
substrates 24 hours after transfection for two days.  Separate preliminary experiments 
determined laminin expression with Western blotting over the same time course using 
anti-laminin 3 (N20), 3 (A6), or 2 (B2) antibodies (SCBT).   
 
Statistics 
Data for figures Figures 3.1F, 3.5C were analyzed with analysis of variance (ANOVA) 
and Tukey’s HSD test.  Data for centrifugation tests were analyzed with Student's t 
test. Plots were reported as mean +/- SE.  Analyses were performed with JMP (SAS, 
Cary, NC). 
 
3.4 Results 
Substrate Stiffness Alters VE-Cadherin Localization  
We have shown previously that substrate stiffness is a critical mediator of capillary 
network assembly, the self-assembly of endothelial cell (EC) networks [112]. On 
compliant (E=0.2 kPa) substrates, ECs assembled into networks characterized by 
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clusters of ECs connected by cords of aligned cells (Figure 3.1A).  When substrate 
stiffness was increased (E=10 kPa), network assembly did not occur and cells were 
instead uniformly distributed across the substrate (Figure 3.1B).  
 
Endothelial cell-cell connections are largely mediated by VE-cadherin, an EC-specific 
adherens junction protein [156]. To investigate the role of VE-cadherin in mediating 
cell-cell interactions with respect to substrate stiffness, ECs were plated on compliant 
(E=0.2 kPa) and stiff (E=10 kPa) substrates and stained to localize VE-cadherin.  On 
compliant substrates where networks spontaneously assembled, cells formed tight cell-
cell junctions that were colocalized with a continuous signal of VE-cadherin at the 
membrane of adjoining cells (Figure 3.1C arrow heads; inset is a magnification of the 
boxed region).  When substrate stiffness was increased, ECs did not form tight cell-
cell junctions, and VE-cadherin localization at the membrane of adjoining cells 
appeared punctate (Figure 3.1D). 
 
To quantify the localization of VE-cadherin with respect to stiffness, ECs plated on 
variably compliant substrates (E=0.2-10 kPa, and tissue culture plastic [TCP; 
polystyrene; E=3 GPa [157]]) were analyzed by Western blot (Figure 3.1E). VE-
cadherin was fractionated into soluble and insoluble fractions with Triton, where 
insoluble VE-cadherin corresponds to association with the cytoskeleton (Ctsk) and 
mature inter-endothelial junctions [152].  A plot of the average percent of total VE-
cadherin indicated that on compliant (E=0.2 kPa) substrates, a greater fraction of total 
VE-cadherin was associated with the cytoskeleton (Figure 3.1F).  The proportion VE-
cadherin associated with the cytoskeleton (Ctsk[+]) decreased with substrate stiffness 
(black bars) while the soluble fraction ((Ctsk[-]); non-cytoskeleton associated) of VE-
cadherin increased proportionately with stiffness (white bars).  These data indicate that 
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compliant substrates foster the development of EC network assemblies characterized 
by tight and mature VE-cadherin-associated cell-cell interactions. 
 
Figure 3.1.  Substrate stiffness alters the localization of VE-cadherin in ECs. 
(A) On compliant (E=0.2 kPa) substrates, ECs self-assembled into networks 
characterized by clusters of cells (*) connected by cords of cells (arrow head).  (B) On 
stiff (E=10 kPa) substrates, cells were uniformly distributed. Scale bars are 100 m.  
(C) On compliant substrates, VE-cadherin localization was continuous at cell-cell 
junctions (arrow heads, inset is a magnification of the boxed region).  (D) On stiff 
substrates, VE-cadherin localization was punctate at cell-cell junctions. Scale bars are 
50 m.  (E) Western blot of VE-cadherin fractionated to localize association with the 
cytoskeleton (Ctsk +/-; E, Young’s Modulus; TCP, tissue culture plastic).  (F) A plot 
of the average percent of total VE-cadherin fractionated for localization with the 
cytoskeleton indicated a significant decrease in cytoskeleton-associated VE-cadherin 
with increasing substrate stiffness (mean + SE, *p<0.001).  Dr. Christine Montague 
performed the Western blot in (E)-(F). 
 45 
Capillary Network Assembly on Compliant Substrates Requires VE-Cadherin 
Engagement  
Our data indicate that substrate stiffness alters the localization of VE-cadherin in ECs. 
To determine whether VE-cadherin is requisite for mediating network assembly, ECs 
were plated in the presence of ethylene glycol tetraacetic acid (EGTA).  Treatment 
with EGTA sequesters extracellular calcium and prevents cadherin-cadherin 
interactions [152,158].  ECs on compliant (E=0.2-0.5 kPa) substrates plated with 
EGTA were adherent to the substrate but poorly spread, and networks did not 
assemble, however cell spreading was not disrupted on stiffer glass or TCP substrates 
(Figure 3.2A).  In control samples, networks assembled on compliant substrates but 
not on stiff glass or TCP (Figure 3.2B).  To determine whether this response was 
reversible, ECs were plated in the presence of EGTA for 24 hours and replenished 
with fresh media.  As before, treatment with EGTA prevented cell spreading and 
network assembly on compliant (E=0.2 kPa) substrates (Figure 3.2C), but did not 
disrupt spreading on stiff (E=10 kPa) substrates (Figure 3.2).  After the addition of 
complete media, samples on compliant substrates (initially treated with EGTA) 
assembled into networks (Figure 3.2C, arrow) that appeared similar to controls 
(double arrow).  On stiff substrates, cells did not assemble networks and grew to 
confluence similar to controls after complete media was replenished (Figure 3.2D, 
double arrow).  
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Figure 3.2.  EGTA treatment prevents EC network assembly. 
ECs were plated on compliant (E=0.2-5) and stiff (glass, TCP) substrates in the 
presence of 5 mM EGTA.  (A) On compliant substrates, ECs were poorly spread and 
did not assemble networks. On stiffer substrates, spreading was not disrupted and cells 
did not assemble networks.  (B) Control samples exhibit network assembly on 
compliant but not stiff substrates.  (C) ECs on compliant (E=0.2 kPa) substrates were 
plated in the presence of 5 mM EGTA for 24 hours then replenished with fresh media 
(arrow). Network assembly was recovered by 120 hours after plating and appeared 
similar to controls (double arrow).  (D) On stiff substrates, cells did not form network 
assemblies after EGTA-treated cells were replenished with fresh media.  Scale bars are 
200 m. 
 
To confirm that EGTA disrupted VE-cadherin, EC in assembled networks on 
compliant substrates were treated with EGTA and fixed and stained for VE-cadherin.  
Staining indicated that EGTA disrupted VE-cadherin at the cell-cell junction 30 
minutes and 2 hours after treatment compared to controls (Figure 3.3).  Notably, 
assembled networks did not disassemble in this time frame.  These data indicate that 
EGTA disrupts network assembly on compliant substrates by altering the localization 
of VE-cadherin in ECs, and suggests that VE-cadherin engagement may not be 
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requisite for maintaining established network morphologies. 
 
 
Figure 3.3.  EGTA disrupts VE-cadherin localization at cell-cell junctions.  
ECs on compliant (E=0.2 kPa) substrates in assembled networks were treated with 5 
mM EGTA and stained for VE-cadherin. VE-cadherin localization was disrupted 30 
minutes and 2 hours after treatment compared to controls.  Scale bar is 100 m. 
 
 While treatment with EGTA disrupts VE-cadherin-mediated cell-cell interactions, 
there may be additional and unintended side effects of extracellular calcium depletion. 
To determine whether VE-cadherin was requisite for network assembly, ECs were 
plated on compliant (E=0.2 kPa) substrates in the presence of a VE-cadherin function-
blocking antibody.  Blocking VE-cadherin prevented network assembly compared to 
control samples (Figure 3.4A).  These results were reminiscent of our previous 
findings indicating that network assembly requires FN polymerization [112].  To 
determine whether blocking VE-cadherin engagement altered FN deposition, ECs 
were plated on compliant (E=0.2 kPa) substrates in the presence of a VE-cadherin 
function-blocking antibody and fixed and stained for FN.  ECs plated with the 
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blocking antibody failed to assemble networks or deposit FN fibrils (Figure 3.4B, inset 
is a magnification of the boxed region).  Instead, FN appeared punctate within the cell, 
similar to results found when samples were treated with an FN polymerization 
inhibitor [112].  These data indicate that VE-cadherin engagement is requisite for 
network assembly and that cell-cell interactions mediate FN deposition that regulates 
network assembly. 
 
Figure 3.4.  Treatment with a VE-cadherin blocking antibody prevents EC 
network assembly. 
(A) ECs plated on compliant (E=0.2 kPa) substrates in the presence of 5 g/mL VE-
cadherin function-blocking antibody failed to assemble networks compared to 
controls.  (B) Treatment with a VE-cadherin blocking antibody disrupted FN 
deposition. Inset is a magnification of the boxed region.  Scale bars are 100 m.   
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Substrate Stiffness Alters Focal Adhesion Assembly and Cell-Substrate Adhesion 
Tissue formation is thought to result from a balance of cell-cell and cell-matrix 
adhesion [147].  Our data indicate that substrate stiffness alters VE-cadherin-mediated 
cell-cell adhesion.  Cell-substrate adhesion is mediated by focal adhesions that link the 
ECM to the cytoskeleton and participate in mechanosensing [43].  To determine the 
role of substrate stiffness in mediating focal adhesion organization, ECs were plated 
on compliant (E=0.2 kPa) and stiff (E=10 kPa) PA substrates and stained for paxillin, 
a focal adhesion adaptor protein.  On compliant substrates, paxillin signal was 
localized to a few small adhesion sites with significant diffuse staining (Figure 3.5A, 
inset is a magnification of the boxed region).  In contrast, paxillin signal appeared to 
localize in numerous elongated adhesions suggesting an increase in focal adhesion size 
and density with increasing substrate stiffness (Figure 3.5B).  Focal adhesion 
organization on stiff substrates also appeared colocalized with the ends of actin 
filaments (Figure 3.5B, merge).  These data indicate that substrate stiffness alters focal 
adhesion organization, and suggest that there are differences in cell-substrate adhesion 
with stiffness. 
 
To determine adhesive strength, we performed a centrifugation assay on ECs plated on 
variably compliant (E=0.5-10 kPa) substrates.  A plot of the ratio of adherent cells 
(cells present after centrifugation compared to static controls) indicated that cell 
adhesivity to the substrate increased significantly with increasing substrate stiffness 
(Figure 3.5C).  These data were fit with a logistic model [adapted from [154]] that 
accurately described the experimental data (sum of squares error = 0.001) indicating 
that the adherent cell fraction increased in a sigmoidal fashion with increasing 
substrate stiffness.  These data indicate that substrate stiffness alters focal adhesion 
organization and cell-substrate adhesion. 
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Figure 3.5.  Substrate stiffness alters focal adhesion localization and cell-
substrate adhesion. 
ECs were plated on compliant (E=0.2 kPa) and stiff (E=10 kPa) substrates and stained 
for paxillin.  (A) On compliant substrates, paxillin was localized to a few small 
adhesions with significant diffuse staining.  (B) On stiff substrates, paxillin was 
localized in numerous elongated adhesions. Insets are magnifications of the boxed 
regions. Scale bar is 50 m.  (C) ECs were plated on variably compliant substrates 
(E=0.5-10 kPa) substrates and subjected to a centrifugation assay.  Quantification of 
the adherent cell fraction indicated that cell-substrate adhesion increased with 
increasing substrate stiffness (mean  SE, *p<0.05).  Alina Starchenko performed the 
centrifugation assay in (C).  
 
Taken together, these data indicate that compliant substrates promote capillary 
network assembly by altering VE-cadherin and focal adhesion localization, mediators 
of cell-cell and cell-substrate adhesion. 
 
Mammary Cell Network Assembly on Compliant Substrates Requires Laminin 
and is Associated with a Reduction in Cell-Substrate Adhesion 
Our data indicate that substrate stiffness alters the cell-cell and cell-matrix interactions 
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that mediated capillary network assembly.  To determine whether the sensitivity of 
network assembly to substrate stiffness was specific to ECs, we investigated network 
assembly in cell types derived from mammary, mesenchymal, and lung tissues that 
exhibited tissue morphogenesis, i.e. network assembly.  Cells derived from mammary 
tissue exhibit morphogenesis that is regulated primarily by the ECM protein laminin 
[159].  To determine the role of substrate stiffness in mediating mammary cell 
network assembly, MCF-10A human mammary epithelial cells (10A) were plated on 
compliant (E=0.2 kPa) and stiff (E=10 kPa) substrates and stained for laminin.  
Analogous to ECs with FN [98,112], 10As on compliant substrates assembled 
networks associated with laminin (Figure 3.6A).  On stiff substrates, cells did not 
assemble networks, and cells and laminin were uniformly distributed across the 
substrates (Figure 3.6B).  Note that laminin staining displayed the characteristic 
leopard-spot pattern [160].  Like FN, laminin was colocalized with 10As in network 
assemblies.  We observed laminin fibrils that spanned a network cord despite an 
individual retracted cell suggesting that laminin fibril deposition supports network 
assembly (Figure 3.6C). 
 
To determine the role of substrate stiffness in mediating cell-substrate adhesion, 10As 
were subjected to a centrifugation assay.  Similar to ECs, 10As exhibited an increase 
in adherent fraction with increasing substrate stiffness (Figure 3.6D).  These results 
indicate that compliant substrates promote a reduction in cell-substrate adhesion and 
network assembly associated with laminin in 10As. 
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Figure 3.6.  Compliant substrates promote mammary cell network assembly 
colocalized with laminin and reduced cell-substrate adhesion. 
(A) MCF-10A mammary epithelial cells plated on compliant (E=0.2 kPa) substrates 
assembled into networks associated with laminin.  (B) On stiff (E=10 kPa) substrates, 
cells and laminin were uniformly distributed. Scale bars are 100 m.  (C) Laminin 
ECM was stretched across a retracted cell in a network cord.  (D) Quantification of a 
centrifugation assay indicated a significant increase in cell-substrate adhesion with 
increasing substrate stiffness (mean + SE, *p<0.05).  
 
To determine if laminin was requisite for network assembly, 10As were treated with 
siRNA against the laminin-5 subunits (3, 3, 2), and plated on compliant (E=0.2 
kPa) substrates.  A Western blot of laminin expression indicated that there was a 
decrease in laminin expression over 24-48 hours (Figure 3.7A-C).  Treatment with 
siRNA against laminin 3 prevented network assembly in 10As (Figure 3.7A). 
However, treatment with siRNA against laminin 3 or 2 did not prevent network 
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assembly (Figure 3.7B-C).  These data indicate that laminin is requisite for 10A 
network assembly on compliant substrates, and suggest that the 3 chain of laminin-5 
mediates cell-cell interactions that enable network formation.  
Figure 3.7.  Laminin  is requisite for mammary cell network assembly. 
MCF-10A mammary epithelial cells were treated with siRNA against laminin-5 
subunits 3, 3, or 2 and plated on compliant (E=0.2 kPa) substrates.  (A-C) Western 
blot for laminin indicated a decrease in laminin expression over two days.  (A) 10As 
treated with siRNA against laminin 3 did not assemble networks compared to control 
siRNA.  (B-C) 10As treated with siRNA against 3 or 2, respectively, did assemble 
networks.  Scale bars are 200 m. 
 
FN is requisite for network assembly in ECs [112].  To determine whether FN 
mediates mammary cell network assembly, 10As were plated on compliant (E=0.2 
kPa) and stiff (E=10 kPa) substrates and stained for FN.  On compliant substrates, 
10As assembled networks that were colocalized with FN (Figure 3.8A).  On stiff 
substrates, cells were uniformly distributed across the substrate and FN signal was not 
closely associated with cells (Figure 3.8B).  These data suggest that multiple ECM 
proteins contribute to network assembly.     
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Figure 3.8.  Networks of mammary epithelial cells are associated with 
fibronectin.  
MCF-10A mammary epithelial cells were plated on compliant (E=0.2 kPa) and stiff 
(E=10 kPa) substrates and stained for FN.  (A) On compliant substrates, 10As formed 
networks associated with FN.  (B) On stiff substrates, cells were uniformly distributed 
and not closely associated with FN.  Scale bar is 200 m. 
 
In addition to capillary and mammary tissue-derived cells, mesenchymal tissue-
derived cells support tissue morphogenesis [161].  To determine the role of substrate 
stiffness in mediating mesenchymal cell network assembly, C3H/10T1/2 murine 
mesenchymal stem cells (C3H) were plated on compliant (E=0.2 kPa) and stiff (E=10 
kPa) substrates.  C3Hs plated on compliant substrates formed network assemblies 
associated with FN (Figure 3.9A).  On stiff substrates, networks did not assemble, and 
cells and FN were instead uniformly distributed across the substrate (Figure 3.9B).  To 
determine whether substrate stiffness mediated cell-substrate adhesion, CH3s were 
subjected to a centrifugation assay.  Similar to ECs and 10As, C3Hs exhibited an 
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increase in adherent fraction with increasing substrate stiffness.  These results suggest 
that mesenchymal cell network assembly is sensitive to substrate stiffness. 
 
Figure 3.9.  Compliant substrates support mesenchymal cell network assembly 
colocalized with FN. 
C3H/10T1/2 murine mesenchymal stem cells were plated on compliant (E=0.2 kPa) 
and stiff (E=10 kPa) substrates.  (A) On compliant substrates, C3H cells assembled 
into networks associated with FN.  (B) On stiff substrates, cells did not assemble 
networks, and cells and FN were uniformly distributed across the substrate. Scale bars 
are 200 m.  (C) Quantification of a centrifugation assay indicated a significant 
increase in cell-substrate adhesion with increasing substrate stiffness (mean + SE, 
*p<0.05). 
 
In the vasculature, smooth muscle cells (SMC) support EC network assembly [162].  
To determine the role of substrate stiffness in mediating network assembly, A7r5 rat 
SMCs were plated on compliant (E=0.2-1 kPa) and stiff (E=10 kPa) substrates and 
stained for collagen or FN.  On compliant, but not stiff, substrates, SMCs formed 
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network assemblies (Figure 3.10A).  Network assemblies on compliant substrates 
were colocalized with collagen, but cells were uniformly distributed and not 
colocalized with collagen on stiff substrates (Figure 3.10B).  On compliant (E=1 kPa) 
substrates, SMCs did not assemble networks despite colocalization with some fibrillar 
FN (Figure 3.10C).  On stiff substrates, SMCs did not assemble networks and FN 
appeared aggregated with some fibrils (Figure 3.10C).  Notably, SMC network 
assemblies on compliant substrates were less robust and persistent than those observed 
in ECs, 10As, and C3Hs.  This was likely due to a reduction in migration and 
proliferation observed in these cells on compliant substrates.     
 
Figure 3.10.  Compliant substrates support SMC network assembly associated 
with collagen. 
(A) A7r5 rat SMCs assembled networks on compliant (E=0.2 kPa) but not stiff (E=10 
kPa) substrates.  (B) Network assemblies were colocalized with collagen on compliant 
substrates.  On stiff substrates cells did not assemble networks and were uniformly 
distributed.  (C) On compliant (E=1 kPa) substrates networks did not assemble despite 
interaction with FN. On stiff substrates, SMCs did not assemble and FN was 
aggregated with some fibrils.  Scale bar is 200 m.  
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Laminin-Deficient Mammary Cells Fail to Assemble Networks and Do Not 
Exhibit a Reduction in Cell-Substrate Adhesion on Compliant Substrates  
Our data indicate that compliant substrates facilitate network assembly in vascular, 
mammary, and mesenchymal tissue-derived cell types.  In these cases, cells on 
compliant substrates are associated with a reduction in cell-substrate adhesion and are 
colocalized with ECM proteins.  In MCF-10A mammary epithelial cells, laminin was 
colocalized with network assemblies.  MDA-MB-231 (231) cells are derived from a 
highly metastatic mammary tumor and are deficient in laminin production compared 
to normal mammary cells [163].  To determine whether laminin-deficient mammary 
cells assembled networks, 231s were plated on compliant (E=0.2 kPa) and stiff (E=10 
kPa) substrates.  In contrast to 10As, 231s did not assemble into networks on 
compliant substrates (Figure 3.11A).  Instead, cells were uniformly distributed across 
the substrate on compliant and stiff substrates (Figure 3.11A).  As expected, 
immunostaining for laminin was undetectable in 231s on compliant and stiff substrates 
(Figure 3.11B).  To determine cell-substrate adhesivity, 231s were plated on compliant 
and stiff substrates and subjected to a centrifugation assay.  In contrast to ECs, 10As, 
and C3Hs, 231s did not exhibit a significant difference in cell-substrate adhesion with 
substrate stiffness (Figure 3.11C).  These findings indicate that 231s do not assemble 
networks, do not colocalize with laminin, and do not exhibit a reduction in cell-
substrate adhesion on compliant substrates.  
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Figure 3.11.  Laminin-deficient mammary cells fail to assemble networks on 
compliant substrates. 
(A) MDA-MB-231 metastatic mammary epithelial cells did not assemble networks on 
compliant (E=0.2 kPa) or stiff (E=10 kPa) substrates. Cells were uniformly distributed 
across the substrate.  (B) Immunostaining indicated that laminin was undetectable on 
compliant and stiff substrates.  Scale bars are 200 m.  (C) Quantification of a 
centrifugation assay indicated that cell-substrate adhesion did not change with 
substrate stiffness (mean + SE). 
 
In addition to vascular, mammary, and mesenchymal cell network assembly, we asked 
whether lung cell network assembly was sensitive to substrate stiffness.  Lung tissue-
derived cells have been shown to be capable of network assembly in vitro [164,165].  
To determine the role of substrate stiffness in mediating lung cell network assembly, 
BEAS-2B human bronchial epithelial cells (2B) were plated on compliant (E=0.2 kPa) 
and stiff (E=10 kPa) substrates and stained for laminin.  Analogous to 231s, 2Bs did 
not assemble into networks on compliant or stiff substrates (Figure 3.12A), were not 
associated with detectible laminin (Figure 3.12B), and did not exhibit a significant 
difference in cell-substrate adhesion with substrate stiffness (Figure 3.12C).  
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Figure 3.12.  Lung cells fail to assemble networks and do not exhibit a reduction 
in cell-substrate adhesion on compliant substrates. 
(A) BEAS-2B bronchial epithelial cells did not assemble networks on compliant 
(E=0.2 kPa) or stiff (E=10 kPa) substrates. Cells were instead uniformly distributed 
across the substrate.  (B) Immunostaining indicated that laminin was undetectable on 
compliant and stiff substrates.  Scale bars are 200 m.  (C) Quantification of a 
centrifugation assay indicated that cell-substrate adhesion did not change with 
substrate stiffness (mean + SE). 
 
Like 2Bs, A549 human alveolar adenocarcinoma epithelial cells also did not assemble 
into networks on compliant or stiff substrates (Figure 3.13A), and were not associated 
with laminin (Figure 3.13B).  These findings further suggest that like 231s, 2Bs and 
A549s are insensitive to substrate stiffness-mediated alterations in cell-cell and cell-
matrix interactions that regulate network assembly. 
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Figure 3.13.  Metastatic lung carcinoma cells fail to assemble networks on 
compliant substrates. 
(A) A549 metastatic lung carcinoma cells did not assemble networks on compliant 
(E=0.2 kPa) or stiff (E=10 kPa) substrates. Cells were instead uniformly distributed 
across the substrate.  (B) Immunostaining indicated that laminin was undetectable on 
compliant and stiff substrates.  Scale bars are 200 m. 
 
MCF-10A mammary epithelial cells assembled into networks that were associated 
with both laminin and FN. To determine if 231s, 2Bs, and A549s (cells with 
undetectable laminin staining) were associated with FN, cells were plated on 
compliant (E=0.2 kPa) and stiff (E=10 kPa) substrates and stained for FN.  In all 
cases, FN appeared uniformly distributed across the substrate (Figure 3.14A-C).  
Network assembly did not occur on compliant substrates, and cells were also 
uniformly distributed. These findings suggest that cell-ECM colocalization is an 
important mediator of network assembly.   
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Figure 3.14.  Mammary and lung tissue-derived cells that do not assemble 
networks are not associated with FN.  
(A) MDA-MB-231 cells on compliant (E=0.2 kPa) and stiff (E=10 kPa) substrate 
failed to assemble networks. Cells and FN were uniformly distributed across the 
substrate.  (B-C) Similarly, BEAS-2B and A549 cells failed to assemble networks on 
compliant substrates.  Instead, cells and FN were uniformly distributes across the 
substrates.  Scale bars are 200 m. 
 
Our findings indicate that 10As assemble networks on compliant substrates but 231s 
do not.  Similar to VE-cadherin in ECs, E-cadherin mediates cell-cell interactions in 
epithelial cells [166].  To determine whether substrate stiffness alters the localization 
of E-cadherin in mammary epithelial cells, 10As and 231s were plated on compliant 
(E=0.2) and stiff (E=10 kPa) PA substrate and stained for E-cadherin.  On compliant 
substrates, 10As assembled networks characterized by a continuous signal of E-
cadherin localized to cell-cell junctions (Figure 3.15A).  In contrast, E-cadherin signal 
was punctate or not detectable at cell-cell junctions of 10As on stiff substrates (Figure 
3.15B).  In contrast, 231s did not exhibit detectable E-cadherin signal at cell-cell 
junctions on compliant (Figure 3.15C) or stiff (Figure 3.15D) substrates.  These data 
indicate that E-cadherin mediates cell-cell interactions between 10As on compliant 
substrates, that E-cadherin localization in 10As changes with substrate stiffness, and 
that 231s do not express E-cadherin.   
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Figure 3.15.  Substrate stiffness alters the localization of E-cadherin in mammary 
cells that assemble networks. 
MCF-10A and MDA-MB-231 mammary epithelial cells were plated on compliant 
(E=0.2 kPa) and stiff (E=10 kPa) substrates and stained for E-cadherin.  (A) 10As 
assembled networks with E-cadherin localized as a continuous signal at cell-cell 
junctions.  (B) On stiff substrates, E-cadherin at cell-cell junctions was punctate or not 
detectable.  In 231 cells, networks did not assemble, and E-cadherin was not 
detectable at cell-cell junctions on compliant (C) or stiff (D) substrates.  Scale bars are 
100 m. 
 
Exogenous Laminin Induces Network Assembly in Laminin-Deficient Mammary 
Cells 
MDA-MB-231 metastatic mammary epithelial cells are laminin-deficient and fail to 
assemble into networks (Figure 3.11).  To determine whether network assembly could 
be recovered with exogenous laminin, 231s were plated on matrigel, a compliant 
substrate rich in laminin [167,168].  At 24 hours after plating, 231s formed transient 
network assemblies compared to cells on tissue culture plastic (TCP) that were 
uniformly distributed (Figure 3.16A).  Network assemblies did not persist, but 
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disassembled into clusters of cells on matrigel by 72 hours while control samples 
remained uniformly distributed across the substrate (Figure 3.16B). 
 
In addition to laminin, matrigel is composed of multiple ECM proteins and growth 
factors [167,168].  To determine whether laminin, and not other proteins, were 
responsible for contributing to network assembly, 231s were plated on compliant 
(E=0.2 kPa) PA substrates derivatized with laminin (90% laminin:10% collagen).  On 
laminin-coated substrates, 231s assembled into network-like structures by 72 hours 
after plating (Figure 3.16C).  In contrast, 231s on collagen-coated substrates did not 
assemble networks and were uniformly distributed across the substrate (Figure 3.16D).  
These data indicate that laminin (and not additional proteins/growth factors) induced 
231 network assembly on compliant substrates, and suggest that substrate stiffness and 
ECM chemistry are critical regulators of mammary cell network assembly. 
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Figure 3.16.  Exogenous laminin induces network assembly in laminin-deficient 
mammary cells. 
MDA-MB-231 cells were plated on matrigel, TCP, or PA substrates derivatized with 
laminin/collagen.  (A) After 24 hours, 231s formed network assemblies compared to 
controls that were uniformly distributed across the plate.  (B) Networks disassembled 
into clusters of cells by 72 hours. Scale bar is 500 m.  (C) 231s plated on compliant 
(E=0.2 kPa) PA substrates derivatized with laminin (90% laminin:10% collagen) 
assembled into networks.  (D) 231s plated on PA substrates derivatized only with 
collagen did not assemble networks and were uniformly distributed across the 
substrate. Scale bar is 200 m.  
 
Our findings indicate that 231 mammary cell network assembly was induced on 
substrates derivatized with laminin, but not collagen.  Interestingly, exogenous laminin 
has been shown to induce E-cadherin expression in 231s in 3D cultures [169].  To 
determine if 231 network assembly was associated with changes in E-cadherin 
localization, cells on laminin or collagen-derivatized substrates were fixed and stained 
for E-cadherin.  On compliant (E=0.2 kPa) substrates, 231s assembled networks with 
cell-cell junctions mediated by E-cadherin (Figure 3.17A; inset is a magnification of 
the region identified by the yellow arrow).  In contrast, E-cadherin was not detectable 
at the cell-cell junction of cells on stiff (E=10 kPa) substrates derivatized with laminin 
(Figure 3.17B), or on compliant or stiff substrates derivatized with collagen (Figures 
3.17C-D).  Instead, laminin staining was diffuse throughout the cell.  These findings 
suggest that E-cadherin expression enables 231 network assembly on compliant 
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substrates, and that substrate stiffness and matrix ligand type alter preferences for cell-
cell vs. cell-substrate adhesion in mammary epithelial cells. 
 
 
Figure 3.17.  Compliant substrates derivatized with laminin induce E-cadherin 
mediated cell-cell interactions in mammary cells. 
MDA-MB-231 mammary epithelial cells were plated on compliant (E=0.2 kPa) and 
stiff (E=10 kPa) PA substrates derivatized with laminin (90% laminin:10% collagen) 
or collagen alone and stained for E-cadherin.  (A) On compliant substrates derivatized 
with laminin, 231s assembled networks with cell-cell junctions mediated by E-
cadherin.  (B) On stiff substrates 231s did not assemble networks and E-cadherin was 
undetectable at cell-cell junctions.  (C-D) 231s plated on PA substrates derivatized 
collagen did not exhibit E-cadherin mediated cell-cell junctions on compliant or stiff 
substrates.  Instead, E-cadherin localization was diffuse throughout the cell.  Scale 
bars are 50 m.  
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3.5 Discussion 
In this study, we investigated the role of substrate stiffness in mediating cell-cell and 
cell-matrix interactions and determined that compliant substrates promote the self-
assembly of tissue-like structures in cell types derived from vascular, mammary, and 
mesenchymal tissues. 
 
Tissue formation is thought to result from differences in intercellular adhesions [147] 
that are sensitive to substrate stiffness.  Guo et al. hypothesized that cell clustering is 
dependent on substrate rigidity and results from attempts to optimize mechanical input 
[87].  For example, cells on mechanically rigid substrates receive adequate mechanical 
input from the substrate and prefer cell-substrate to cell-cell interactions.  When 
substrate stiffness is reduced, insufficient mechanical input from the substrate causes 
cells to seek out additional input from neighboring cell-cell interactions. 
 
Our results support these hypotheses.  On compliant substrates, ECs assembled into 
networks and formed tight cell-cell junctions mediated by VE-cadherin.  Substrate 
stiffness altered the cellular localization of VE-cadherin indicating that cell-cell 
junctions were mature.  At the same time, ECs on compliant substrates exhibited a 
reduction in focal adhesion organization and a measurable decrease in cell-substrate 
adhesion.  On stiff substrates, ECs did not form tight cell-cell junctions and exhibited 
an increase in cell-substrate adhesion.  These data demonstrate a clear role for 
substrate mechanics in modulating cell-cell adhesion and tissue formation.  This 
response may be relevant in cancer, where the tumor microenvironment is associated 
with ECM stiffening [16,39] and vasculature that is poorly organized and leaky [17].  
Our data indicate that stiff substrates promote loose cell-cell junctions (here and 
[170]), suggesting that the increased ECM stiffness of the tumor microenvironment 
 67 
promotes pathologic vessel formation, and that controlling ECM stiffening may be a 
target for cancer treatment. 
 
Network assembly is not unique to ECs. Previous reports indicate that mammary, 
lung, and mesenchymal tissue-derived cells are capable of tissue morphogenesis—i.e. 
tissue/network assembly.  Our data indicate that compliant substrates promote network 
assembly in mammary, mesenchymal, and vascular tissue-derived cell types.  In each 
of these cases (ECs, 10As, C3Hs, A7r5s), cells exhibit i) networks tightly colocalized 
with ECM on compliant substrates and/or ii) a measurable reduction in cell-matrix 
adhesion on compliant substrates.  Cells that did not assemble networks (231s, 2Bs, 
A549s) exhibit i) no obvious association with ECM and/or ii) no measurable reduction 
in cell-matrix adhesion on compliant substrates.  These findings indicate that there is a 
correlation between compliant substrates and preferences for cell-cell vs. cell-substrate 
adhesion, and support the hypothesis that network assembly arises from a balance of 
cell-cell and cell-matrix adhesion, i.e. reduced mechanical input on compliant 
substrate drives network assembly.  While these findings are in no way exhaustive, 
they provide evidence that substrate stiffness alters the cell-cell and cell-matrix 
interactions that regulate network assembly.     
 
Interestingly, our data indicate that in addition to cell-cell and cell-matrix adhesion, 
ECM colocalization is requisite for network assembly.  We previously determined that 
ECs require FN polymerization to assemble networks [112].  Specifically, FN 
polymerization stabilized cell-cell interactions.  Herein, we demonstrated that laminin 
is required for the assembly of mammary cells.  A requirement for ECM in mediating 
cell-cell interactions likely results from crosstalk between ECM proteins (FN, laminin) 
and cadherins.  For example, integrin engagement by FN alters VE-cadherin-mediated 
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cell-cell interactions and actin cytoskeletal organization [171] necessary for the 
polymerization of FN into fibrils [172,173].  We demonstrated that blocking VE-
cadherin engagement prevented network assembly, but also altered FN deposition, 
suggesting feedback mechanisms governing cell-cell and cell-matrix interactions.  
More work is needed to fully understand the role of these interactions in mediating 
vascular cell network assembly.           
 
Our findings with MDA-MB-231 mammary epithelial cells provide additional insight 
about the complexity of these interactions.  231s are deficient in the production of 
laminin (Figure 3.11B, [163]), a protein that is crucial for mammary cell network 
assembly on compliant substrates (Figure 3.7, [160]), and also did not exhibit 
alterations in cell-substrate adhesion with changes in substrate stiffness (Figure 
3.11C).  Moreover, E-cadherin was undetectable in these cells (Figure 3.15).  
However, 231s were induced to form network-like assemblies when plated on 
laminin-rich matrigel substrates or compliant substrates derivatized with laminin 
(Figure 3.16).  These results suggest that the presence of exogenous laminin on 
compliant substrates directs 231s to prefer cell-cell vs. cell-substrate adhesion.  
Indeed, similar to another report [169], laminin induced changes in E-cadherin 
localization in 231s (Figure 3.17) suggesting that E-cadherin expression enabled 
network assembly.  (In addition, 2Bs have been shown to assemble into networks on 
matrigel, but not collagen- or FN-coated TCP [164] suggesting the induction of cell-
cell adhesion molecules in this cell type as well).  These findings indicate that both 
substrate stiffness and ECM type alters the expression of cell-cell adhesion proteins 
and preferences for cell-cell vs. cell-matrix interactions that govern network assembly 
in mammary (and lung) epithelial cells.  This has important ramifications for cancer, 
where preferences for cell-cell interactions are involved with epithelial to 
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mesenchymal transition and metastasis [174]. 
 
In conclusion, these data indicate that substrate stiffness regulates network assembly 
by altering cell-cell and cell-matrix adhesion, and cell-ECM colocalization, and 
suggest that the sensitivity of network assembly to stiffness is universal across tissue 
type.  
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CHAPTER 4 
 
SUBSTRATE STIFFNESS AND CELL AREA PREDICT CELLULAR TRACTION 
STRESSES IN SINGLE CELLS AND CELLS IN CONTACT  
 
Published in Cellular and Molecular Bioengineering [149]. 
 
Portions of this chapter were recognized with a Graduate Research Award by the 
Biomedical Engineering Society (BMES) in 2009. 
 
4.1 Abstract 
Abstract—Cells generate traction stresses against their substrate during adhesion and 
migration, and traction stresses are used in part by the cell to sense the substrate.  
While it is clear that traction stresses, substrate stiffness, and cell area are related, it is 
unclear whether or how area and substrate stiffness affect force generation in cells.  
Moreover, multiple studies have investigated traction stresses of single cells, but few 
have focused on forces exerted by cells in contact, which more closely mimics the in 
vivo environment.  Here, cellular traction forces were measured where cell area was 
modulated by ligand density or substrate stiffness.  We coupled these measurements 
with a multilinear regression model to show that both projected cell area and 
underlying substrate stiffness are significant predictors of traction forces in endothelial 
cells, and interestingly, substrate ligand density is not.  We further explored the effect 
of cell–cell contact on the interplay between cell area, substrate stiffness, and force 
generation and found that again both area and stiffness play a significant role in cell 
force generation.  These data indicate that cellular traction force cannot be determined 
by cell area alone and that underlying substrate stiffness is a significant contributor to 
traction force generation. 
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4.2 Introduction 
Cellular traction forces are involved in cell adhesion and migration, [87,175] 
extracellular matrix (ECM) assembly and reorganization, [173] and cellular 
mechanotransduction [176,177].  The advent of multiple methods to measure cellular 
traction stresses has lead to numerous studies of the origin of force generation and its 
relationship to normal and pathologic conditions [16,178-180].  Recent work suggests 
that cellular force generation is dictated in part by the elasticity of the surrounding 
matrix [81], where cell traction force increases with substrate stiffness [86].  These 
studies imply that increased tissue stiffness increases the intrinsic force state of the 
cell.  The ramifications of these studies have been far-reaching, as there are a number 
of pathological states where tissues stiffen, including cancer progression [16], wound 
healing [26], and atherosclerosis [176].  However, in addition to increasing force 
generation, ECM stiffness also increases cell area [31,112].  Together, these results 
suggest a potential relationship between substrate stiffness, cell area, and traction force 
generation; however, the specific interplay of these parameters is unknown.  It is not 
clear whether increased ECM stiffness drives increases in cell area that increase cell 
force, or if ECM stiffness and cell area can drive increased force independently 
(Figure 4.1). 
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Figure 4.1.  Proposed interplay between substrate stiffness, cell area, and traction 
force in ECs. 
 
Much of what is known about cellular traction stress generation is based on studies of 
single cells in isolation.  However, this does not accurately depict the physiological 
state in many cases.  Many cells whose traction stresses have been studied extensively, 
such as epithelial and endothelial cells, are in contact with adjacent cells, however, 
much less is known about traction forces of cells in contact.  Interestingly, there is 
mounting evidence to show that increased matrix stiffness disrupts cell–cell contacts 
[16,112], yet little is known about the changes in traction generation of cells in contact 
that accompany such changes in matrix stiffness.  It is unclear if substrate mechanics 
plays a role in dictating cell forces once cells are in contact.  There is evidence to 
suggest that substrate mechanics has a more pronounced effect on cell area and stress 
fiber formation when cells are in isolation.  On compliant substrates, isolated cells 
exhibit fewer well-formed stress fibers and are typically less well spread. Upon cell–
cell contact, stress fiber formation increases [71].  Recent work investigating cells in 
contact indicate that monolayer geometry may influence the magnitude and orientation 
of traction forces across cell aggregates [181,182].  However, it is not known whether 
or how cell area and substrate stiffness contribute to traction force generation of cells 
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in contact, and whether these effects parallel the results found for single cells. 
 
Using measures of cellular traction forces coupled with a multilinear regression 
model, we show that both cell area and substrate stiffness are significant predictors of 
traction force generation in single and two endothelial cells (EC) in contact.  These 
data show for the first time that cell area is not the sole predictor of traction generation 
and that substrate stiffness plays a significant role in dictating force generation in cells 
even when they are in contact with other cells.  Our study indicates that both substrate 
stiffness and cell area play an important role in contributing to the mechanical 
response of cells. 
 
4.3 Materials and Methods 
Cell Culture 
Bovine aortic endothelial cells (VEC Technologies) were maintained at 37 °C and 5% 
CO2 in Medium 199 (Invitrogen) supplemented with 10% FetalClone III (Fisher), and 
1% each of penicillin–streptomycin, MEM amino acids (Invitrogen), and MEM 
vitamins (Mediatech).  ECs were used up to passage 12. 
 
Polyacrylamide Gel Synthesis 
Variably compliant poly(acrylamide) (PA) gels were prepared by altering the ratio of 
acrylamide to bis-acrylamide (BioRad) in the polymerization solution as described 
previously [28,112].  Gels were functionalized with N-6-((acryloyl)amino)hexanoic 
acid, succinimidyl ester (synthesized in our lab [32]) to allow covalent attachment of 
type I collagen (Sigma) to the gel surface.  Gels were polymerized and covalently 
bound to activated glass coverslips as described previously [112], and were 
derivatized with an applied collagen concentration of 100 g/mL for variable stiffness 
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studies, and 0.01–100 g/mL for variable concentration studies.  Gels were 
synthesized with Young’s Moduli (E) of 1, 2.5, 5, and 10 kPa to mimic 
physiologically relevant tissue stiffness [151]. 
 
PA Gel Stiffness Characterization 
The stiffness of PA gels was confirmed by measuring Young’s Modulus (E) at the gel 
surface using Hertz theory [86].  E = 3(1-2)f/4d 3/2 r 1/2, where d is the indentation 
depth of a steel ball with radius r exerting a buoyancy-corrected force f on the surface 
of a gel with Poisson’s ratio  = 0.3 [183].  A steel ball (r = 0.32 mm, Abbott Ball Co.) 
was placed on gels embedded with fluorescent beads (Invitrogen, 500 nm diameter) 
and indentation depth was measured by focusing the microscope on beads that 
returned to their original position in the gel after removal of the ball as we have done 
previously to confirm E [30]. 
 
Traction Force Microscopy 
Traction force microscopy (TFM) was used to quantify cellular traction forces. TFM 
maps the magnitude and spatial orientation of traction stresses exerted by a cell on its 
substrate by tracking displacements created in the substrate domain by the cell [61].  
Cells were seeded on PA gels embedded with fluorescent beads, allowed to attach and 
spread overnight, and were imaged in a custom temperature, humidity, and CO2-
controlled stage of a Zeiss Axio Observer Z1m microscope with a Hamamatsu ORCA-
ER camera. Bead fields were imaged before (stressed configuration) and after removal 
(relaxed configuration) of the cell with trypsin (Invitrogen).  These images allowed 
substrate displacements to be tracked with correlation-based optical flow [184].  
Substrate displacements were translated into a strain field that was used to compute 
traction stresses using Bayesian statistics that maximized the most likely traction field 
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that describes the given strain field [185].  The substrate strains were converted to 
traction stresses using the LIBTRC analysis library developed by Professor Micah 
Dembo of Boston University, who also invented the basic theory that underlies TFM. 
Images were processed with LIBTRC to determine the cellular traction vectors, T 
(stress vectors), the total magnitude of the force, |F|, and the projected cell area. |F| is 
an integral of the traction field magnitudes over the cell area, 
|F| = ∫∫   dxdyyxTyxT yx
2/122 ),(),(  , where T(x,y) = [Tx(x,y), Ty(x,y)] is the continuous 
field of local cellular traction vectors defined at local spatial positions (x, y) in the 
projected cell area [31].  Note that the mean traction vector over the entire cell area is 
assumed to be zero to satisfy a constraint of global force balance. 
 
Statistics and Regression Modeling 
Data for Figures 4.3, 4.5-4.6 were analyzed with analysis of variance (ANOVA) and 
Tukey’s Honestly Significant Difference test, or Student’s t for Figure 4.8, after 
natural log transformation to ensure assumptions of normality and equal variance.  For 
regression modeling, force and area data were transformed by natural log to ensure 
model assumptions of residual normality and equal variance.  All regression model 
parameter residuals had a Cook’s distance less than one indicating that no data point 
influentially distorted the regression outcome, and all parameter estimate variance 
inflation factors were less than three indicating the regression model did not suffer 
from multicollinearity [186].  ANOVA, Student’s t, and regression modeling were 
performed in JMP software (SAS Institute).  Sample sizes (n) for single cells (Figures 
4.3, 4.5, and 4.8) were n = 24, 14, 25, and 38 for E = 1, 2.5, 5, and 10 kPa substrates, 
respectively, and n = 17, 23, 6, 15, and 12 for collagen concentrations of 0.01, 0.1, 1, 
10, and 100 g/mL, respectively (Figure 4.5).  Sample sizes for two-cells in contact 
(Figure 4.8) were n = 16 and 20 (pairs of cells) for E = 1 and 10 kPa substrates, 
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respectively.  All analyses satisfied a statistical power of 0.8 or higher and a level of 
significance of 0.05 was assumed for all statistics. 
 
4.4 Results 
Endothelial Cell Traction Force and Area Increase with Increasing Substrate 
Stiffness 
To investigate the role of substrate stiffness in mediating EC traction force generation, 
cells were seeded on PA substrates where the applied collagen concentration was fixed 
(100 g/mL) across stiffness.  Figure 4.2 shows representative traction maps of ECs 
on compliant to stiff (E = 1–10 kPa) PA substrates.  The magnitude and orientation of 
the traction stresses, T, are shown by the color-coded vector plot over the projected 
cell area.  Traction vectors are oriented toward the center of the cell (contractile) and 
are largest at the cell edge of lamellipodia.  Note that cell morphology changes from 
spindle shaped on compliant gels toward more isotropic spreading with increasing 
substrate stiffness.  Further analysis showed that the magnitude of the traction force, 
|F|, increased significantly (*) over the range of increasing substrate stiffness E = 1–10 
kPa (Figure 4.3A) with a concomitant significant increase in projected cell area with 
substrate stiffness at fixed applied collagen concentration (100 g/mL) (Figure 4.3B).  
A plot of the traction force of each cell normalized by its projected area and averaged 
for each substrate stiffness demonstrated the same statistically significant positive 
correlation suggesting substrate stiffness influenced traction force generation (Figure 
4.3C). 
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Figure 4.2.  Representative images of EC morphology and traction stresses on 
variably compliant substrates. 
Representative images of EC morphology and traction stresses, T, on 
poly(acrylamide) gel substrates of increasing substrate stiffness (E = 1-10 kPa).  Inner 
circles depict localization of cell nuclei. 
 
 
 
 
 
 
 
 
 
Figure 4.3.  Traction force magnitude and cell area 
increase with increasing substrate stiffness. 
Traction force |F| (A) and cell area (B) versus substrate 
stiffness over the range E = 1-10 kPa at constant collagen 
concentration (100 g/mL).  Mean ± SEM.  (C) |F| of 
each cell normalized by its projected area (|F|/A) and 
averaged for each substrate stiffness.  Mean + SEM.  * 
indicates p<0.0001. 
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A Linear Regression Model Indicates Substrate Stiffness and Cell Area Are 
Predictors of Cellular Traction Force 
We established experimentally that cells of greater spread area exerted greater traction 
force, but it was not clear whether cells of a similar area exerted the same traction 
force across substrate stiffness levels.  To determine if the ratio of traction force to 
spread cell area was independent of substrate stiffness, we plotted force vs. area for 
each stiffness level (E = 1–10 kPa), and fit the data with linear regression lines (Figure 
4.4; inset represents magnification of the boxed region to emphasize regression trends 
between stiffness levels).  The data plot indicated that cell area alone could not always 
predict traction force.  Small cell areas usually correlated with less traction forces on 
compliant 1 kPa gels (Figure 4.4 inset—open circles); however, as cell area increased, 
the traction force magnitude output varied with substrate stiffness (Figure 4.4 inset—
e.g., see shaded region centered at 1750 m2).  Moreover, the slopes of the linear 
regression lines were non-parallel and increased with substrate stiffness suggesting 
that stiffness was a crucial parameter that contributed to the interaction between cell 
area and traction force.  Re-plotting this data set as traction force normalized by cell 
area against substrate stiffness indicated a statistically significant positive association 
with increasing stiffness (Figure 4.3C).  To formally test whether substrate stiffness 
and cell area were significant predictors of traction force, we used a least-squares 
multiple linear regression model that related force to area and stiffness.  We used an 
additive linear model of the form  
 
  ii xxY 110 ,     (1) 
 
where Y represents the response traction force, 0 is the intercept, 1 is the partial 
slope of quantitative variable x1 representing area, i is the partial slope of qualitative 
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variable xi representing the parameter stiffness, where xi = [(1 if level i), (0 
otherwise)], represents the four levels of stiffness tested (1, 2.5, 5, and 10 kPa), with 
summation implied over i=2-4, and  is random error.  This regression model assumed 
a linear relationship between force and area [30,187] and quantitatively assessed if the 
partial slopes representing the parameters area and stiffness were significant predictors 
of traction force.  The p-values of the linear regression model parameters indicated 
that both cell area and substrate stiffness were significant predictors of EC traction 
force (Table 4.1).  A comparison of p-values between parameters stiffness (p = 
0.0187) and area (p < 0.0001) suggests that cell area may be more influential in 
driving traction forces in single ECs. 
 
Figure 4.4.  Plot of traction force magnitude vs. cell area fit with linear regression 
lines. 
Plot of traction force |F| versus cell area fit with linear regression lines for each 
stiffness level E = 1-10 kPa at constant collagen concentration (100 g/mL).  Inset 
represents magnification of the boxed region to clarify regression trends.  Shaded 
region of inset highlights variable force output for cells of similar spread area. 
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Table 4.1.  List of p-values for significance of predictors E and Area on |F| 
 
Regression Model Predictor of |F| p-Value 
Single cells/Eq. (1) 
E 0.0187 
Area <0.0001 
Cell pairs/Eq. (2) 
E <0.0001 
Area 0.0010 
 
Endothelial Traction Force and Area Increase with Increasing Matrix Ligand 
Concentration 
Since increases in force correlate with both increases in substrate stiffness (Figure 
4.3A) and spread cell area (Figure 4.3B), we asked whether force could be modulated 
by cell area when substrate stiffness was held constant and area was modulated using 
substrate ligand density.  To test this, ECs were seeded on PA gels of constant 
stiffness (E = 5 kPa) with variable applied collagen concentration (0.01–100 g/mL).  
EC traction force (Figure 4.5A) and cell area (Figure 4.5B) increased significantly (*) 
with increasing collagen concentration when substrate stiffness was held constant.  To 
determine how cell area and ligand concentration contributed to force generation at 
constant stiffness, traction force vs. cell area was plotted for each collagen 
concentration and fit with linear regression lines (Figure 4.5C).  The data suggested 
that for a given collagen concentration, force increased with area.  To formally test 
whether area and ligand concentration were predictors of force, we applied the model 
presented in Eq. (1) where ixi was summed over i = 2-5 to represent the five levels of 
collagen concentrations tested (0.01, 0.1, 1, 10, and 100 g/mL), and all other 
parameters were as described above.  The analysis indicated that cell area was a 
significant predictor of traction force (p = 0.0002), but that ligand density was not (p = 
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0.9404).  Importantly, these data show that traction forces are driven by cell area, not 
ligand density.  Together with the results presented in Figure 4.3, these data indicate 
that traction force increased when cell area was increased through changes in either 
substrate stiffness (Figure 4.3A) or ligand density (Figure 4.5A). 
 
 
Figure 4.5.  Traction force magnitude, cell area, and regression modeling for 
substrates of variable collagen concentration. 
Traction force |F| (A) and cell area (B) versus applied collagen concentration of 0.01-
100 g/mL at fixed substrate stiffness (E = 5 kPa). Mean ± SEM; * indicates p 
<0.001; ** indicates p <0.0001.  (C) Plot of |F| versus area for each collagen 
concentration on E = 5 kPa gels and fit with linear regression lines. 
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Similar to substrates derivatized with collagen, we determined that EC area increased 
with increasing concentrations of fibronectin (Figure 4.6).  These data indicate that 
cell area is sensitive to collagen or FN matrix density.  
Figure 4.6.  EC area increases with increasing fibronectin concentration. 
ECs were plated on 9 kPa substrates derivatized with variable concentrations (1-1000 
g/mL) of fibronectin (FN).  (A) Cells appeared spread on substrates derivatized with 
1 g/mL FN and increased in size up to 1000 g/mL FN. Scale bar is 50 m.  (B) 
Quantification of cell area (n=50 for each condition) indicated a significant increase in 
cell area with increasing FN concentration (*p<0.05; ANOVA).  
 
Endothelial Two-Cell Aggregates Exert Increased Traction Forces 
Cells do not typically reside in isolation in vivo.  While our data indicate that substrate 
stiffness and cell area both play a role in cell force generation in single cells, it is not 
clear if these relationships are maintained while cells are in contact with other cells.  
Two ECs in contact on E = 1 and 10 kPa gels were analyzed with TFM and modeled 
as a single force-generating unit (Figure 4.7).  Note that cell–cell connections on 
compliant 1 kPa gels tend to be oriented end-to-end compared to cell–cell connections 
between cells on stiffer 10 kPa gels that exhibit increased spreading.  Similarly to 
single cells (Figure 4.2), traction forces of cells in contact are contractile and greatest 
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at cell edges and in lamellipodia.  As expected, |F| of two cells in contact was 
significantly greater (*) than the force generated by single cells across the two 
substrate moduli tested (Figure 4.8).  Notably the increase in traction force generation 
of two cells in contact compared to single cells is greater on stiff substrates (a 126% 
increase on 10 kPa gels compared to a 76% increase on 1 kPa gels). 
 
 
Figure 4.7.  Representative images of cell morphology and traction stresses for 
two ECs in contact.  
Representative images of two ECs with a portion of their membrane in contact on E = 
1 and 10 kPa substrates were modeled as a single force generating unit with TFM.  
Inner circles depict localization of cell nuclei.  Scale bars in phase images are 50 m. 
 
 
 
 
 
 
 
 
 
 
 
 84 
Figure 4.8.  Traction force magnitude increases when ECs are in contact. 
Traction force |F| of single and two ECs in contact on E = 1 and 10 kPa substrates at 
constant collagen concentration (100 g/mL).  Relative increases in force between 
single and two ECs in contact are 76% on 1 kPa gels and 126% on 10 kPa gels.  Mean 
+ SEM; * indicates p<0.005; ** indicates p <0.001. 
 
To determine if cell area and substrate stiffness were significant predictors of traction 
force of cells in contact, as we found for single cells, we used an additive linear model 
of the form 
  3322110 xxxY ,   (2) 
 
where Y, 0, 1, x1, and  are as defined above for Eq. (1), 2 is the partial slope of 
qualitative variable x2 representing the parameter stiffness (1 and 10 kPa), and 3 is the 
partial slope of qualitative variable x3 representing the parameter number of cells (one-
cell and two-cell aggregates).  Similarly to model Eq. (1), this model assumed a linear 
relationship between force and area and quantitatively accounted for the parameters 
substrate stiffness, cell area, and cell number in mediating traction force.  Again, the 
linear regression model indicated that both cell area and substrate stiffness were 
significant predictors of traction force (Table 4.1).  A comparison of p-values 
indicated that substrate stiffness was a more significant predictor of traction force than 
area for cells in contact (p < 0.0001 for stiffness compared to p = 0.0010 for area) 
 85 
which was in contrast to our findings in single cells where area was more significant.  
Additionally, substrate stiffness was a more significant predictor of force for cells in 
contact compared to single cells (p < 0.0001 for cell pairs compared to p = 0.0187 for 
single cells).  These data indicate that substrate stiffness plays a prominent role in 
directing traction forces of cells in contact. 
 
4.5 Discussion 
In this study, we show for the first time that both cell spread area and substrate 
stiffness are significant predictors of cellular traction force in endothelial cells, and 
that substrate ligand density does not directly drive traction generation.  Our previous 
data indicate that EC area increases with increasing substrate stiffness [31,112], and 
EC traction force positively correlates with greater cell spread area [64].  Together, 
these findings support a model of interaction where traction force is driven by a 
coupling of cell area and substrate stiffness.  Further, we demonstrate that traction 
force cannot be predicted by cell area alone—force also depends on underlying 
substrate stiffness (Figure 1).  These results are important because they show for the 
first time that substrate stiffness can alter cellular force profiles independently of 
changes in cell area.  Because matrix stiffening occurs in a number of disease states 
including atherosclerosis, wound healing, and cancer, these results have important 
ramifications for understanding the baseline force profiles of cells as a function of 
their extracellular mechanical environment. 
 
To investigate the relationship between cell area and traction generation, cell area was 
manipulated experimentally by changing substrate stiffness and increasing the density 
of ligand on the surface of the substrate.  In both cases, we found a positive correlation 
between cell area and traction force magnitude.  When substrate stiffness was varied, 
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normalizing force by area showed an increase relative to stiffness, indicating that 
substrate stiffness (and not area alone) was driving an increase in force.  When 
stiffness was held constant, cell area (and not ligand density) was driving an increase 
in force.  Data from our lab and others indicates that increasing substrate stiffness or 
ligand density can lead to integrin clustering and increased focal adhesion number and 
size [29,31,71].  Since ligand density is not a predictor of traction force, it is unclear 
whether we can attribute changes in force to differential integrin clustering when 
stiffness is held constant.  While integrin clustering may contribute to increases in 
force generation, our data suggest that substrate stiffness and cell area (whether 
modulated by stiffness or ligand density) are prominent and significant contributors to 
force. 
  
While our study specifically focused on endothelial cells, the results may translate to 
other cell types as well.  Substrate stiffness and cell area have been shown to influence 
traction force generation in other cell types, and should be the subject of future 
investigations.  It has been demonstrated in 3T3 fibroblasts and mammary epithelial 
cells that increases in traction force generation with substrate stiffness are 
accompanied by an increase in cell area [16,86].  As was studied here, it would be 
interesting to investigate whether cell area, substrate stiffness, and traction stress 
generation are linked in other cellular systems and whether their interactions are 
universal. 
 
In addition to studying single cell force generation, we also investigated the 
relationship between force, cell area, and substrate stiffness of cells in contact.  Our 
goal in these studies was to determine whether the relationship we found for single 
cells, which indicated that both substrate stiffness and cell area were important 
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determinants of force generation, holds once cells are in contact.  Very few studies 
have tackled the question of traction stress distribution of cells in contact.  Because 
cell contact occurs in the healthy physiological state, these studies are critical to 
understanding cell contractility and response to the mechanical properties of the 
extracellular matrix in vivo. 
 
Our results of traction forces of cells in contact indicate that both substrate stiffness 
and cell area predict force in two-cell aggregates.  Importantly, these data show that 
once in contact, cells maintain sensitivity to substrate stiffness.  We demonstrate for 
the first time that once in contact with an adjacent cell, ECs exert greater traction 
forces compared to single cells.  The increase in traction force output by cell 
assemblies compared to single cells suggests an increase in cellular contractility with 
contact.  It was shown previously that stress fiber organization follows cell–cell 
contact on compliant substrates [71].  An increase in actin fiber organization upon 
cell–cell contact likely facilitates increased cellular contractility thereby increasing 
traction force output compared to single ECs.  An increase in traction force with cell 
contact has also been reported in epithelial cell monolayers that exert traction forces 
that are greater than stresses measured in single cells [188].  Taken together, these data 
suggest that the increase in traction force generation that is initiated upon cell–cell 
contact may be sustained during tissue formation and depend significantly on substrate 
stiffness. 
 
Interestingly, the increase in traction force with cell–cell contact on compliant gels 
was less than two-fold greater (76%) while the increase on stiff gels was more than 
two-fold (126%).  We have previously established that ECs are capable of sensing the 
traction forces exerted by adjacent cells that drive cell–cell interactions, and that cell–
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cell connectivity changes with substrate stiffness; cells on compliant gels prefer cell–
cell connections and cluster while those on stiffer substrates prefer cell–substrate 
interactions and migrate away from each other [36].  The difference in magnitude of 
increased traction force output with substrate stiffness may result from an optimization 
of cell–substrate and cell–cell interactions.  It has been shown that integrins and 
cadherins, mediators of cell–substrate and cell–cell connections, respectively, are 
involved in crosstalk with intracellular mediators of contractility [171,189] that govern 
traction force.  While our use of TFM to model two cells in contact did not account for 
changes in the temporal stability of cell–cell contacts with stiffness or potential effects 
of cadherin-mediated changes in cellular contractility, our measurements of traction 
forces during cell–cell contact further implicate substrate mechanics as an important 
modulator of cellular traction forces. 
 
In summary, we have used TFM to quantify a relationship between cell spread area, 
substrate stiffness, and traction force generation.  We have used a multilinear 
regression model to show for the first time that both cell area and substrate stiffness 
are significant predictors of traction force in endothelial cells.  Our data underscore the 
importance of substrate stiffness and cell spreading as key contributors to the ability of 
cells to generate force. 
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CHAPTER 5 
 
SUBSTRATE STIFFNESS ALTERS FIBRONECTIN SYNTHESIS AND 
DEPOSITION  
 
Portions of this chapter are in preparation for submission. 
 
5.1 Abstract 
The mechanical microenvironment is an important mediator of cell function.  In 
particular, the stiffness of the extracellular matrix (ECM) regulates cell responses 
including adhesion, migration, differentiation, and tissue morphogenesis.  These 
responses are facilitated by cell-ECM interactions, and suggest that matrix stiffness 
fundamentally alters the interaction between cells and the ECM; however, this 
relationship is not well understood.  Here, we investigate the role of substrate stiffness 
in mediating the synthesis and deposition of fibronectin (FN) by endothelial cells.  We 
demonstrate that substrate stiffness alters the dynamics and density of FN deposition, 
and the expression of EDB-FN, an FN isoform specific to neovasculature.  ECs on 
compliant substrates adopt a bipolar morphology and deposit unidirectional fibrils of 
FN in contrast to an omnidirectional web-like mesh deposited on stiff substrates.  
Unidirectional deposition of FN can be recapitulated on stiff substrates by enforcing a 
bipolar morphology.  Differences in FN deposition with stiffness are due to changes in 
cell shape and the directionality of ROCK-mediated traction forces.  These findings 
indicate that substrate stiffness is a crucial regulator of ECM synthesis and deposition, 
and suggest that the mechanical microenvironment fundamentally alters cell-ECM 
interactions.  
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5.2 Introduction 
The mechanical microenvironment is an important regulator of cell function.  The 
stiffness of the extracellular matrix (ECM) has emerged as a prominent mediator of 
cell adhesion, spreading, migration, and differentiation [71,86,112,149,190].  These 
responses all require cell-ECM interactions, and suggest that matrix stiffness 
fundamentally alters the interaction between cells and the ECM.  Previously, we 
demonstrated that compliant matrices support the self-assembly of capillary networks 
that require the polymerization of fibronectin (FN) [98,112], a major ECM constituent 
that mediates cell adhesion, migration, and differentiation [191].  While these findings 
suggest that substrate stiffness mediates the differential expression and deposition of 
FN that enables capillary network assembly, this relationship is unknown.   
  
FN is a dimeric glycoprotein required for embryonic development [99] and 
cardiovascular morphogenesis [100].  In tissues, FN may contain extra domain B 
(EDB), a type-III homology domain resulting from differential exon splicing [106].  
While essentially undetectable in normal adult tissues [107], EDB-FN is a specific 
marker for angiogenic blood vessels [108] and may be an important clinical target for 
localizing tumor vasculature [109].  In cancer, solid tumors are associated with an 
increase in tissue stiffness [16], alterations in local vasculature [110], and growth 
requiring neovascularization [111].  These findings suggest that matrix stiffness plays 
a role in mediating angiogenic (EDB-containing) vessel formation; however, the 
sensitivity of EDB-FN expression to substrate stiffness is unknown. 
 
During FN ECM assembly, compact FN dimers are converted into an insoluble 
fibrillar matrix [101].  Such fibril polymerization is associated with cell contractility 
that exposes cryptic self-assembly sites that may contribute to fibril assembly 
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[103,104].  Deposited FN fibrils are thus directed by cellular traction forces [173].  In 
addition, we have demonstrated that substrate stiffness and cell size are important 
contributors to endothelial cell contractility [149].  Taken together, these data suggest 
that FN is sensitive to substrate stiffness-mediated alterations in EC shape and 
endogenous traction forces, however, these relationships are poorly understood.  
 
Here, we investigated the role of substrate stiffness in mediating FN deposition.  We 
demonstrate that substrate stiffness regulates the dynamics of FN deposition through 
alterations in cell shape and the directionality of ROCK-mediated traction forces that 
guide fibril deposition.  Furthermore, these data for the first time indicate that 
substrate stiffness is a mediator of EDB-FN synthesis and deposition.  These findings 
suggest that the mechanical microenvironment fundamentally alters EC-FN 
interactions.  
 
5.3 Materials & Methods 
Cell Culture 
Bovine aortic endothelial cells (BAEC; VEC Technologies, Rensselaer, NY) were 
maintained as described previously [149].  Primary human umbilical vein endothelial 
cells (HUVEC) were maintained at 37°C and 5% CO2 in Medium 200 supplemented 
with 5% fetal bovine serum (Gibco, Life Technologies, Grand Island, NY), 2% low 
serum growth supplement, and used to passage 9.  MCF10A human mammary 
epithelial cells (ATCC, Mannassas, VA) were maintained at 37°C and 5% CO2 in 
Dulbecco’s Modified Eagle Medium (Gibco) supplemented with 5% horse serum 
(Gibco), 1% penicillin-streptomycin (Gibco), 0.1% insulin, 0.05% hydrocortisone 
(Sigma-Aldrich, St. Louis, MO), 0.02% epidermal growth factor (Gibco), and 0.01% 
cholera toxin (Sigma).  
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Polyacrylamide Gel Synthesis and Stiffness Characterization 
Variably compliant PA gels were prepared as described previously [28,30,112,149].  
and derivatized with an applied type I collagen (BD, Franklin Lakes, NJ) 
concentration of 100 µg/mL [112].  Gels were synthesized with Young’s Moduli (E) 
of 0.2-10 kPa to mimic physiologically relevant tissue stiffness [151].  Substrate 
stiffness was confirmed by measuring E at the gel surface as described previously 
[30,149]. 
 
Fibronectin Immunofluorescence Localization  
Endothelial cells on PA gels were processed for fluorescence imaging as described 
previously [112].  Briefly, samples were fixed for 15 min in 3.7% (v/v) formaldehyde 
(JT Baker, Phillipsburg, NJ) in PBS (Gibco) and blocked with 3% (w/v) BSA (Sigma) 
in PBS for one hour.  To localize fibronectin (FN), samples were incubated 1:50 in 1% 
(w/v) BSA in PBS with an anti-FN primary antibody (A17, or BC1 for EDB-FN only, 
Santa Cruz Biotechnology (SCBT), Santa Cruz, CA) overnight at 4°C and an Alexa 
Fluor-labeled secondary antibody (Molecular Probes, Life Technologies, Grand 
Island, NY) for one hour at room temperature.  Actin was localized with Alexa Fluor-
labeled phalloidin (Molecular Probes) and nuclei labeled with DAPI (Sigma). 
Fluorescent images were acquired with a Zeiss Axio Observer Z1m or a Zeiss 710 
confocal microscope.  Images were pseudo-colored and z-stacks were reconstructed 
with Zen software (v. 2009, Carl Zeiss, Germany).  To determine FN solubility, 
samples were treated with 10% (w/v) sodium deoxycholate (DOC; EMD Chemicals, 
Gibbstown, NJ) in deionized water for 5-10 minutes before fixation. 
 
Laminin Immunofluorescence Localization 
MCF10A cells on PA gels were fixed as described above and stained for laminin-5 
 93 
with an anti-laminin-2 primary antibody (GB3, SCBT).  Confocal z-stacks were used 
for 3D reconstructions as described above. 
 
Fibronectin Fluorescent Quantification 
Images of fluorescently-labeled FN used for quantification were acquired under the 
same microscope exposure settings.  To quantify the fluorescent signal, ImageJ [153]  
was used to measure the integrated density (the product of the image area and the 
mean gray-scale pixel value) of each input image (microscope fields of the FN 
channel) after subtraction of the mean gray-scale value to reduce background signal.  
Since the area of each image analyzed used for comparisons was of identical and 
constant area, the results were reported as simply the mean gray-scale pixel value. 
 
Fibronectin Western blot  
HUVECs were plated on 1 and 10 kPa PA gels, rinsed with ice-cold Tris-buffered 
saline (TBS), and lysed on ice with 2X Laemmli lysis buffer (62.5 mM Tris-HCl, 25% 
glycerol (JT Baker), 5% b-mercaptoethanol (BioRad, Hercules, CA), 2% sodium 
dodecyl sulfate (SDS; JT Baker), and 0.01% bromophenol blue (BioRad) in deionized 
water) after three days.  The lysate was harvested, mixed, and spun at 14k xg at 4°C 
and the supernatant was removed for analysis.  1X Laemmli buffer was added to the 
supernatant and samples were heated for 5 min at 95°C.  Equal volumes of sample 
were loaded into SDS-polyacrylamide gels and subjected to electrophoresis with a 
Mini-PROTEAN Tetra System (BioRad) in Tris-glycine running buffer (25mM Tris, 
192 mM Glycine, 0.1% SDS).  Proteins were transferred to nitrocellulose membranes 
(BioRad) with a Criterion Blotter system (BioRad) in cold transfer buffer (25 mM Tris 
and 192 mM Glycine).  Membranes were blocked with 5% (w/v) milk (Nestlé, 
Wilkes-Barre, PA) in TBS-polyoxyethylene (20) sorbitan monolaurate (Tween; JT 
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Baker), incubated overnight 1:500 in TBS-Tween with an anti-fibronectin primary 
antibody (A17, or BC1 for EDB-FN, SCBT) at 4°C, and 1:2000 in TBS-Tween with 
0.1% (v/v) milk with a horseradish peroxidase-conjugated secondary antibody for one 
hour at room temperature.  Samples were images with a Las-4000 imaging system 
(Fujifilm Life Science, Japan) after addition of Immobilon Chemiluminescent 
Substrate (Millipore, Billerica, MA).  Samples were stripped with Restore Stripping 
Buffer (Thermo Scientific, Logan, UT), re-blocked with milk, incubated 1:1000 in 
TBS-Tween with an anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
primary antibody (6C5, Millipore) at room temperature for one hour, incubated 1:2000 
in TBS-Tween with 0.1% (v/v) milk with a horseradish peroxidase-conjugated 
secondary antibody for forty-five minutes at room temperature, and reimaged.  
Densitometry was performed with imageJ and expressed as the fold change of the ratio 
of FN to GAPDH of samples from 10 kPa gels compared to 1 kPa gels.  Data were the 
results of three independent experiments. 
 
Laminin Western blot 
MCF-10A human mammary epithelial cells were plated on 0.2 and 10 kPa PA 
substrates.  Samples were lysed after three days, subjected to PAGE, transferred to 
nitrocellulose, and analyzed as described above, but treated with an anti-laminin-2 
primary antibody (B2; SCBT).  Data were the results of three independent 
experiments.  
 
Fibronectin Quantitative Real-Time PCR  
HUVECs were plated on 1 and 10 kPa PA gels, rinsed with PBS, and collected after 
the addition of 0.25% trypsin-EDTA (Gibco) for 10 min at 37°C after three days.  
Cells were pelleted, rinsed with PBS, and total RNA was purified with an RNeasy 
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Plus Mini Kit (Qiagen, Valencia, CA).  To generate cDNA, 1 g of total RNA per 
sample was mixed with 80 M random primers (Invitrogen, Life Technologies, Grand 
Island, NY), 10 mM deoxynucleotide solution mix (New England Biolabs (NEBL), 
Ipswich, MA), nuclease-free water, and heated for 5 minutes at 75°C.  After the 
addition of 40U/L RNase inhibitor, and 200 U/L M-MuLV Reverse Transcriptase 
in M-MuLV reaction buffer (NEBL), cDNA was synthesized in an iCycler thermal 
cycler (BioRad).  cDNA was diluted 1:50 in deionized water, prepared for quantitative 
real-time PCR by the addition of 300 nM forward primer, 300 nM reverse primer 
(Integrated DNA Technologies (IDT), Coralville, IA), 1X iQ SYBR Green Supermix 
(BioRad), and analyzed with a My iQ Real-Time PCR Detection System (BioRad).  
The primers used for EDB-FN were 5’-CCTGGAGTACAATGTCAGTG-3’ 
(Forward) and 5’-GGTGGAGCCCAGGTGACA-3’ (Reverse) [192].  Primers for the 
reference gene GAPDH were 5’-CATGAGAAGTATGACAACAGCCT-3’ (Forward) 
and 5’-AGTCCTTCCACGATACCAAAGT-3’ (Reverse).  The results were expressed 
as a fold change in gene expression of EDB-FN relative to GAPDH on 10kPa gels 
compared to 1 kPa gels using the Livak method.  Data were the results of three 
independent experiments.  
 
Fibronectin Transfection 
To determine the quality of FN deposition in real time, BAECs were transfected with 
YFP-FN, a kind gift from Dr. Harold Erickson and Dr. Tomoo Ohashi.  Plasmid DNA 
was amplified in DH5a cells (Invitrogen) and purified with a Quantum Prep Plasmid 
Midiprep Kit (BioRad).  For transfection, BAEC were grown to 90% confluency in 
wells of six-well plates, washed twice with Optimem (Gibco), and incubated with 2 g 
DNA plus 5 L Lipofectamine 2000 (Invitrogen) in Optimem per well for five hours, 
and replenished with fresh complete Medium 199.  Transfected ECs were plated on 
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PA substrates 24 hours after transfection and imaged with time-lapse microscopy 
beginning 48 hours after transfection.  
 
ROCK Knockdown 
To disrupt ROCK1-mediated cellular contractility, BAEC were plated on PA gels in 
the presence of 10 M Y27632, a concentration we have shown previously to reduce 
cell-generated traction forces [170].  Samples were fixed at 4-48 hours after plating 
and stained to localize FN, actin, and nuclei as described above.  ROCK1 was also 
disrupted with RNAi.  BAEC were also treated with an siRNA against bovine ROCK1 
(Invitrogen) or a control siRNA (SCBT).  To knockdown ROCK1, BAEC were grown 
to 60-80% confluency in wells of six-well plates, washed twice with Optimem, and 
incubated with 20 pmol siRNA in 5 L Lipofectamine 2000 in Optimem per well for 5 
hours, and replenished with complete Medium 199.  Transfected cells were plated on 
PA substrates 24 hours after transfection, and samples were fixed at 24-hour time 
points over the next three days and stained to localize FN, actin, and nuclei as 
described above.  Separate experiments determined the expression of ROCK1 with 
Western blotting over the same three-day period as described above but using an anti-
ROCK1 primary antibody (H-85; SCBT).  Similarly, HUVEC were treated as 
described above for BAECs with siRNA against human ROCK1 (H-85; SCBT) or a 
control siRNA (SCBT), and stained to localize EDB-FN on the third day post-plating 
as described above.  Western blotting was performed at this same time-point as 
described above but using an anti-ROCK1 primary antibody (H-85; SCBT). 
 
Traction Force Microscopy 
Traction force microscopy (TFM) was used to quantify cellular traction stresses as 
described previously [149].  Substrate strains generated by cells were converted to 
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traction stresses using the LIBTRC analysis library developed by Professor Micah 
Dembo of Boston University, who also invented the basic theory that underlies TFM 
[61,185].  LIBTRC was used to determine the cellular traction stresses, and their 
components projected along the long and short axis of the cell area by taking the 
integral of the absolute value of the traction magnitudes dotted with a unit vector 
directed along the long and short cell axis, respectively.  Data were plotted as the 
relative percent each projection (long and short) contributed to the total of both 
projections.  Traction vectors were omitted from every other node for pictorial clarity. 
 
Fibronectin Polymerization Inhibitor 
Fibronectin polymerization was inhibited by the addition of 500 nM pUR4B [193] to 
the cell suspension during plating [112].  Control samples were plated in the presence 
of control peptide III-11C [112] (kind gifts from Dr. Jane Sottile).  Traction force 
microscopy was performed on n=60 and 72 cells for control and pUR4B treatment 
conditions, respectively, for cells on E=5 kPa PA gels 24 hours after plating.  For area 
measurements over time, n=15 cells per condition on E=0.2 kPa PA gels were imaged 
with time-lapse microscopy and analyzed with imageJ to determine the projected cell 
area, and cell centroids at ten-minute intervals for a period of four hours starting 24 
hours after plating.  Migration speed was determined with MATLAB (The 
MathWorks, Inc., Natick, MA) code [175] that fit the mean-square cell displacement 
<d
2
>, the time interval t, persistence time P, and cell speed S, to the random walk 
equation with nonlinear least-squares regression analysis: <d
2
>=2S
2
P(t-P[1-exp(-t/P)]) 
[194]. 
 
Micropatterning Polyacrylamide Substrates 
Polyacrylamide substrates were micropatterned with methods adapted from Rape et al. 
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[195].  Silicon molds were fabricated with arrays of 15x300 m2 rectangular or 22x22 
m2 square features as described previously [196], and used to cast PDMS stamps.  
Prior to gel polymerization, type I collagen (100 g/mL) was mixed with 20 mol/mL 
N-6-((acryloyl)amido)hexanoic acid (synthesized in our lab according to the method 
of Pless et al. (N6; [32])) in HEPES buffer (pH 8) (EMD Chemicals) for 2 hours on 
ice.  This mixture was pipetted onto PDMS stamps (4 arrays of 4x7 mm
2
 regions of 
features) and incubated for 30 minutes at room temperature to “ink” the stamps.  
Excess collagen-N6 mixture was removed, and inked stamps were placed in contact 
with clean glass 22x22 m2 coverslip for 5 minutes, and carefully removed.  This 
stamped glass was used as the top coverslip in the traditional polyacrylamide gel-
synthesis protocol [112].  Micropatterned 10 kPa PA substrates were fixed and stained 
as described above to localize collagen patterning with an anti-type I collagen primary 
antibody (Millipore) and an Alexa fluor-labeled secondary antibody (Molecular 
Probes).   
 
Cell, Actin and FN Polarization Quantification 
Cell elongation was determined for individual cells by measuring the aspect ratio 
(ratio of lengths of the major to minor axes of a fit ellipse) from cell outlines with 
ImageJ.  Fluorescent images of actin and FN were acquired three days after plating 
cells, to allow fibril deposition, and processed with ImageJ to determine their 
respective angle of orientation.  Cell outlines were traced and fit with an ellipse to 
determine the orientation angle of the long axis of the cell [80] and the overall 
orientation of the filamentous actin and FN associated with the cell with OrientationJ, 
a free ImageJ plug-in that characterizes the orientation and isotropy properties of a 
region of interest qualitatively with hue and quantitatively as an output angle with 
respect to the horizontal axis [197].  The output angles between cell and actin, and 
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actin and FN were compared. The overall angle range was converted to 0-90 degrees 
(acute supplementary angles were determined from obtuse output orientation angles) 
to determine the minimum difference in degrees between orientations. 
 
Statistics 
EDB-FN deposition (Figures 5.5B, 5.14C) resulted from n=10 and 40 fields of view 
per condition, respectively, and were analyzed with Student’s t test.  Actin and FN 
polarization data (Figure 5.7C-D) resulted from n=30 cells per condition and were 
analyzed with Student’s t test.  The aspect ratio of individual cells (not in contact with 
other cells) resulted from n=70 cells per condition (Figure 5.8C), and n=71 and 68 
cells for E=0.2 and 10 kPa substrates, respectively (Figure 5.18E), and were analyzed 
with Student’s t test.  Traction polarization data (Figure 5.8D) resulted from n=24, 14, 
25, and 38 cells on E=1, 2.5, 5, and 10 kPa substrates, respectively, for individual cells 
and were analyzed with ANOVA and Tukey’s HSD test.  For cell-cell contact, n=16 
and 20 pairs of cells for E=1 and 10 kPa, respectively (Figures 5.8E-F) were analyzed 
with Student’s t test.  The sample size of cells on micropatterned substrates (Figure 
5.9C) were n=58 and 29 for 1 cell pattern and 2 cell pattern, respectively.  Patterned 
vs. non-patterned results for a given stiffness were compared with Student’s t test.  
Quantification of FN deposition for Y27632 experiments (Figure 5.12B) and ROCK 
siRNA experiments (Figure 5.13C) resulted from n=8-12 and n=11-16 fields of view 
per condition, respectively, and were analyzed with 2-way ANOVA and Tukey’s HSD 
test.  Cell area measurements (Figures 5.12C, 5.13D) resulted from n=50 cells per 
condition and were also analyzed with 2-way ANOVA and Tukey’s HSD test.  
Quantification of traction forces and area for cells treated with FN siRNA (Figures 
5.16C-D) resulted from n=52 and n=57 cells for treatment and control conditions, 
respectively.  Traction forces for cells treated with FN inhibitor pUR4B (Figure 
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5.16E) resulted from n=60 and 72 cells for control and pUR4B treatment, respectively, 
and n=15 cells per condition for area (Figure 5.16F) and migration data (Figure 
5.16G), respectively, and were analyzed with Student’s t test.  All bar graphs were 
reported as mean +/- SEM. Analyses were performed with JMP after natural log 
transform (v.8-9, SAS, Cary, NC). 
 
5.4 Results 
Substrate Stiffness Alters the Quality and Dynamics of Fibronectin Deposition 
Previously we investigated the role of substrate stiffness in mediating capillary 
network assembly, and demonstrated that network assembly requires FN 
polymerization [112].  Herein, we investigated the role of substrate stiffness in 
mediating EC-FN interactions.  
 
ECs plated on compliant (E=0.2 kPa) substrates assembled a network-like morphology 
characterized by clusters of cells connected by cords of aligned cells and circular 
lacunae (Figure 5.1A “Actin/Nuclei).  Immunostaining for FN revealed colocalization 
between the morphology of cell assemblies and FN staining (Figure 5.1A “FN”). 
When substrate stiffness was increased (E=10 kPa), network assembly did not occur, 
and both cells and FN staining were uniformly distributed across the substrate (Figure 
5.1B). 
 
Further investigation into the dynamics of FN deposition utilized ECs transfected with 
a plasmid encoding YFP-FN (a kind gift from Dr. Harold Erickson and Dr. Tomoo 
Ohashi) that were plated on compliant and stiff substrates and imaged with time-lapse 
fluorescence microscopy.  On compliant substrates, ECs deposited thin and directed 
fibrils of FN during migration over the substrate surface (Figure 5.1C white arrow 
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head; yellow arrow head identifies a cell of interest; white arrow identifies migration 
path).  In contrast ECs on stiff substrates deposited a web-like mesh of FN during 
migration (Figure 5.1D white arrow head). 
Figure 5.1.  Substrate stiffness alters fibronectin deposition. 
(A) ECs on compliant (E=0.2 kPa) substrates assembled a network morphology 
associated with fibronectin (FN).  (B) Stiff (E=10 kPa) substrates did not support 
network formation but cells and FN were instead uniformly distributed.  (C) ECs 
deposited thin and directed YFP-FN fibrils (white arrow head) on compliant substrates 
over time (white arrow identifies migration path; yellow arrow head identifies a cell of 
interest).  (D) ECs on stiff substrates deposited a web-like mesh of YFP-FN over time 
(bars are 50 m).  YFP-FN was a gift from Dr. Harold Erickson and Dr. Tomoo 
Ohashi.  
 
Assembled or polymerized FN fibrils are identified by their insolubility in 
deoxycholate (DOC) [101,198].  To determine whether EC in networks were 
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associated with assembled FN, networks on compliant substrates were treated with 
deoxycholate [198] and stained for FN.  Our results indicated that cell networks on 
compliant substrates were associated with insoluble (assembled) FN (Figure 5.2A).  
Since DOC lyses cells, these data also indicated that the network morphology of FN 
was retained despite cell removal (confirmed by staining for actin and nuclei, not 
shown).  On stiff substrates treated with DOC, insoluble FN appeared uniformly 
distributed across the substrate (Figure 5.2B). 
 
To determine the spatial localization of FN in 3D, ECs on compliant and stiff 
substrates were fixed, stained for FN, and imaged with confocal microscopy.  Image 
stacks were reconstructed and oriented to display the apical and basolateral surface.  
When plated on compliant substrates, ECs assembled into networks where FN was 
localized to the basolateral side (Figure 5.2C, “Basolateral”).  Notably, extended cell 
processes ran atop tracks of fibrils of FN that appeared oriented in the direction of the 
long axis of the cell (Figure 5.2C, arrow heads).  On stiff substrates, ECs were still 
enmeshed in FN primarily from the basolateral side (Figure 5.2D, “Basolateral”), but 
FN appeared as a web-like mesh beneath cells.  Taken together, these data indicate 
that compliant substrates foster the development of EC networks associated with 
assembled FN that enmeshes cells from the basolateral side, and suggest that there are 
differences in the quality of FN deposition on compliant (oriented fibrils) vs. stiff 
(web-like mesh) substrates.  
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Figure 5.2.  Substrate stiffness alters FN localization. 
(A) On compliant (E=0.2 kPa) substrates, ECs assembled into networks associated 
with assembled (insoluble) fibronectin (FN).  (B) Stiff (E=10 kPa) substrates did not 
support network formation and assembled FN was instead uniformly distributed.  (C) 
3D reconstruction of confocal z-stacks of ECs on compliant substrates oriented to 
display the apical and basolateral surface.  Arrow heads indicate ECs assembled atop 
tracks of FN fibrils.  (D) On stiff substrates, FN appeared as a web-like mesh beneath 
cells. Bars are 100 m. 
 
In addition to collagen, we investigated the solubility and localization of FN on 
substrates derivatized with an RGD sequence-containing peptide.  Similar to collagen, 
we determined that networks on compliant (E=0.2 kPa) substrates were associated 
with insoluble FN (Figure 5.3A).  On stiff (E=10 kPa) substrates, ECs and FN were 
uniformly distributed (Figure 5.3B), however insoluble FN formed a less extensive 
network compared to that observed on collagen-derivatized gels (cf. Figure 5.2B).  
This may be due to less robust FN-RGD interactions, as collagen contains an FN 
binding site [137] that may help retain fibrillar FN during processing for 
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immunostaining.  3D reconstructions of confocal slices indicated that EC assemblies 
occurred atop FN fibrils on compliant substrates (Figure 5.3C, arrow head).  On stiff 
substrates, cells did not assemble networks and FN was again localized to the 
basolateral surface (Figure 5.3D).  These data indicate that networks assemble atop FN 
fibrils on substrates derivatized with collagen or an RGD-containing peptide. 
 
Figure 5.3.  ECs on RGD-derivatized substrates assemble networks atop fibrillar 
assembled FN. 
ECs were plated on compliant (E=0.2 kPa) and stiff (E=10 kPa) substrates derivatized 
with 100 g/mL of an RGD sequence-containing peptide (NH2-YAVTGRGDS-OH), 
and fixed and stained for FN.  (A) On compliant substrates, ECs assembled into  
networks that were colocalized with FN.  To determine FN insolubility, samples were 
treated with deoxycholate, and fixed and stained for FN.  EC networks were associated 
with assembled FN (“Insoluble FN”).  (B) In contrast, ECs and FN were uniformly 
distributed across stiff substrates.  Treatment with deoxycholate indicated that 
assembled FN was distributed across the substrate.  Scale bars are 100 m.  To 
determine the 3D localization of FN, samples were analyzed with confocal 
microscopy, and z-stacks were reconstructed to orient the apical and basolateral 
surface.  (C) On compliant substrates, ECs formed network cords atop fibrils of 
oriented FN (arrow head).  Image for “actin/nuclei” and “FN” are representative 
images from a slice in the z-stack.  (D) On stiff substrates, ECs did not assemble 
networks, but were uniformly distributed atop omnidirectional FN. Scale bars are 50 
m.   
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Our findings suggest that substrate stiffness alters the dynamics of FN deposition.  To 
investigate whether substrate stiffness mediates the dynamics of FN deposition, ECs 
were plated on compliant and stiff substrates, fixed at 4-48 hours after plating, and 
stained for FN.  On compliant substrates, FN signal appeared colocalized with cells as 
background staining (Figure 5.4A “FN” and “Actin/Nuclei”).  Staining for FN after 
treatment with DOC revealed that assembled FN deposition at 4 hours after plating 
was punctate (Figure 5.4A "Insoluble FN") suggesting that cell spreading precedes 
significant FN deposition.  Small fibrils of FN were deposited by 24 hours after 
plating and appeared oriented and aligned with cells by 48 hours (Figure 5.4A).  In 
contrast, ECs on stiff substrates were associated with short omnidirectional fibrils of 
FN as early as 4 hours after plating (Figure 5.4B).  Over 4-48 hours assembled FN 
deposition on stiff substrates proceeded to cover the substrate surface and appeared as 
a web-like mesh (Figure 5.4B “Insoluble FN”). 
 
Figure 5.4.  Substrate stiffness alters the dynamics and quality of FN deposition. 
(A) On compliant (E=0.2 kPa) substrates, FN deposition was punctate over 4-12 
hours, with short fibrils deposited and elongated over 24-48 hours.  (B) On stiff (E=10 
kPa) substrates, FN deposition was omnidirectional as early as 4 hours after plating. 
Bars are 50 m.   
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These data indicate that substrate stiffness mediates differences in the quality of FN 
deposition by ECs over time, i.e. compliant substrates foster the deposition of thin 
directed fibrils while stiff substrates promote a "painting" of web-like FN across the 
substrate. 
 
Substrate Stiffness Mediates the Expression and Deposition of EDB-Fibronectin 
EDB-FN is an isoform of FN that specifically localizes to angiogenic blood vessels 
[108] that may be an important clinical target for localizing tumor vasculature [109].  
Our data suggest that there are differences in the density of FN deposition with 
stiffness.  To determine whether the EDB isoform of FN was sensitive to substrate 
stiffness, ECs were plated on compliant (E=1 kPa) and stiff (E=10 kPa) substrates and 
grown to confluency.  Fluorescent staining and quantification indicated that there was 
a significant increase in EDB-FN density with increasing substrate stiffness (Figure 
5.5A-B).  To quantify FN deposition, Western blots for EDB-FN and total FN were 
performed.  As expected, there was a significant increase in EDB-FN with increasing 
substrate stiffness (Figure 5.5C).  There was a slight but significant increase in the 
amount of total FN detected (Figure 5.5D), however normalizing the ratio of EDB-FN 
to total FN as determined by Western blotting indicated that there was a 30% increase 
in EDB-FN with increasing substrate stiffness (Figure 5.5E).  Furthermore, 
quantitative real-time PCR was used to quantify the gene expression of EDB-FN.  Our 
results indicated that EDB-FN gene expression increased approximately 2.5 fold on 
stiff substrates (Figure 5.5F).  These data indicate that substrate stiffness alters the 
density of total FN deposition, and indicate that substrate stiffness mediates the 
expression and deposition of the EDB-isoform of FN.  
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Figure 5.5.  Substrate stiffness mediates the expression and deposition of EDB-
fibronectin. 
(A) Confluent ECs on compliant (E=1 kPa) and stiff (E=10 kPa) substrates were 
stained for EDB-FN (bar is 100 m).  (B) EDB-FN density increased significantly 
with increasing substrate stiffness (n=10 fields per condition).  (C) Western blot for 
EDB-FN expression by ECs on compliant and stiff substrates indicated a significant 
increase with increasing substrate stiffness (3 independent experiments).  (D) Western 
blot for total FN expression by ECs on compliant and stiff substrates indicated a slight 
but significant increase in total FN with increasing stiffness (3 independent 
experiments).  Panels represent lanes from the same gel where empty lanes were 
removed for data consolidation.  (E) The ratio of EDB-FN to total FN based on 
Western blot data indicated a 30% increase in EDB-FN expression with increasing 
stiffness.  (F) EDB-FN gene expression as determined by quantitative real-time PCR 
indicated a significant increase in gene expression with increasing stiffness (3 
independent experiments). Plots are mean + SEM, *p<0.05.  PCR was performed with 
Dr. Libin Yuan.  
 
When using PA substrates we have assumed that substrate-FN interactions were 
independent of substrate stiffness.  To determine whether this was a valid assumption, 
we investigated FN binding to substrates derivatized with collagen.  We incubated 
substrates directly with exogenous FN, or with complete media (serum in media 
contains FN), and examined FN-substrate interactions.  While this method was 
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indirect, fluorescent localization and Western blot were a first approximation indicator 
that substrate-FN interactions were stiffness independent (Figure 5.6A-B). Moreover, 
to confirm the source of EDB-FN to cells (since serum used in the media contains FN) 
we utilized Western blotting to show that EDB-FN was undetectable in serum (Figure 
5.6C).  These data suggest that FN-substrate interactions are independent of substrate 
stiffness and that ECs are the source of EDB-FN. 
 
Figure 5.6.  FN controls. 
(A) Compliant (E=0.2 kPa) and stiff (E=10 kPa) substrates were synthesized and 
derivatized with collagen, and incubated with 50 g/mL FN, and fixed and stained for 
FN.  FN signal was uniformly distributed across the surface on compliant and stiff 
substrates.  Scale bar is 100 m.  (B) 1 and 10 kPa substrates were incubated with 
complete Media 199 for 24 hours, incubated with Laemmli buffer, and analyzed with 
SDS-PAGE and Western blot.  A Western blot for FN indicated a similar amount of 
FN across stiffness levels.  (C) Complete Media 200 was subjected to analysis with 
SDS-PAGE and Western blot.  A Western blot for EDB-FN indicated that no EDB-FN 
was detectable in the media.  In contrast, and as expected, total FN was detectable.   
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Fibronectin Orientation Correlates with Actin Cytoskeletal Polarity 
Our data suggest that substrate stiffness mediates differences in the orientation of FN 
deposition.  To determine and quantify the spatial orientation of FN deposition with 
regard to substrate stiffness, ECs were plated on compliant (E=0.2 kPa) and stiff 
(E=10 kPa) substrates, and stained to localize actin and FN.  The overall orientation of 
cells, their actin cytoskeleton, and associated FN was determined using OrientationJ.  
On compliant substrates, actin and FN staining appeared fibrillar and oriented in the 
direction of the long axis of cells (Figure 5.7A; close-up view of an individual cell).  
The prevalence of blue-purple pseudo-coloring in both actin and FN images on 
compliant substrates indicated a similar actin cytoskeletal and FN fibril orientation 
with respect to the horizontal axis (inset in "actin" image is a legend for hue with 
orientation angle).  In contrast, the actin and FN staining exhibited a more uniform 
distribution of orientations in cells on stiff substrates (Figure 5.7B; close up view of an 
individual cell).  The rainbow hue of both actin and FN pseudo-colored images on stiff 
substrates indicated a multidirectional distribution of orientations with respect to the 
horizontal axis. 
 
To quantify these observations, the overall orientation angle of actin was compared to 
the orientation angle of the cell with OrientationJ to determine the minimum 
difference between orientation angles in degrees.  This analysis indicated that there 
was a significant increase in the difference in orientation angles (i.e. less correlation) 
between cells and their actin cytoskeleton with increasing substrate stiffness (Figure 
5.7C).  Similarly, the difference in orientation angles between the actin cytoskeleton 
and FN also increased with increasing substrate stiffness (Figure 5.7D).  These results 
indicate that there is a significant correlation between the orientation of cells and their 
actin cytoskeleton, and between the actin cytoskeleton and the local FN matrix in cells 
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on compliant substrates, and that this correlation is diminished with increasing 
substrate stiffness.     
Figure 5.7.  FN orientation correlates with actin cytoskeletal polarity. 
(A) Close-up of fibrillar and oriented actin and FN associated with an EC on a 
compliant (E=0.2 kPa) substrate analyzed with OrientationJ.  Inset is a legend for hue 
with orientation angle.  (B) Close-up of actin and FN associated with an EC on a stiff 
(E=10 kPa) substrate indicated a more uniform distribution of actin and FN (bars are 
50 m).  (C-D) Quantification of the difference in orientation angle (in degrees) 
between cells and their actin cytoskeleton (C) and between the actin cytoskeleton and 
FN (D) indicated an increase (less correlation) with increasing substrate stiffness 
(n=30 per stiffness, mean + SEM, *p<0.05).  
 
Substrate Stiffness Alters Traction Force Polarization 
Substrate stiffness mediates differences in the quality and orientation of FN 
deposition, and suggests that these differences are due in part to alterations in the 
orientation of the EC actin cytoskeleton (Figures 5.4, 5.7).  FN assembly into fibrils 
requires cell-generated forces [103,104] suggesting that differences in FN deposition 
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may be due to alterations in actomyosin interactions that generate contractility 
[54,56,199].  However, the role of substrate stiffness in mediating force directionality 
that may be responsible for FN deposition is not well characterized. 
 
To investigate the role of substrate stiffness in mediating traction force polarity, ECs 
on compliant (E=1 kPa) and stiff (E=10 kPa) substrates were analyzed with Traction 
Force Microscopy (TFM), a technique used to measure endogenous cellular traction 
forces [30,149].  On compliant substrates, cells adopted an elongated and bipolar 
morphology with force vectors oriented toward the cell area centroid (Figure 5.8A; 
single cell), but appeared more multipolar on stiffer substrates (Figure 5.8B; single 
cell).  Quantification of the aspect ratio of individual cells indicated a significant 
decrease in aspect ratio (i.e. more circular) with increasing substrate stiffness (Figure 
5.8C).  The directionality of traction forces exerted by the cells was determined by 
projecting the total magnitude of the traction force along the long and short axis of the 
cell. Traction force projections along the long axis of the cell decreased significantly 
with increasing substrate stiffness (E=1-10 kPa) in isolated cells (Figure 5.8D, gray 
bars). 
 
These results arise from single isolated cells, however cell-cell interactions occur 
during FN deposition over time.  To determine whether cell-cell interactions alter 
traction force polarity, ECs making a cell-cell contact were analyzed with TFM.  
When two ECs on a compliant substrate made a cell-cell connection, their elongated 
morphologies were maintained.  Analysis with TFM, where the cells in contact were 
modeled as a single force-generating unit, indicated that traction forces maintained 
polarization toward the center of the aggregate cell area centroid (Figure 5.8A, two 
cells).  Quantification indicated that traction forces remained polarized when two cells 
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came into contact (Figure 5.8E).  When cell-cell contact was made with an adjoining 
cell on stiff substrates, individual cell morphology remained spread and traction forces 
were oriented toward the center within each cell region (Figure 5.8B, two cells).  Cells 
in contact on stiff substrates exhibited a significant decrease in force polarization 
along the long axis of the cell aggregate area (Figure 5.8F), i.e. cells exert 
omnidirectional forces. 
Figure 5.8.  Substrate stiffness alters traction force polarization. 
(A) ECs on compliant (E=1 kPa) substrates adopted an elongated and bipolar 
morphology with traction forces directed toward the area centroid.  An elongated 
morphology and polarized forces were maintained with cell-cell contact.  (B) ECs on 
stiff (E=10 kPa) substrates appeared more multipolar. Cells in contact retained a 
spread morphology with traction forces oriented toward the aggregate cell area 
centroid (bars are 50 m).  (C) The aspect ratio of individual cells decreased (became 
more circular) with increasing substrate stiffness (n=70 per stiffness).  (D) 
Quantification of traction force projections along the long and short axis of cells.  
Force projections along the long axis decreased significantly with increasing substrate 
stiffness in isolated cells (n=24, 14, 25, 38 per stiffness, respectively).  (E-F) Force 
projections between single cells and two cells in contact exhibited no significant 
difference between force polarization along the long axis (n=16 pairs) on compliant 
substrates (E) but significantly decreased (n=20 pairs) on stiff substrates (F).  Plots are 
mean +/- SEM, *p<0.05. 
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These data indicate that in addition to mediating the magnitude of EC-generated 
traction forces [149], substrate stiffness alters cell shape and the orientation forces.  
Furthermore, they suggest that the maintenance of polarized traction forces despite 
cell-cell interaction may contribute to FN polarization on compliant substrates. 
 
FN Deposition is Directed by Enforcing Cell Polarity  
Our results indicate that stiff substrates facilitate the multipolar spreading of ECs that 
are accompanied by traction forces that exhibit a near-uniform distribution and an 
omnidirectional web-like mesh of deposited FN (Figures 5.1-5.4), and suggest that 
polarized traction forces on compliant substrates guide the deposition of directional 
FN.  To determine whether enforcing an elongated cell morphology on stiff (E=10 
kPa) substrates was correlated with an alteration in the directionality of traction forces 
and FN deposition, ECs were plated on stiff substrates micropatterned with adhesive 
rectangular island of collagen (Figure 5.9A) and analyzed with TFM.  Instead of 
exhibiting a multipolar morphology, single cells and two-cells in contact on stiff 
patterned substrates exhibited an elongated bipolar morphology and distribution of 
traction forces that appeared oriented along the long axis of the cell (Figure 5.9B), a 
phenotype similar to cells on compliant substrates (cf. Figure 5.8A).  Quantification of 
traction forces in elongated cells on patterned substrates (“1 Cell Patt”; “2 Cell Patt”) 
revealed a significant increase in force polarization along the long axis of the cell area 
compared to non-patterned cells in single cells and two cells in contact (“1 Cell; 2 
Cell), respectively (Figure 5.9C; gray bars). Fluorescent localization of FN indicated 
that elongated cells on micropatterned substrates were accompanied by directed fibrils 
of FN (Figure 5.9D arrow heads; inset is a magnification of the boxed region 
pseudocolored with OrientationJ). Note the prevalence of green pseudocoloring 
indicating a preferred (left-right) orientation of FN similar to oriented FN observed in 
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cells on compliant substrates (cf. Figure 5.7A). In contrast, cells on non-patterned 
substrates exhibited a uniform distribution of orientations of FN (Figure 5.9E, inset is 
a magnification of the boxed region; note the rainbow hue of FN signal).  These data 
indicate that the quality of FN normally observed on compliant substrates 
(unidirectional fibrils) can be recapitulated on stiff substrates by enforcing an 
elongated cell morphology with concomitant polarization of traction forces.     
 
Figure 5.9.  FN deposition is directed by enforcing cell polarity. 
(A) Stiff (E=10 kPa) substrates were micropatterned with adhesive islands of collagen 
(bar is 200 m).  (B) Single ECs and two ECs in contact plated on micropatterned 
substrates exhibited an elongated bipolar morphology and traction forces oriented 
along the long axis of the cell (bars are 100 m).  (C) Cells on patterned ("Patt") 
substrates exhibited a significant increase in force polarization vs. non-patterned 
substrates when forced into an elongated morphology (n=58, 29 for 1 Cell Patt and 2 
Cell Patt, respectively).  (D-E) Fluorescent localization of FN associated with 
elongated ECs on micropatterned (D) vs. non-patterned substrates (E).  Arrow heads 
point to oriented FN.  Insets are magnifications of the boxed regions pseudocolored 
with OrientationJ (bars are 100 m).  Plots are mean  SEM, *p<0.05.  Silicon 
masters used to patterned gels were prepared by Jonathan Charest. 
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In addition to the orientation of traction forces, we determined that enforcing an 
elongated cell morphology on stiff substrates reduced the total magnitude of traction 
force exerted by individual cells or cells in contact compared to cells on non-patterned 
substrates (Figure 5.10).  These data indicate that restricted cell spreading alters the 
magnitude of traction force generation in isolated ECs and ECs in contact.  
 
Figure 5.10.  Enforcing an elongated cell morphology reduces traction force 
magnitude on stiff substrates. 
ECs were plated on stiff (E=1-10 kPa) micropatterned substrates that enforced a 
bipolar elongated morphology and analyzed with traction force microscopy.  On 
patterned substrates, single cells (“1 Cell Patt”) exhibited a significant reduction in 
traction force magnitude compared to individual cells allowed to spread unrestricted 
(“1 Cell”).  Similarly, traction force magnitude was significantly reduced for two cells 
in contact on micropatterned substrates (“2 Cell Patt”) compared to two cells allowed 
to spread unrestricted (“2 Cell”) (*p<0.05, Student’s t test). 
 
ROCK-Mediated Contractility and Cell Area Regulate FN Deposition 
It is established in fibroblasts that endogenous contractility mediates FN assembly 
[104,173].  Our data suggest that substrate stiffness alters FN deposition by 
modulating contractility-mediated traction force polarity.  Cellular contractility is 
mediated in part by the Rho signaling pathway, where ROCK is a downstream effector 
of Rho [200,201].  We have shown previously that ROCK is a critical mediator of EC 
contractility and that Y27632 treatment decreases the magnitude of traction forces in 
ECs (Figure 5.11, [170]).  To determine whether ROCK-mediated contractility 
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mediates FN deposition in ECs, cells were plated on stiff (E=10 kPa) substrates in the 
presence of the ROCK inhibitor Y27632, fixed at 4-48 hours after plating, and stained 
for FN.  Samples treated with Y27632 exhibited a decrease in assembled FN 
deposition compared to control samples at each time point over 48 hours (Figure 
5.12A; insoluble FN images were acquired by staining FN after DOC treatment and 
were taken at the same exposure settings as control samples for each time point).  
Quantification of the fluorescent signal from DOC-treated samples indicated that there 
was a significant decrease in the density of insoluble FN fluorescent signal at each 
time point over 48 hours (Figure 5.12B).  FN deposition of Y27632-treated samples 
appeared to lag behind the deposition observed in control samples, and appeared to 
correlate with the 12-16 hour half-life of Y27632 [202].  However, there was recovery 
of deposition in Y27632-treated samples over time (Figure 5.12B; compare control bar 
at 12 hours with Y27 bar at 48 hours).  Quantification of cell area indicated that the 
decrease in FN deposition was not accompanied by alterations in cell area (Figure 
5.12C).  Separate analogous experiments that used RNAi to disrupt ROCK found 
similar results (Figure 5.13). 
 
Figure 5.11.  Inhibiting ROCK or myosin 
light chain kinase reduces traction force 
magnitude. 
ECs were plated on variably compliant (E=1-10 
kPa) substrates, allowed to adhere overnight, 
treated with 50 M myosin light chain kinase 
inhibitor (ML7) or 10 M ROCK inhibitor 
(Y27632) for 30 minutes, and analyzed with 
traction force microscopy.  (A) Treatment with 
ML7 or Y27632 significantly reduced traction 
force magnitude exerted by ECs on all 
substrates.  (B) Cell area was reduced with ML7 
or Y27632 treatment on 2.5-10 kPa substrates, 
but was not changed significantly on 1 kPa 
substrates (*p<0.05; ANOVA).  Portions of this 
data appeared in Huynh et al. [170].  
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Figure 5.12.  ROCK-mediated contractility mediates FN deposition (Y27). 
(A) ECs plated on stiff (E=10 kPa) substrates with 10 M Y27632 exhibited a 
decrease in assembled FN deposition compared to control samples at each time point 
over 4-48 hours (bars are 100 m).  (B) Quantification of insoluble FN signal 
(acquired at the same exposure settings) indicated a significant decrease in FN density 
at each time point over 48 hours between Y27632 treatment (Y27) and control (Ctrl) 
(n=8-12 fields per condition per time point).  (C) There was no change in cell area 
between Y27632 treatment and control samples (n=50 per condition per time point). 
Plots are mean +/- SEM, *p<0.05. 
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Figure 5.13.  ROCK-mediated contractility mediates FN deposition (siRNA). 
(A) Western blot of ROCK after treatment with siRNA against ROCK (si) compared 
to control (Ctrl) over 72 hours.  (B) ECs treated with siRNA against ROCK were 
plated on stiff substrates and stained for FN over 72 hours (bars are 100 m).  (C) 
Quantification of FN density indicated a significant decrease in insoluble FN with 
siRNA treatment against ROCK over 48 hours compared to controls, but similar levels 
of FN density by 72 hours (n=11-16 fields per condition per time point).  (D) 
Knockdown of ROCK with siRNA was not accompanied by alterations in cell area 
compared to controls (n=50 per condition per time point).  Plots are mean +/- SEM, * 
indicates p<0.05). 
 
To determine if EDB-FN was sensitive to ROCK-mediated contractility, ECs treated 
with siRNA for ROCK were plated on stiff (E=10 kPa) substrates and stained for 
EDB-FN.  Western blotting for ROCK indicated a knockdown with siRNA treatment 
compared to controls (Figure 5.14A).  Fluorescent staining and quantification of EDB-
FN indicated a decrease in EDB-FN with siRNA treatment compared to controls 
(Figure 5.14B-C).  Taken together, these results indicate that the deposition of FN and 
the EDB-FN isoform by ECs depends on ROCK-mediated contractility. 
 
In addition to ROCK-mediated contractility, cell shape directs FN deposition (Figure 
5.9).  To determine the role of cell area in mediating FN deposition, ECs were plated 
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on stiff (E=10 kPa) micropatterned substrates that restricted cell spreading. EDB-FN 
and total FN deposition was disrupted on micropatterned substrates that restricted 
spreading (Figure 5.14D).  In contrast, fibrillar EDB-FN and total FN deposition was 
observed in control ECs that were allowed to spread fully (Figure 5.14E).  These 
results indicate that cell area regulates FN and EDB-FN deposition, and suggest that in 
addition to the polarity of traction forces, substrate stiffness alters FN expression 
through changes in cell area.      
  
Figure 5.14.  ROCK-mediated contractility and cell area mediate EDB-FN 
deposition. 
(A) Western blot for ROCK expression after treatment with siRNA against ROCK 
compared to control.  (B) Fluorescent staining for EDB-FN after treatment with 
siRNA against ROCK on stiff (E=10 kPa) substrates.  (C) Quantification of EDN-FN 
density after ROCK siRNA treatment indicated a significant decrease in EDB-FN 
compared to controls (n=40 fields per condition).  (D) Fluorescent staining of EDB-
FN and total FN in an EC on a stiff (E=10 kPa) micropatterned substrate that restricted 
cell spreading.  (E) Fluorescent staining of EDB-FN and total FN in an EC on a stiff 
control substrate where spreading was not restricted (bars are 100 m).  Plots are 
mean + SEM, *p<0.05. 
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Based on our findings that a disruption in ROCK-mediated contractility reduced FN 
deposition, we hypothesized that increasing cellular contractility on compliant 
substrates would in turn increase FN deposition.  To test this hypothesis, cells were 
transfected with a plasmid encoding constitutively active Rho (RhoV14, an upstream 
activator of ROCK and cellular contractility) and plated on compliant (E=0.2 kPa) and 
stiff (E=10 kPa) substrates.  Our data indicated that there was not a significant 
increase in FN deposition on either substrate (Figure 5.15).  Moreover, there appeared 
to be a reduction in FN deposition on stiff substrates (Figure 5.15).  A lack or 
reduction of increased FN deposition was likely due to a disruption in contractile 
dynamics.  Recent data suggests that dynamic traction forces are requisite for FN 
[173], i.e. tonic contraction, via inhibition or stimulation of contractility, prevents FN 
assembly.  Our results, while preliminary, suggest that FN deposition by ECs requires 
dynamic cellular traction forces. 
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Figure 5.15.  Constitutively active Rho reduces assembled FN deposition on stiff 
substrates. 
ECs were transfected with a plasmid encoding GFP-tagged constitutively active Rho 
(RhoV14-GFP), plated on compliant (E=0.2 kPa) and stiff (E=10 kPa) substrates for 
24 hours, and fixed and stained for FN.  On compliant substrates, significant FN was 
not detectible near transfected cells (phase image and “FN”).  To localize assembled 
FN, samples were treatment with deoxycholate and stained for FN.  Detected FN was 
punctate or in small fibers in both RhoV14-GFP samples and controls.  On stiff 
substrates, short fibrils of FN were detected in both RhoV14-GFP samples and 
controls.  However, treated with deoxycholate indicated a reduction in assembled FN 
(“Insoluble FN”) with RhoV14-GFP treatment.  Scale bars are 100 m. 
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Disrupted Fibronectin Deposition or Polymerization Does Not Alter Traction 
Force Magnitude 
Our results demonstrate that cellular contractility alters FN deposition.  To determine 
whether FN deposition in turn alters cell contractility, cells were treated with siRNA 
against FN, plated on stiff (E=5 kPa), substrates, and analyzed with TFM.  Our results 
indicated that there was no significant difference in the magnitude of traction forces 
exerted by siRNA-treated cells, or cell spread area, compared to controls (Figure 
5.16A-D).  Alternatively to FN knockdown, FN assembly was be inhibited with the 
small peptide pUR4B [193] (a kind gift from Dr. Jane Sottile, University of 
Rochester).  Our results indicated that the magnitude of traction forces, cell spread 
area, and migration speed exhibited no significant difference between ECs treated with 
pUR4B compared to controls (Figure 5.16E-G).  Taken together, these data suggest 
that FN synthesis or assembly did not alter cellular shape, migration, or contractility. 
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Figure 5.16.  Disrupted fibronectin deposition or polymerization does not alter 
traction force magnitude. 
(A) Western blot for FN after treatment with siRNA against FN or control (Ctrl). 
Panels represent lanes from the same gel where empty lanes were removed for data 
consolidation.  (B) Fluorescent staining for FN after treatment with siRNA against FN 
confirmed a decrease in insoluble FN fluorescent signal in treated samples compared 
to controls (bar is 100 m).  (C) Quantification of traction force magnitude (|F|) 
generated by ECs treated with siRNA against FN compared to controls on stiff (E=5 
kPa) substrates.  (D) Plot of cell area of ECs treated with siRNA against FN compared 
to controls on stiff (E=5 kPa) substrates (n=57, 52 for control and siRNA, 
respectively).  (E) Quantification of traction forces generated by ECs treated with FN 
polymerization inhibitor pUR4B (500 nM) compared to controls (500 nM III-11C 
control peptide) (Ctrl) on stiff (E=5 kPa) substrates (n=60, 72 for control and pUR4B, 
respectively).  (F) Plot of cell area after treatment with pUR4B compared to controls 
on stiff (E=5 kPa) substrates.  (G) Quantification of EC migration speed on compliant 
(E=0.2 kPa) substrates after treatment with pUR4B compared to controls (n=15 per 
condition). Plots are mean + SEM. 
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In addition to utilizing mean square-displacement to track cell migration, we measured 
cell displacement with three other metrics.  These data indicate that pUR4B treatment 
did not alter cell displacement (Figure 5.17A-C)  
 
Figure 5.17.  Inhibiting FN polymerization does not alter cell displacement. 
ECs were plated on compliant (E=0.2 kPa) substrates, treated with  500 nM pUR4B 
FN polymerization inhibitor or 500 nM III-11C control peptide (gifts from Dr. Jane 
Sottile), and analyzed with time lapse microscopy every 10 minutes for 4 hours.  The 
cell centroid was used to calculated three measures of cell displacement that exhibited 
no significant difference between treatment and control samples.  (A) Average speed 
determined with the distance formula calculated between successive time points.  (B) 
Average total distance traveled calculated by summation of distance between 
successive time points.  (C) Net cell displacement calculated from the initial and final 
time point centroid locations (no significant difference, Student’s t test).  
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Substrate Stiffness Mediates Laminin Deposition in Epithelial Cells 
Our data investigated the role of substrate stiffness in mediating cell-ECM interactions 
by determining the interactions between ECs and FN.  To determine if these 
interactions were unique to ECs, we investigated the role of substrate stiffness in 
mediating laminin deposition in mammary epithelial cells (MEC).  Since this cell type, 
analogous to ECs with FN, requires laminin for network assembly [160], we 
hypothesized that MECs may exhibit similar responses to alterations in substrate 
stiffness.  Analogously to ECs with FN, MECs plated on compliant (E=0.2 kPa), but 
not stiff (E=0.2 kPa) substrates formed network assemblies associated with laminin 
(Figure 5.18A-B).  3D reconstructions of confocal z-stacks indicated that network 
cords of MECs occurred atop tracks of laminin on compliant substrates and on the 
basolateral surface of cells on stiff substrates (Figure 5.18C-D).  Individual MECs 
exhibited a decrease in aspect ratio with increasing substrate stiffness, and an increase 
in laminin expression (Figure 5.18E-F).  These data indicate that substrate stiffness 
regulates laminin matrix deposition in MECs, and suggest that the alteration of ECM 
deposition by substrate stiffness is not unique to ECs.   
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Figure 5.18.  Substrate stiffness mediates laminin deposition in epithelial cells. 
(A) MCF-10A mammary epithelial cells (MEC) were plated on compliant (E=0.2 kPa) 
substrates formed network assemblies associated with laminin (inset in merge image 
depicts laminin signal that traversed a retracted cell within a network cord).  (B) Stiff 
(E=10 kPa) substrates did not support network assembly, but instead cells and laminin 
were uniformly distributed.  (C) 3D reconstructions of confocal z-stacks of laminin 
indicated that cords of MECs occurred atop tracks of laminin on compliant substrates.  
(D) Laminin was found on the basolateral surface of MECs on stiff substrates (bars are 
50 m).  (E) Quantification of MEC aspect ratio indicated a significant decrease (more 
circular) with increasing substrate stiffness (n=71, 68 per stiffness, respectively).  (F) 
Western blot of laminin expression by MEC on compliant and stiff substrates.  
Quantification indicated a significant increase in laminin expression with increasing 
substrate stiffness (3 independent experiments).  Panels represent lanes from the same 
gel where empty lanes were removed for data consolidation.  Plots are mean + SEM, * 
indicates p<0.05. 
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5.5 Discussion 
The interactions between cells and the ECM enable cell responses.  Herein we 
investigated the role of substrate stiffness in mediating cell-ECM interactions.  We 
determined that substrate stiffness mediates the synthesis and deposition of FN by 
altering EC shape and traction force directionality.  In addition, we demonstrated that 
the synthesis and deposition of EDB-FN, an FN isoform specific to angiogenic blood 
vessels, is sensitive to substrate stiffness. 
 
Cell-ECM interactions have been studied extensively in fibroblast models, where it is 
thought that cell contractility facilitates FN fibril assembly by inducing 
conformational changes in FN that expose self-assembly sites.  While the exact 
mechanisms governing conformational changes in FN are still under debate [203-205], 
fibril assembly is directed by traction forces [173].  Lemmon et al. demonstrated that 
the orientation of a traction force vector applied to an FN fibril directs the growth 
orientation of that fibril, and that FN assembly is regulated by the contractile 
machinery of the cell [173].  Similarly, our data indicate that FN assembly by ECs is 
directed by the orientation of endogenous traction forces, and that the dynamics of FN 
assembly are altered by perturbations to ROCK-mediated contractility that are 
sensitive to substrate stiffness.  These findings suggest that FN assembly by ECs is 
sensitive to perturbations in the mechanical microenvironment that impinge on 
traction forces generated by the cell.  Furthermore, we have shown that FN deposition 
can be directed by constraining the directionality of both cell spreading and traction 
forces.  This has ramifications for tissue engineering, where EC-controlled FN 
deposition may aid the development of vascularized constructs. 
 
As FN matrix matures, growing fibrils are converted to a DOC-insoluble form [101].  
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While the exact mechanisms are still under investigation, FN insolubility is thought to 
result from strong protein-protein interactions [206,207].  Our findings indicate that 
FN assembly is sensitive to ROCK-mediated contractility, and suggest that the 
conversion of FN to an insoluble form requires cell-generated force.  More work is 
needed to understand the specific role that traction forces have in mediating the 
soluble-insoluble transition in FN.  
 
The EDB-containing isoform of FN is preferentially localized at sites of angiogenic 
blood vessel formation.  While not required for angiogenesis or survival [208,209], 
EDB-FN expression in ECs may contribute to changes in cell spreading, motility, FN 
assembly, and capillary morphogenesis in vitro [192,209].  Inclusion of the EDB 
domain is thought to unmask cryptic sequences in FN that can affect cell adhesion and 
spreading [210,211].  This may facilitate adhesive interactions and cellular 
contractility associated with integrin 51 [192], a receptor pairing for FN [212,213] 
whose interaction is crucial for vertebrate survival [99,214,215].  Recent experiments 
indicate that 51 functions as a catch-bond that alternates between tensional states in 
responses to cellular contractility, and is sensitive to substrate stiffness [216].  Our 
data indicate that increased substrate stiffness increases the synthesis and deposition of 
EDB-FN, and that EDB-FN deposition is regulated by ROCK-mediated contractility.  
Taken together, these findings suggest that substrate stiffness may affect EDB-FN 
interactions through feedback mechanisms relating contractility to 51-FN 
interactions and FN conformation, however, more work is needed to fully characterize 
these interactions.   
 
Our findings may have important ramifications for the understanding of tumor 
angiogenesis, where EDB-FN is a specific marker for angiogenic vasculature [109] 
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found localized in brain [108], breast [217], and liver [218] tumor environments.  The 
tumor microenvironment is often accompanied by an increase in tissue stiffness [16], a 
feature exploited by physicians in the clinical detection of tumors.  Our data indicate 
that increasing substrate stiffness is sufficient for increasing both the synthesis and the 
deposition of EDB-FN.  This suggests that changes in the micromechanical 
environment of tumors may contribute to EDB-FN expression in angiogenic blood 
vessels.  Interestingly, EDB-FN was also detected at the mRNA level early after injury 
in a model of hepatic fibrosis [219].  While these changes preceded fibrosis and tissue 
stiffening that accompanies chronic liver disease [220], they suggest that EDB-FN 
expression is an early biomarker of disease.  
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CHAPTER 6 
 
CONCLUSIONS AND FUTURE DIRECTIONS  
 
6.1 Conclusions 
We investigated the role of substrate stiffness in regulating capillary network assembly 
and determined that network assembly results from a balance between cell-cell and 
cell-matrix adhesion that gives rise to the propensity for cell-cell connectivity.   
 
In Chapter 2, we hypothesized that the mechanical microenvironment plays a role in 
mediating endothelial cell (EC) network assembly.  This hypothesis resulted from the 
observation that experiments in the literature investigating EC network assembly all 
shared a common thread—the use of compliant substrates.  Moreover, in addition to 
collagen and fibrin gels used to study angiogenesis in vitro [19,22-25], the Matrigel 
Assay had emerged as a gold-standard for determining cellular angiogenic potential 
[20,21].  While matrigel provided cells with a complex semi-native ECM, it was also a 
compliant substrate, with an elastic modulus on the order of hundreds of pascals 
[16,221].  Thus, we sought to determine whether substrate stiffness was a contributor 
to EC network assembly.  
 
We determined that network assembly was controllable by altering substrate stiffness.  
Compliant (E<1 kPa) substrates enabled network self-assembly while stiff (E>1 kPa) 
substrates did not.  Moreover, we could induce network assembly on stiff substrates by 
reducing the substrate ligand concentration suggesting that network assembly resulted 
from a balance between substrate stiffness and matrix density, and ultimately changes 
in cell-cell vs. cell-matrix adhesion.  We used collagen-derivatized substrates, but 
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were able to recapitulate these findings with fibronectin, and RGD-derivatized 
substrates suggesting that the stiffness of the substrate was modulating network 
assembly independent of ligand type.  This work was the first demonstration that the 
stiffness of the local microenvironment was an important factor regulating capillary 
network assembly.   
 
Inspired by the work of Zhou et al., who determined that network formation in 3D 
fibrin gels required fibronectin (FN) polymerization [98], we determined that network 
assembly on compliant 2D substrates was also associated with FN.  We demonstrated 
that ECs secrete and polymerize FN that is requisite for network assembly and 
stabilizes cell-cell interactions.  These findings were the impetus for our additional 
work that focused on investigating the mechanisms of how substrate stiffness regulates 
capillary network assembly. 
 
Initially we asked whether the sensitivity of network assembly to substrate stiffness 
was unique to ECs, or whether it was a more universal phenomenon.  In Chapter 3 we 
determined that substrate stiffness also mediated mammary and mesenchymal cell 
network assembly.  Our initial hypothesis regarding network assembly came from the 
work of Guo et al. who postulated that substrate stiffness mediates tissue formation by 
altering cell preferences for cell-cell vs. cell-matrix adhesion [87].  In Chapter 3, we 
presented data that confirmed this hypothesis.  In ECs, substrate stiffness altered the 
spatial localization of vascular endothelial (VE)-cadherin, a protein important for 
endothelial cell-cell connectivity.  At the same time, cells on compliant substrates 
were less adherent to the substrate than those on stiff substrates that did not exhibit 
significant VE-cadherin mediated cell-cell interactions.  Differences in substrate 
adhesion were likely due to changes in focal adhesion size and density that increased 
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with increasing substrate stiffness.          
 
In vascular, mammary, and mesenchymal tissue-derived cells, we determined that 
compliant substrates fostered network assembly that was associated with i) ECM 
colocalization and ii) a reduction in cell-matrix adhesion.  Moreover, analogous to 
ECs with FN, mammary epithelial cell network assembly required laminin, a 
mammary basement membrane protein [222,223].  In contrast, we determined that 
some cell types did not assemble networks, and that these cells i) did not colocalize 
with ECM and ii) did not exhibit a reduction in cell-matrix adhesion on compliant 
substrates.  However, in laminin-deficient mammary cells that did not assemble 
networks, network formation was induced by providing these cells with exogenous 
laminin.  These findings indicate that in addition to cell-cell and cell-matrix adhesion, 
cell-matrix interactions govern network formation.  These data suggest that substrate 
stiffness promotes network assembly by regulating preferences for cell-cell and cell-
matrix adhesion, and were the first demonstration that matrix stiffness regulates 
network assembly in a variety of cell types.     
     
Capillary network assembly is a complex biological process, and we determined that 
substrate stiffness altered cell-cell and cell-matrix interactions that enabled network 
assembly.  To sense substrates stiffness, cells use contractility and tractions forces in 
part to probe the mechanical microenvironment  [35].  Reinhart-King et al. had shown 
previously that traction forces create strains in compliant substrates that other cells can 
sense and respond to [36].  In Chapter 4, we examined the role of substrate stiffness in 
mediating EC traction forces in individual cells and during cell-cell contact, an early 
event of network assembly.  We first determined that cell area and the magnitude of 
traction forces increased with increasing substrate stiffness.  However, normalizing the 
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traction force magnitude by cell area still led to an increase in force magnitude with 
stiffness suggesting that stiffness was contributing to force development in ECs.  
Using regression modeling, we demonstrated that substrate stiffness and cell area were 
significant predictors of traction force in single ECs and ECs in contact.  These 
findings suggest that ECs sense and respond to the stiffness of the microenvironment 
by altering cellular contractility, a critical mediator of cellular responses like 
spreading, migration, and cell-cell interactions.  These findings were the first 
demonstration that substrate stiffness was a significant contributor to ECs in contact.  
 
In Chapter 5, we revisited FN.  In addition to being requisite for network assembly, 
FN polymerization requires cell-generated traction forces that enable matrix assembly 
and deposition [103,104].  Based on our observations in Chapters 2-3, we 
hypothesized that substrate stiffness mediated the regulation of FN deposition by ECs.  
We determined that substrate stiffness mediated the deposition of FN by altering cell 
shape and the directionality of ROCK-mediated traction forces.  We also demonstrated 
that substrate stiffness altered the expression and deposition of EDB-FN, an FN 
isoform preferentially localized to neovasculature.  This was the first demonstration 
that substrate stiffness mediated FN synthesis and deposition by ECs.        
 
Ultimately, the findings presented in this dissertation have implications for controlling 
angiogenesis for therapeutic use.  For example, a current limitation in tissue 
engineering is the creation of vascularized tissue constructs.  Our data suggest that the 
stiffness of the biomaterial scaffold as well as the relationship between ECs and the 
matrix protein FN within the scaffold are important design considerations.  
Additionally, our findings suggest that angiogenesis is particularly sensitive to the 
stiffness of the ECM.  This may be an important consideration during cancer, where 
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tumor growth is associated with changes in ECM stiffness [16] that may enable 
angiogenesis.   
 
6.2 Future Directions 
Despite the progress we have made, much work remains to fully understand the role of 
the mechanical microenvironment in mediating a complex response like angiogenesis.  
There are several avenues of approach necessary to proceed in this field. 
 
1) Does matrix stiffness regulate capillary network assembly in vivo? 
The work we have presented was completed solely on a 2D construct in vitro.  Future 
studies should test whether our findings may be recapitulated in a 3D 
microenvironment in vivo.  To do this, it is crucial to develop constructs that vary 
stiffness independently of protein concentration.  Current work utilizing glycated 
collagen gels may enable this work [224,225].  Other challenges in 3D are measuring 
cellular contractility via traction forces.  While traction force measurements in 3D are 
a recent accomplishment [226], the development of robust methods to measure 
contractility in 3D will greatly elucidate the understanding of how traction forces 
enable cell behaviors in 3D. 
 
Our findings should be validated by in vivo models that better recapitulate the true 
physiological conditions of angiogenesis.  This may be possible with animal models of 
angiogenesis coupled with techniques that introduce variable stiffness 3D constructs 
either embedded with cells, or that allow cell ingrowth during angiogenesis.  
   
2) What is the role of cell-cell interactions? 
We have started to investigate how cell-cell interactions mediate angiogenesis by 
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investigating traction forces during cell-cell contact.  During angiogenesis, ECs work 
en masse to form a new capillary.  In this work, we have begun to understand the 
relationship between VE-cadherin-mediated cell-cell interaction and FN regulation, 
and undoubtedly cell-cell interactions play a role in mediating all EC responses during 
angiogenesis.  Future work should further investigate these relationships.  
 
3) What is the role of supporting cell types? 
Cell behaviors in vivo occur in a complex microenvironment that is nearly always 
made up of cells from several lineages.  In addition to ECs, the vasculature is 
comprised of smooth muscle cells, pericytes, blood cells, and fibroblasts.  Future work 
should consider the role of these other cells types as generators of mechanical and 
chemical signaling events.  For example, we have determined that substrate stiffness 
alters EC monolayer permeability, a response that facilitates changes in leukocyte 
transmigration [170].  However, more work is needed to understand the role of 
supporting cell types in mediating angiogenesis.   
 
4) What are the molecular signaling pathways? 
Our approach in understanding the role of the mechanical microenvironment in 
mediating angiogenesis was primarily a biophysical endeavor.  Future work should 
focus on understanding how matrix stiffness alters EC proteomics and signaling that 
enable the behaviors required for angiogenesis.    
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CHAPTER 7 
 
BRINGING POLYMER SCIENCE TO THE CLASSROOM  
 
7.1 Abstract 
In 2010, I served as a National Science Foundation STEM Fellow in GK-12 
Education.  During this time, I developed novel curricula based on my research for 
local middle school science students.  This chapter overviews my GK-12 experience, 
and culminates with an article based on our work in the classroom submitted to 
Science Scope. 
 
7.2 Introduction 
In the spring of 2010, I was awarded a fellowship from the National Science 
Foundation Science, Technology, Engineering, and Mathematics (STEM) GK-12 
program.  The goal of the STEM program is to bridge the gap between basic science 
concepts and current research.  As a STEM fellow, I was paired with a teacher from a 
local school, and we worked together both in my lab, on an original research project, 
and in the classroom, implementing new science activities based on my work.   
 
In the summer of 2010, I was paired with Jackie Henkel and Mike McNall, 7
th
 grade 
science teachers from Eagle Hill Middle School, in Fayetteville, NY.  Over the course 
of the summer and the subsequent school year, I worked to develop projects that 
would introduce students to polymers, and the utility of polymers for studying 
biological phenomena.  This was an invaluable experience that helped me learn about 
and practice teaching, and ways to communicate science effectively.  
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7.3 The Role of Substrate Stiffness in Mediating Cell Proliferation 
During the summer of 2010, I worked with Jackie supervising a research project that 
she conducted in our lab.  Her project was to determine the role of substrate stiffness 
in mediating cell proliferation, a project I had started working on with Tracy Cheung 
while she was an undergraduate in our lab.  I taught Jackie how to make 
polyacrylamide substrates, to culture, plate, and fix cells, and to stain and image 
samples with fluorescence microscopy.  We quantified and analyzed Jackie's data and 
prepared a poster that she presented at the end of the summer research program.  
Jackie determined that endothelial cell proliferation rate increased with increasing 
substrates stiffness (Figure 7.1).  The raw data from Jackie’s experiments were used to 
develop a laboratory activity where students were asked to determine the role of 
substrate stiffness in mediating cell proliferation.  This was a rewarding experience for 
me because I was able to teach Jackie about current research in biomedical 
engineering, and to brainstorm ideas with her about possible projects to implement in 
her classroom.  Jackie's poster was hung in her classroom at Eagle Hill for her students 
to see.  
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Figure 7.1.  EC proliferation increases with increasing substrate stiffness. 
Endothelial cells were plated on variable compliant (E=1-10 kPa) substrates and 
imaged every 24 hours over four days.  (A) Representative phase contrast images for 
each time point and stiffness (scale bar is 500 m).  (B) To measure proliferation, 
phase images were used to determine the average number of cells per microscope field 
for each stiffness and time point. Mean + SEM, *p<0.05, ANOVA.  
 
7.4 The Approach 
During the academic year (September 2010-June 2011), I worked with students at 
Eagle Hill a few times a month.  In the beginning my role was to observe and assist 
lab activities that Jackie and Mike had developed previously.  In the winter of 2011 I 
was able to present my own curriculum to the class.  
 
I developed three lesson plans that focused on polymer stiffness.  These lessons were 
shaped as modules rooted in New York State education requirements for middle 
school science to accompany units in chemistry, physics, and biology.  Jackie and 
Mike were instrumental in helping facilitate the development and implementation of 
the activities.  They both were a wealth of knowledge about pedagogical methods and 
were a helpful sounding board when I approached them with ideas for activities. 
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The lessons were all structured the same way, and took place over three consecutive 
days.  On the first day, I presented the students with a lecture that gave the conceptual 
foundation to the lesson.  The students followed along with a "notes" worksheet that I 
created to accompany the lecture.  This was done so that the students would not get 
bored during the lecture, and also so that they would have a copy of the main content 
of the lesson.  The worksheets contained examples and problems that I designed to test 
their understanding.  These examples were placed throughout the lecture and were 
used to break the lecture format into interactive periods, a tool that helped keep 
students interested.  After giving the students time to work independently, we 
discussed the answers as a class to check understanding.  On the second and third day, 
the students worked on a lab activity that I designed to accompany the lecture.  The 
activities were focused on polymers, their characterization, and their role in biology.  
Several days to weeks after the lesson, Mike administered a quiz to the students.  This 
same quiz was given to students several days before my initial lecture, and served as a 
tool to assess student learning.      
 
7.5 The Lessons 
7.5a Introduction to Polymers 
The first lesson plan I designed and implemented was called “Introduction to 
Polymers” and accompanied the chemistry unit.  I wanted to build on the chemistry 
unit that was focused on the elements in the periodic table and types of matter by 
presenting polymers as a type of material that is ubiquitous and relevant for 
biomedical research. 
 
My presentation overviewed the classes of polymers, methods to name polymers, the 
role of crosslinkers in polymers, the chemical and physical properties of polymers, and 
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examples of polymers used in medical devices.  During my lecture, students worked 
through an accompanying notes handout (Appendix J.1a). 
 
The accompanying laboratory activity allowed students to synthesize their own 
polymers—“silly putty” made from mixing ratios of borax and glue.  It also asked 
them to hypothesize, design, and execute an experiment to determine the role of 
chemical crosslinkers in mediating polymer stiffness.  This activity went over very 
well with students—they really enjoyed making and playing with the putty. 
 
The students came up with several methods to characterize polymer stiffness including 
i) recording the time it took for a polymer ball to change a given diameter (the putty is 
viscoelastic), ii) recording the length the polymer stretched while hanging off the desk 
edge over a given time period, and iii) recording the bounce height of a polymer ball 
dropped from a given height.  These methods reinforced the concept of measurement 
that was a central theme throughout the school year.  The students were asked to 
determine what ratios of monomer to crosslinker made the stiffest polymer, to 
characterize and make a plot of their results, and to communicate their findings to the 
class.  Not all ratios of monomer and crosslinker can be used to make a polymer; this 
led to a class discussion about how this could happen (usually students added too 
much monomer).  Notably, while discussing results as a class, one group claimed that 
a specific ratio of monomer to crosslinker was the stiffest, while another group said 
that this same ratio did not polymerize.  This led to a class discussion about the need 
to repeat research findings in science to confirm hypotheses. 
 
As determined by the pre-and post-quiz (Appendix J.1b) results, there was a 
significant increase in quiz scores given after the lesson was complete (Figure 7.2 
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"3/11/11").  To determine if there was knowledge retention from the lesson, we 
administered the quiz again four months later.  Again, there was a significant increase 
in scores (Figure 7.2 "6/23/11"). It is not clear whether students remembered the actual 
content or simply the correct quiz answers, however, these findings suggested that the 
students were able to retain some information from the lesson.  I was extremely happy 
with these results, but would have been happy if they came away with nothing other 
than an understanding that polymers are an important material found in items all 
around them.     
 
Figure 7.2: "Introduction to Polymers" quiz scores.   
Pre-and post-lesson testing was used to assess curriculum efficacy.  The mean quiz 
score increased significantly (*p<0.0001) for the quiz administered after lesson 
implementation (post).  Three months later, students retained a significant increase in 
quiz score (post post) compared to pre-quiz scores. Quiz score out of 10 points. 
 
7.5b Mechanical Testing of Polymers 
As the students progressed chemistry to a unit in physics, I wanted to implement a 
lesson about more detailed methods to characterize polymer stiffness.  This lesson was 
admittedly more ambitious than the previous lesson, but I wanted to challenge the 
students.  Mike agreed that it would be challenging but that the students would get a 
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taste for how to apply physics.   
 
Like my first lesson plan, the activity started with a presentation about the concepts of 
force, Newton’s Second Law, stress and strain, and Young’s Modulus.  The 
accompanying worksheet (Appendix J.2a) contained example problems where 
students could calculate and convert between their mass and weight, find the stress 
and strain in a cylinder or block under application of a force, and calculate Young’s 
Modulus from a plot of stress vs. strain with SI units. 
 
The laboratory was framed as a biomedical problem (Appendix J.2b).  The goal of the 
lab was to determine the Young's Modulus of rubber, and to determine whether rubber 
is a mechanically suitable material for making replacement teeth.  The students were 
supplied with a set of hooked weights, rubber bands, ring stands, rulers, and 
calculators.  To determine the Young’s Modulus, the students needed to make a plot of 
stress vs. strain.  This was done by hanging three different weights from one end of a 
rubber band looped over a ring stand laid parallel to their desks (Figure 7.3).  Making 
measurements of the rubber band before and after stretching, and knowing the mass of 
the attached weight, the students populated a table with values they obtained for mass, 
force, area, stress, and strain.  The values of stress and strain were plotted, and an 
approximate best-fit line was used to determine the Young’s Modulus.   
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Figure 7.3. Mechanical testing apparatus.  
The mechanical testing apparatus consists of a laboratory ring stand laid over the side 
of the desk.  The rubber band is looped over the end of the stand and a hooked weight 
is hung from the bottom of the band.   
 
This was a challenging activity, and I wasn’t sure how far the students would be able 
to get through the lab.  However, I was surprised that most students were able to 
measure and calculate stress and strain for three different weights applied to a rubber 
band.  Some students were even able to make a plot of stress vs. strain, but they had 
trouble calculating the Young’s Modulus (slope of the line) and understanding how 
changes in the slope related to changes in polymer stiffness.  This was due to the fact 
that the students at this grade level had not yet formally learned how to plot lines and 
calculate line slope in math class.  I was surprised and pleased that the students were 
able to work with the concepts of stress and strain despite not fully making the 
connection to Young’s Modulus.  There was a significant increase in quiz (Appendix 
J.2c) scores suggesting that the students did retain some of the information I presented 
after the completion of the lesson (Figure 7.4). 
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Figure 7.4.  "Mechanical Testing of Polymers" quiz scores.     
Pre-and post-lesson testing was used to assess the efficacy of the Mechanical Testing 
of Polymers unit.  The mean post-quiz score (post) increased significantly 
(*p<0.0001) compared to the pre-quiz (pre).  Quiz score out of 10 points. 
 
7.5c Polymer Stiffness and Cell Proliferation 
This activity was the culmination of my GK-12 experience.  I designed a lesson 
stemming from biology where students investigated the role of substrate stiffness in 
mediating cell proliferation.  This research problem came directly from my research 
and from work that Jackie completed in lab with me before the start of the school year.  
 
The presentation and notes (Appendix J.3a) were an overview of cell biology, where I 
introduced students to the hierarchy of structure and function in the body, described 
cells and extracellular matrix, discussed scientific research in practice, and presented 
some of my own work showing that substrate stiffness alters cell spread area in 2D.  
 
The lab activity was framed as a discovery experiment where students were asked to 
determine whether substrate stiffness influences cell proliferation.  The tie-in to 
biomedical research is considering the role of the mechanical microenvironment of 
tumors that are often stiffer than the local surrounding tissue they reside in.  This 
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activity was a paper lab where students were taught about fluorescence staining and 
microscopy as a method to identify cells, and asked to ascertain whether stiffness 
affected cell growth.  We did this by supplying pictures representing data that Jackie 
had acquired over the summer.  Students were asked to count the number of cells per 
microscope field, to make plots of their findings, and to communicate their results to 
the class.  This was a relatively easy activity, and most students determined that 
proliferation increased with increased substrate stiffness, results determined in our lab.  
At the end of the lecture, we discussed what this could mean in the context of cancer 
(could we influence tumor growth by treating ECM stiffness?).  While we did not have 
sufficient time for pre- and post-quiz assessment, the students were interested in 
current research in biomedical science.  
 
7.6 Conclusion 
I had a great time working with Jackie, Mike, and the students at Eagle Hill.  I learned 
a lot about teaching methods and ways to communicate science.  More than learning a 
set of facts about polymers, I hope that the students gained an appreciation for 
scientific research, and that science, while challenging, can also be fun. 
 
7.7 Science Scope Article 
The following article, entitled Biomedical Application of Polymers: Inquiry based 
Exercises for the Classroom, was submitted to Science Scope. 
 
Abstract 
Polymers are a class of materials that are found in everyday objects like plastic water 
bottles and polyester fabrics.  In biomedical sciences, polymers help treat disease 
through applications like sutures or replacement joints.  Polymers are also used in 
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research laboratories to study biological phenomena.  Here, we present two classroom 
activities that introduce middle school science students to polymers, polymer stiffness, 
and the role of polymers in biomedical research.  These activities allow students to 
synthesize polymers and to determine how crosslinkers affect polymer stiffness.  In 
addition, they allow students to discover the role of polymer stiffness in mediating cell 
proliferation by analyzing original research data collected at Cornell University.  The 
activities are grounded in New York State education requirements and can be used to 
enrich fundamental science concepts with current research.  
 
Introduction 
Take a minute to look at the items sitting around you right now (go ahead, we’ll wait).  
Maybe you see a plastic water bottle, or sheets of paper, or even a polyester raincoat.  
These items might look very different, and help us perform different tasks, but they 
are all made from a class of materials called polymers.  In biomedical sciences, 
polymeric materials play an important role in treating disease and are found in 
applications ranging from sutures used for wound closure to joint-replacement 
implants.   
 
Depending on their intended biomedical use, polymers are designed with specific 
chemical and mechanical properties.  One important property is polymer stiffness.  For 
example, we want polymers that touch our eyes (contact lenses) to be much softer 
(less stiff) than those used in replacement hips designed to withstand our bodyweight 
with every step. 
 
What exactly are polymers and how can we tailor their stiffness?  What role does 
polymer stiffness play in biomedical sciences?  Here, we present two classroom 
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activities that introduce middle school science students to polymers, and allow them to 
conduct experiments synthesizing polymers and understanding their application in 
biomedical research.  These activities were designed in collaboration with New York 
State middle school seventh-grade science teachers and a Cornell University 
Biomedical Engineering graduate student, and are grounded in state education 
requirements.  The overall goal of these activities was to introduce students to the role 
of polymers in biomedical sciences to enrich fundamental science concepts with 
current research. 
 
I. What are polymers? 
Polymers are large molecules made up of repeating parts, where the repeating parts, or 
monomers, are chemical compounds.  As a material, most polymers can be classified 
as either synthetic (“plastics” used for food and beverage containers, sports equipment, 
and medical devices like contact lenses) or natural (polymers synthesized by cells in 
plants and animals, like cellulose and DNA). 
 
If we could look at the chemical structure of a polymer, we would see long chains of 
repeating monomers tied together like beads on a string.  Crosslinkers are other 
compounds that tie monomer strings together.  The physical properties of polymers are 
determined by the chemistry of both the monomer and crosslinker.  Examples of 
physical properties that are altered by changes in polymer chemistry include density, 
melting temperature, and stiffness. 
 
Activity I: Polymer Synthesis  
Overview 
This activity was designed to introduce students to polymers and built upon a 
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chemistry unit focused on the scientific method, the periodic table, and types of 
matter.  Students synthesized their own polymers and were asked to hypothesize, 
design, and execute an experiment to determine the role of chemical crosslinkers in 
mediating polymer stiffness.  A presentation and accompanying worksheet (available 
at http://climb.bme.cornell.edu/polymer.php) overviewed the classes of polymers, 
methods to name polymers, the role of crosslinkers in polymers, the physical 
properties of polymers, and examples of polymers used in medical devices.  Pre- and 
post-lesson quizzes were used to assess student performance.  
 
Materials and Teacher Preparation 
The teacher should prepare a 50% (v/v) mixture of glue (Elmer's Glue-All, $3/L) in 
water (“Solution A”, monomer) by combining 1.9 L water and 1.9 L glue in a 3.8 L 
plastic (1 gal) jug.  To prepare a 7.4% (w/v) mixture of sodium tetraborate 
decahydrate (borax; VWR cat# AA40114-36, $29/500 g) in water (“Solution B”, 
crosslinker), combine 272 g of borax and 3.7 L water in a 3.8 L jug and shake to mix 
thoroughly.  3.8 L each of solutions A and B were used for 30 groups of 4 students.  
Extra reagents can be stored for several years at room temperature.  
 
The teacher should review the MSDS information for sodium tetraborate decahydrate 
and glue (available from vendor).  Students should be supplied with splash safety 
goggles, aprons, gloves, and should wash their hands after the activity.  Gloves are 
recommended as the polymer may dry skin after prolonged handling.      
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Performing the Activity 
Groups of 3-4 students should be supplied with one plastic cup of “Solution A” (125 
mL), one plastic cup of “Solution B” (125 mL), an empty 237 mL (8 oz) plastic cup, 
spoons, a ruler, and a timer.  Food coloring may be added to Solution A and stirred to 
incorporate.  Students are directed to add three-parts Solution A to one-part solution B 
in the empty cup, and to stir until the solution polymerizes (3-5 minutes).  Once 
solidified, students can remove the polymer from the cup and knead it with their hands 
(Figure 7S.1).  The polymer displays time-dependent properties (viscoelastic) and will 
flow over time.  The polymer can be stored in zip-lock bags for many days.   
 
 
Figure 7S.1.  Polymer synthesis in the classroom. 
(A) Solution A colored with blue food coloring in a plastic cup with a plastic spoon 
used for mixing.  (B) A student kneads the polymer in her hands during synthesis.  (C) 
The polymer displays viscoelastic (time-dependent) properties and flows over the desk 
edge with time.  (D) A student completes the lab activity worksheet while her polymer 
spills over the desk.  (E) A comparison of quiz scores from pre- and post-lesson 
testing indicated a significant increase (*p<0.0001) in score for both post-lesson time 
points compared to the pre-lesson score.  Score out of 10. 
 
To determine the role of crosslinkers in polymer stiffness based on their hypothesis, 
students will mix ratios of Solutions A and B of their choosing, and will measure 
polymer stiffness (see example worksheet).  Note that not all ratios of monomer and 
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crosslinker will make polymers—instead the mixture will remain watery. 
 
Students may need help brainstorming ways to measure the stiffness of their polymer.  
Common examples devised by students included recording the change in length of a 
hanging polymer strip over a given time period and recording the bounce height of a 
polymer ball dropped from a given height. 
 
Once each group has synthesized and characterized several polymers, students should 
report their findings to the class.  In general, students found that increasing ratios of 
crosslinker increased polymer stiffness.  This facilitated a discussion about the 
chemistry of the polymer and why this might be happening (additional crosslinker 
decreases monomer chain mobility and rigidifies the polymer).  Groups in our 
classroom identified discrepancies in the reported data.  This stimulated a class-wide 
discussion about sources of scientific error (“Are you certain that you used a ratio of 
3:1?”) and the need for reproducibility and documentation in scientific 
experimentation. 
 
II. Does tissue stiffness affect cell behavior? 
Over half a million deaths were attributed to cancer in 2011, and 1.6 million new cases 
of cancer are projected for 2012 [227].  Cancer is a disease characterized by the 
abnormal and uncontrolled growth of cells that may result in tumor formation and 
metastasis (relocation of tumor cells throughout the body).  Many cancers are first 
detected as a hard lump in a soft tissue, a feature exploited by physicians in tumor 
detection.  An interesting theory that is being studied by cancer scientists is, once a 
tumor develops, does the increase in tissue stiffness affect cell function?   
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Cell proliferation is the cycle of cell growth and division where one cell becomes two, 
a process that is exploited in cancer.  In the body, most cells are in constant contact 
with protein scaffolds outside the cell that support cell attachment and give tissues 
structure.  This extracellular matrix is the site of increased stiffness during tumor 
growth [16].  One hypothesis is that increased matrix stiffness increases cell size, and 
subsequently nuclear volume and DNA synthesis that enable proliferation.  In fact, it 
has been shown that cell size can be altered by changing matrix stiffness [112,176]. 
 
Researchers at Cornell University are investigating whether the stiffness of the tumor 
extracellular matrix plays a role in affecting cell growth to understand the relationship 
between stiffness and cancer.  This is done by growing cells on polymer substrates of 
tunable stiffness, and measuring cell behaviors like migration or growth.  By altering 
the ratios of monomer and crosslinker, researchers synthesize polymers with a 
stiffness that mimics the stiffness of body tissues, like blood vessels, bones, or tumors.  
In contrast to traditional glass or plastic substrates, polymer substrates provide a more 
"physiologically relevant" platform to study cell behavior.  This research will aid in 
the understanding of the role of tissue stiffness as a regulator of cell behavior, and may 
one day help researchers design new cancer treatments.     
 
Activity II: Polymer Stiffness and Cell Growth 
 
Overview 
This activity was designed to allow students to determine the role of stiffness in 
mediating cell proliferation and built upon a biology unit focused on body systems.  
Students were asked to analyze data resulting from an experiment conducted by their 
teacher at Cornell University (Figure 7S.2).  In this experiment, cells were grown on 
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polymers with a range of stiffness (1-10 kPa) over three days.  The purpose of the 
experiment was to determine if polymer stiffness had an effect on the rate of cell 
proliferation.  A presentation and accompanying worksheet (available at 
http://climb.bme.cornell.edu/matrix.php) overviewed the hierarchy of tissue 
organization in the body, presented pictures of cells and their extracellular matrix in 
tissues like bone and blood vessels, detailed functions that cells can perform (adhere, 
change shape, migrate, communicate), and presented data from research publications 
indicating that cell size increases when cells are grown on polymers of increasing 
stiffness [112,176].  Due to time constraints, quizzes were not administered for this 
lesson. 
 
Figure 7S.2.  Cell growth increases with increasing polymer substrate stiffness. 
Plot of the percent gain in cell proliferation over three days with respect to substrate 
stiffness.  Cells were grown on polymer substrates with Young's Moduli of 1, 5, and 
10 kPa and were imaged over 3 days after plating.  The results indicated that there was 
an increase in proliferation with time and with increasing polymer stiffness.  
 
Materials and Teacher Preparation 
The teacher should remind or teach students about the principles of microscopy to 
understand how the experimental data was collected.     
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Performing the Activity  
Students are given copies of the laboratory activity (see example worksheet) and asked 
to hypothesize whether polymer stiffness influences cell proliferation.  Students are 
presented with images representing microscope fields-of-view containing cells stained 
to localize their nucleus with fluorescence microscopy (Figure 7S.3).  Students count 
cells from images representing polymers of different stiffness at two time points.  
They are asked to make a plot of their data, to identify potential sources of 
experimental error (what if a cell has more than one nucleus?), and to report their 
findings to the class.  The experimental data suggests that cell proliferation increases 
with increasing polymer stiffness, a finding that led to a discussion in our class 
hypothesizing new cancer treatments (can we influence tumor growth by targeting 
matrix stiffness?).  Students seemed genuinely excited about working with data from 
current research.   
 
Figure 7S.3.  Cells stained and imaged with fluorescence microscopy. 
Cells from a cow aorta (bovine aortic endothelial cells) were fixed with formaldehyde 
and stained to localize nuclei and actin, a structural protein used to identify the cell 
body.  The nuclei images were segregated and used to determine the number of cells 
per field of view.   
 
Conclusion 
We have designed two activities centered on polymer stiffness and rooted in units of 
chemistry and biology.  The activities allow students to synthesize polymers, and to 
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learn about the use of polymers in biomedical research.  The activities can be 
completed individually or as a series to enrich existing middle school science curricula 
with concepts from current research in biomedical science.    
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Worksheet: Polymer Synthesis 
 
Materials 
 Plastic cups, teaspoons 
 A cup of “Solution A” (50% v/v glue in water) 
 A cup of “Solution B” (7.4% w/v borax in water)  
 Food coloring 
 Ruler, timer 
 
Safety 
Splash safety goggles, aprons, and gloves are recommended. 
 
Procedure 
1) Label a cup with “3:1.” 
2) Add 3 teaspoons of solution A to the cup. 
3) Add 1 teaspoon of solution B to the cup. 
4) Stir the mixture until all of the liquid is gone. 
5) Once you have a polymer gel, take it out of the cup and knead it with your hands. 
 
Questions  
1) Write down your observations of the polymer (color, shape, stiffness, etc.).  
2) What happens when you pull the polymer apart quickly? Why do you think this happens? 
3) What happens when you pull the polymer apart slowly? Why do you think this happens? 
4) Roll the polymer into a ball and let it sit on the table for a few minutes.  How does the polymer 
change? Why do you think this happens? 
5) Would you characterize the polymer as a solid or a liquid? Why? 
 
Design an experiment to determine how the amount of polymer crosslinker alters the stiffness of 
the polymer. 
1) State your hypothesis: 
2) Record the ratios of solution A to solution B you used here: 
 i) ___:___ 
 ii) ___:___ 
 iii) ___:___ 
3) Based on your observations, what happens to the stiffness of the polymer when you change the 
amount of crosslinker? 
4) Describe the methods you used to measure polymer stiffness. 
5) How will you communicate your findings to the rest of the class? Explain/show below.  
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Worksheet: Substrate Stiffness and Cell Proliferation  
 
Dr. L. wants to know whether substrate stiffness affects cell proliferation.  In the laboratory, she put 
cells on polymers with a stiffness of 1 or 10 kPa.  Dr. L. then stained the cell nuclei so that she could 
see the cells when she looked at them with a microscope.  
 
Research Question and Hypothesis 
Does substrate stiffness influence cell division?  Yes or No and why—write your hypothesis here. 
 
Procedure 
To determine whether substrate stiffness influences cell proliferation, Dr. L. took images 24 hours and 
48 hours after she put cells on the 1 and 10 kPa substrates.  She took 2 images from each condition at 
each time point (see images below). 
1. Dr. L. asks you to analyze her data by counting the number of cells present in each condition to 
determine whether matrix stiffness influences cell proliferation. 
 
 
2. Using the count data from above, calculate the average number of cells per condition and make 
a bar graph of the data. 
 
Questions 
1. Is your hypothesis correct or incorrect? Does matrix stiffness influence cell proliferation? How 
do you know? 
2. Identify one problem with this experiment.  How can you fix it? 
3. During cancer, uncontrolled cell division contributes to tumor growth.  These tumors are often 
detected by physicians as a hard lump in soft tissue.  Cancer treatments use drugs that target 
and prevent cell division.  In light of the data from this experiment, what target may be an 
alternative avenue for cancer treatment? Why?  
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APPENDIX A 
      
Protocol for Coverslip Activation 
 
Modified from the methods of Wang and Pelham [28] and Reinhart-King [228]. 
 
1. Line up coverslips on top of 100 mm diameter Petri dishes (non-tissue culture 
treated).  Any glass substrate is amenable to activation: for six-well dishes, use 22 
mm square coverslips (No. 1); for traction force microscopy, use 45x50 mm 
rectangular coverslips (No. 1). 
a. Tip: For washing steps below, five 22 mm square coverslips will fit into 
one Petri dish; use one Petri dish per 45x50 mm coverslip.   
2. Using forceps briefly pass the glass coverslip through flame of a Bunsen burner 
3x.  Be careful, if the glass gets too hot, it will break.  If the glass is not hot 
enough, the NaOH will not spread well. 
3. Using a clean cotton swab, immediately apply 0.1 N NaOH to flamed side.    
4. Repeat steps 1 and 2 until the required number of slides have been coated.   
5. Allow coverslips to dry inside chemical fume hood (approximately 10-20 
minutes).   
6. When slips are dry, re-coat with NaOH and allow to dry. 
7. Remove 70% glutaraldehyde from -20 °C freezer and place inside fume hood 
approximately 10 minutes prior to use.   
8. In fume hood: Add 30 µL/22 mm square, or 80 µL/45x50 mm rectangle, of 3-
aminopropyl-trimethyoxysilane (APTMS) to each coverslip and spread quickly 
using a glass Pasteur pipette.  The amount scales with the size of the coverslip, and 
should be just enough to cover the coverslip surface. 
a. Tips: Work in groups of two or more slips.  Spread the drop until the glass 
looks evenly coated and glossy.  Use one pipette per group.  To spread the 
drop, it is easiest to pick up the coverslip with a gloved hand and spread.  
Discard gloves after this step.  
b. Note: once the drop is deposited on the glass, it should be spread quickly 
before the APTMS starts to dry.  
c. Note: APTMS is corrosive.  Be sure not to get APTMS on the lid of the 
bottle.  Otherwise, you will need a wrench to loosen the lid.   
9. Allow coverslips to dry for 5 minutes inside chemical fume hood.  Do not allow to 
dry for more than 10 minutes.   
10. Place each coverslip in a Petri dish filled with MilliQ water.  Wait until APTMS 
layer starts to crack, or an oily residue is visible in the dish. 
a. Tip: Make sure coverslips are not overlapping in dish—use a pipette to 
move them being careful to not touch the activated surface. 
11. Shake dishes to dislodge APTMS from each slip and discard water.   
12. Rinse 3x with MilliQ water.  Incubate for 5 minutes between each rinse. 
a. Be sure coverslips are rinsed thoroughly—if not, the APTMS will react 
with the glutaraldehyde in the next step to form a yellow/orange-red 
precipitate making the coverslip unusable. 
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13. In fume hood: Dilute 70% glutaraldehyde stock solution 1:140 in 1X PBS (without 
calcium and magnesium, pH 7.1). Each 22 mm square coverslip requires 200 µL, 
each 45x50 mm rectangle requires 500 µL. 
a. Tip: To calculate amount of glutaraldehyde necessary, divide total number 
of mL of solution needed by 140. 
i. Note: Glutaraldehyde is very viscous.  Wait for it to come to room 
temperature and pipette up very slowly, waiting for a few seconds 
before moving the pipette tip out of the glutaraldehyde, giving the 
glutaraldehyde time to enter the pipette tip. 
ii. Vortex the solution to mix thoroughly. 
14. Pipette the required volume of glutaraldehyde solution per slip onto parafilm. 
15. Invert slips on the droplet of glutaraldehyde solution ("activated" side down). 
16. Incubate for 30 minutes.   
17. Remove slips from parafilm, invert ("activated" side up), and return to Petri dish.  
Dispose of glutaraldehyde solution in waste a hazardous waste.  Wash each 
coverslip 3x with MilliQ water.  Incubate for 5 minutes between each rinse.   
18. Remove coverslips from dishes and place on a clean paper towel.   
19. Allow slides to dry inside fume hood.  This step can be performed overnight if 
necessary. 
20. Store slips in coverslip boxes in a dessicator at room temperature.  Slips can be 
stored and remain "active" for many months.    
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APPENDIX B 
Protocol for Polyacrylamide Gel Synthesis 
 
Modified from the methods of Wang and Pelham [28] and Reinhart-King [228]. 
 
 
1. Activate glass coverslips as described in Appendix A.  These coverslips are the 
"bottom" substrate that the gel becomes covalently bound to during 
polymerization.  Polymerization proceeds between this bottom slip and a "top" 
coverslip that will determine the size of the gel. 
2. Coat clean "top" coverslips with RainX.  The size of the coverslip used is based on 
the desired size of the gel.  Usually 18 mm diameter circles, or 22 mm squares, are 
used with 22 mm square and 45x50 mm rectangular coverslips.  Apply RainX 
using a clean cotton swab and allow to dry for at least 5 minutes.  Buff off excess 
with a kimwipe. Use canned air to dust the coverslip.  
a. Tip: Make sure to buff the edges well. 
3. If making gels for traction force microscopy, place 20 µL fluorescent beads per 5 
mL tube (see Step 7) into an eppendorf tube and sonicate for 10 minutes. 
4. Remove N6 and from the refrigerator and allow to come to room temperature 
before opening.  Do not open if cold. 
5. Combine the following components in a 50 mL centrifuge tube to prepare the gel 
mixture needed.  Compliance is based on the ratio of stock acrylamide (40%) to 
bis-acrylamide (2%). 
 
Young's 
Modulus 
(kPa) 
Volume 
acrylamide 
(mL) 
Volume 
bis-
acrylamide 
(mL) 
HEPES 
pH6 
(mL) 
Temed 
(µL) 
MilliQ 
water 
(mL) 
0.2 1.50 0.40 2.6 10 13.99 
0.5 1.50 0.50 2.6 10 13.89 
1.0 1.50 1.00 2.6 10 13.39 
2.5 2.50 1.00 2.6 10 12.39 
5.0 3.75 1.75 2.6 10 10.39 
9.0 3.78 2.75 2.6 10 9.31 
10 3.75 3.50 2.6 10 8.64 
15 6.00 1.30 2.6 10 8.59 
20 6.00 1.90 2.6 10 7.99 
30 6.00 2.80 2.6 10 7.09 
 
6. pH the solution to 6.0 by adding 45-50 µL of  2M HCl.  
7. Remove 845 µL of acrylamide mixture and place in a 5 mL plastic culture tube.  
Add 20 µL of fluorescent beads and 60 µL of water (80 µL total, variable ratio).  
Place the tube(s) into a vacuum flask and degas for 30 minutes.  The vacuum flask 
is sealed with a large stopper. 
a. Tip: Mix the gel solution by rocking the tube and pipetting up and down 
gently before the removal of 845 µL. 
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b. The vacuum flasks can hold up to four 5 mL tubes. 
8. Weigh out 5.6 mg of N6 linker in an eppendorf tube—be precise. 
9. Add 70 µL of 200 proof ethyl alcohol (molecular biology grade) to N6.  Pipette 
solution until well mixed and add it to the 845 µL of acrylamide mixture. 
a. Tip: Mechanically mix the N6 with a pipette tip until it is a saturated 
solution. 
 
10. To initiate polymerization: 
a. Add 5 µL freshly prepared 10% ammonium persulfate (APS) (0.1 grams in 
1 mL of MilliQ water). 
b. Mix gently by pipetting up and down being careful not to introduce 
bubbles. 
i. Tip: Once APS is added, work quickly.  Lay out all materials and 
micropipettes ahead of time. 
ii. Tip: Initiate polymerization in increasing stiffness, i.e. 0.2 kPa gels 
are first to polymerize and last to remove top coverslips. 
 
11. Add 20-30 µL (for 18 mm diameter "top" slips on 22 mm square "bottom" slips) of 
gel solution to activated coverslips from step 1.  This volume is scaled based on 
the desired size/thickness of the gel.  
12. Gently press the drop of gel solution with RainX-coated glass circle by carefully 
touching the round coverslip to the edge of the drop and then lowering it slowly 
using forceps. 
a. For traction gels: invert the coverslip sandwich onto a 60 mm dish so that 
the beads can sink to the top of the gel. 
13. Allow polymerization to occur for 30 minutes.  The edges of the gel should recede 
beneath the top coverslip.  Lower stiffness gels may need to polymerize up to 35 
min.   
14. While gels are polymerizing, remove protein from fridge/freezer and place/thaw 
on ice.   
15. Dilute the protein in ice-cold 50 mM HEPES (pH8) to the desired concentration 
(usually 1-100 g/mL). 
a. Tip: Need 200 µL of protein/gel minimum. 
16. Peel off cover slip from each gel using a clean razor blade.   
17. Add 200 µL of the dissolved protein to the gels: deposit 200 µL of protein solution 
onto parafilm.  Invert the gel onto the drop. 
a. Tip: Introduce no bubbles.  The gel can be lifted slightly on its edge with a 
razor blade to remove bubbles. 
18. Incubate at 4°C for 2 hours. 
19. Remove gels from parafilm and place in labeled 6-well plates. 
20. In a tube, mix a 1:1000 volume of ethanolamine with 50 mM HEPES (pH8).  (1 
µL of ethanolamine for each 1 mL of HEPES buffer).  Each gel requires 200 µL of 
solution.   
21. Dispense 200 µL of the ethanolamine/HEPES solution directly onto the gels.  
There is no need to rinse off the protein first. 
a. Tip: Make sure the dispensed volume covers the gel.  
22. Incubate gels at room temperature for 30 minutes. 
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23. Rinse gels with MilliQ water—add liquid to side of well, not directly on gel. 
24. Place gels in MilliQ water and store at 4C for up to 2 weeks (total experimental 
time including cell-seeding; best to use gels ASAP). 
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APPENDIX C 
Advanced Methods for Polyacrylamide Gel Synthesis: Double Gels and 
Micropatterned Gels 
 
 
Double Gels 
This is a polyacrylamide gel ("base gel") cast with a thin gel at the top surface ("top 
gel") incorporated with fluorescent beads.  This will ensure that fluorescent beads are 
in a single plane at the surface of the gel for traction force microscopy or mechanical 
testing 
 
1. Activate glass coverslips (Appendix A). 
2. Synthesize polyacrylamide gels (Appendix B) with the following amendments 
 to the steps indicated: 
a. Step 7: For each stiffness wanted, degas a 5 mL tube of gel mix with no 
beads, and a vial with 0.5-2 uL of beads (be sure to sonicate the beads 
as described in step 3). 
b. Step 11: Prepare base gel with the no-bead gel mix.  Use 40 uL of gel 
mix sandwiched between two 22 mm square coverslips (one activated 
and one RainX-treated).  Proceed with steps 12-16. 
c. Step 16: After polymerization, remove the top coverslip and add the 
"top" gel: Add 20 uL of initiated gel mix (step 10) with beads under 
another RainX-coated 22 mm square top coverslip (could also use a 
patterned glass square from below).  
d. Proceed with Steps 13-24. 
  
Micropatterned Gels 
This is a gel micropatterned with adhesive islands transferred from PDMS stamps.  
Modified from the methods of Rape et al. [195]. 
 
1. Combine N6 linker and collagen in HEPES pH8 at the desired concentration 
 on ice for 2 hours. 
2. Cut out PDMS stamps to the desired size and shape (a 2x2 array works well for 
 22x22 mm glass coverslips). 
3. Clean coverslips to be patterned with ethanol and remove dust with canned air. 
4. After 2 hours, apply collagen to stamp surface (“inking”) in a bubble on top—
 let sit for 30 min at RT. 
5. After inking, gently remove excess collagen by dabbing the side of the stamp 
 on a paper towel.  Hold stamps with forceps but make sure the features do not 
 touch the paper towel.  
6. Air dry the stamps until no excess collagen is visible. 
7. Place inked stamps on clean coverslips and press gently.  Incubate for 5 min.  
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8. Remove stamp vertically and carefully with forceps—do not let stamp move 
 around or retouch glass during removal. 
9. Use the patterned glass as the top coverslip in the conventional gel-making 
 protocol (Appendix B) 
Notes: 
-Patterns on the glass coverslip may not be visible—but they exist! 
-Do not use RainX on the patterned coverslip 
-This procedure can also be used with the Double Gel protocol—see above. 
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APPENDIX D 
      
Protocol for N6 Linker Synthesis 
 
Modified from the methods of Swift [229] and Reinhart-King [228]. 
 
Structure of N6 [N-6-((acryloyl)amino)hexanoic acid, succinimidyl ester] 
 
N
O
O
O
N
O
O
 
Molecular Weight: 283 g/mol 
Formula: C13H18N2O5 
 
It should be noted that this linker is now available from Invitrogen (Cat # A-20770). 
 
1. Assemble the following in a fume hood: 
 250 mL Erlenmeyer flask 
 Ice bath with beaker containing 150 mL DI water 
 Stir plate 
 9 cm filter (ceramic with long neck) with fine glass filter paper 
 Vacuum flask with tubing and filter 
 250 mL beaker 
 100 µL pipetter with tips 
 pH meter 
 spatula 
 crystallization dish 
 Plastic transfer pipettes 
 10 g 6-amino hexanoic acid (do not use "caproic" acid) 
 10 g Ca(OH)2  
 7.0 mL acryloyl chloride in 10 mL graduated cylinder 
 2 mL 12 N HCl in 10 mL beaker 
 100 mL beaker of 50 mL dry (100 proof) ethanol; for cleaning the pH probe 
2. To the 150 mL DI water in the ice bath, add 10 g 6-amino hexanoic acid and a 
stir bar 
3. Stir at 0°C in the ice bath until dissolved 
4. Add 10 g Ca(OH)2 to the solution on the stir plate.  Note--it will not fully 
dissolve 
5. Add acryloyl chloride in 1 mL aliquots every 2 minutes, continuing to stir at 
0°C 
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6. 2 minutes after the final addition of acryloyl chloride,  filter with 9 cm filter 
(with glass filter paper) on vacuum flask 
 *All filter steps take place with filter paper and upon a vacuum flask 
7. Put liquid filtrate in a 250 mL beaker with a stir bar and place in the ice bath 
8. Use 100 uL aliquots of 12 N HCl to pH to 2.6, continuing to stir with a stir bar.  
Note--pH will start above 12; it should take about 8.4 mL to get down to 2.6 
9. Filter with 9 cm filter  
10. Keep ice cold and wait for precipitate to form; should be thick and white 
11. Remove precipitate using a spatula and put in the crystallization dish on ice 
12. Clean the pH probe with pH 2 ethanol 
13. Take samples for TLC in small vials: 1. 40 uL of filtrate. 2. a small sample of 
precipitate 
Drying of 6-acrylamidohexanoic acid 
OVEN DRY ALL GLASSWARE PRIOR TO USE 
1. Assemble the following in the fume hood: 
 2 ice baths 
 2x 250 mL beakers 
 4x 250 mL Erlenmeyer flasks 
 1x 500 mL Erlenmeyer flask 
 4.7 cm filter 
 Stir plate with stir bar and thermometer 
 100 mL 1:1 mix of chloroform and dry ethanol in wide-mouth 500 mL 
Erlenmeyer 
 130 g Na2SO4 
 6 g activated carbon (charcoal) 
 Diatomaceous earth 
2. Place Erlenmeyer flask with 1:1 chloroform and ethanol in ice bath for 10 
minutes 
3. Add precipitate (thin white paste) and stir at 0°C until dissolved 
4. Add 130 g Na2SO4 and 6 g activated carbon.  Mix by swirling to dehydrate 
5. Make a 250 mL suspension of diatomaceous earth in dry ethanol.  No need to 
measure, just combine to make a slurry.  Pour over the 4.7 cm filter to form a 1 
inch plug.  Rinse the plug with ethanol and change the receiver flask 
6. Vacuum filter the suspension and repeat---create a fresh plug 
7. Place the clear solution in a dry 250 mL beaker 
8. Heat the bath to 40-50°C and evaporate the solution to 10-30 mL while 
stirring.  Note--place a vacuum hose with filter above the solution surface to 
significantly reduce evaporation time (lower vapor pressure) 
 *Pull vacuum above evaporating mixture for all Evaporation steps 
9. Place the syrup in the ice bath 
10. Clean up except the ice baths 
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Synthesis of N6 
1. Assemble the following in a chemical fume hood: 
 Ice bath on stir plate 
 200 mL ice-cold ethanol in a dry 250 mL flask 
 8.7 g NHS 
 17 g EDAC 
2. Add 200 mL ice-cold ethanol to product syrup and place flask in ice bath 
3. Add 8.7 g NHS and 17 g EDAC 
4. Stir 3-4 hours at 0°C 
5. Take TLC sample: Label 3 
6. Evaporate and reduce syrup by half at 45°C while stirring 
7. Clean up 
Extraction of N6 
1. Assemble the following in a chemical fume hood: 
 500 mL separatory funnel 
 Ice bath 
 Stir plate 
 4x 250 mL flasks 
 2x 500 mL flasks 
 4.7 cm filter with filter paper 
 200 mL methylene chloride 
 0.2 mL glacial acetic acid 
 Sodium bicarbonate 
 65 g anhydrous sodium sulfate 
2. Pre-chill the methylene chloride in an ice bath 
3. Add 200 mL methylene chloride and 0.2 mL glacial acetic acid to product 
syrup 
4. Stir on ice 10 minutes 
5. Prepare a 500 mL flask of saturated sodium bicarbonate solution in water at 
0°C.  No need to mix, just add enough sodium bicarbonate so that an over-
saturated suspension is made 
6. Mix 200 mL of suspension from step 5 with product syrup in a 500 mL flask.  
Separate in a separatory funnel and retain lower phase 
7. Repeat, always retain lower phase, filter into fresh flasks 
8. Repeat twice more with cold water 
9. Add 65 g anhydrous sodium sulfate to product 
10. Filter using 4.7 cm filter  
11. Transfer to a 250 mL flask and evaporate at ~40°C (solution will boil) 
12. Clean up 
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Assemble the following in a chemical fume hood: 
Stir plate 
Dry 100 mL crystallization dish 
 
1. Add 200 mL dry ethyl acetate to product syrup 
2. Evaporate to 100 mL at 60°C 
3. Pour into crystallization dish and add seed crystals of N6 
4. Leave at room temperature for 10 minutes, then cover with parafilm and place 
in refrigerator 1-2 hours 
5. Move to -20°C freezer and leave overnight 
6. Recover crystals (will look like wet N6) —break up crystals with a spatula and 
place in a 9 cm filter atop a vacuum flask for 30 min to dry out crystals.  When 
done the crystals should look like dry fine powder 
7. Reduce the volume of the supernatant by 50% and re-do crystallization 
Note--the first crystallization will reduce the 100 mL solution to about 50 mL and 
yield approximately 3-4 g of N6  
 
Run Mass Spectrometry on final sample.  N6 is the peak at 283: 
 
 +Q1: 0.050 to 0.953 min from Sample 1 (Faber_1_InfusionQ1MS) of Faber_1_InfusionQ1MS.wiff (Turbo Spray) Max. 7.3e6 cps.
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APPENDIX E 
Protocol for Mechanical Testing of Polyacrylamide Gels 
 
Assemble to following materials: 
 Thick polyacrylamide gels (polymerize 80-100 L of gel mix) cast on 45x50 
mm coverslips 
 Traction chambers 
 Steel (440C) ball bearings (0.64 mm diameter), Abbott Ball Company 
 Magnetic stir bars 
 Forceps 
 Media 
Steps: 
1. Cast thick gels embedded with fluorescent beads (10-20 L) onto large 
coverslips and assemble gels in traction chambers.  Gels may be cast with a 
thin layer of beads at the surface if desired (Appendix C).  
2. Equilibrate gels in media in an incubator. 
3. Load gel into stage insert for traction chambers on scope—run stage incubator. 
4. Attach a single steel ball to forceps (magnetic) and hold over chamber. 
5. Use fingers to carefully remove ball from forceps and drop onto the gel. 
6. Use a magnet beneath the sample to move the ball around to a desired position 
on top of the gel. 
7. Find the ball in a field of view (20X objective works well) and focus on the 
depressed bead field beneath the ball. 
8. Record the z-location of this focal plane with the “mark and find” menu in 
Axiovision (Z1). 
9. Use the magnetic stir bar to remove the steel ball from its initial position. 
10. Refocus the scope on the bead field at the top surface of the gel. 
11. Record the z-location (Z2). 
 
12. The absolute value of the difference between Z1 and Z2 is the indentation 
depth, δ, used in the following equation to determine the Young’s Modulus at 
the surface of the gel, based on Hertz theory  [86]: 
  
E = (3(1-2) f ) / (43/2r 1/2) 
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Where 
E = Young’s Modulus 
ν = Poisson’s ratio 
 f = W – Fb  (ball weight - buoyant force of the ball) 
  [see diagram and calculation below] 
r = ball radius 
δ =  indentation depth [see diagram below] 
 
 
 
  
Notes: 
-We assume ν = Poisson’s ratio = 0.3 [183] 
-Density =  = 7200 kg/m3 
-To calculate f: 
  
 f = W-Fb 
  
where 
W = weight of ball = [(mass of ball * g)]: Wball=mg 
Fb = buoyant force of ball = 
  [density of ball * volume of ball submerged into gel * g]: Fb= Vg 
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Since mass (m) =V, we can write: 
 
 Wball=ball*Vball*g 
  
 Fb = ball*Vsubmerge*g 
  where Vsubmerge = (1/3)
2
(3r-)   
This is the formula of a sphere cap with sphere radius r and height  
 (which is the indentation depth in this analysis) 
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APPENDIX F 
Protocol for Immunofluorescence Staining of Cells on Polyacrylamide Gels 
 
Volumes are for gels in wells of a six-well dish 
  
1. Aspirate media and rinse the samples 3x with PBS.  Dispense against the well 
wall, not onto the gel.  
2. To fix samples, add 2 mL of 3.7% (v/v) formaldehyde in PBS for 15 min at RT. 
3. Wash 3x with PBS for 5 min each. 
 
Notes: -During washing periods, place samples on a rocker 
  -Samples can be stored in PBS at 4°C at this point for a couple of days 
  if necessary 
 
4. To permeabilize cells, add 2 mL 1% (v/v) Triton (octyl phenol ethoxylate) in 
PBS for 5 min at RT 
5. Wash 3x with 0.02% (v/v) Tween 20 (polyoxyethylene 20 sorbitan 
monolaurate) in PBS for 5 min each 
6. To block samples, wash 1x with 3% (w/v) BSA in 0.02% (v/v) Tween 20 in 
PBS for 1 hour 
 
7. Prepare 1’ antibody in 1% (w/v) BSA in PBS.  Dilute antibodies according to 
the manufacturer’s recommendation on the product data sheet.  1:50 is often a 
good dilution (1 L of antibody in 50 L BSA/PBS) 
 
8. Add drops (100 L/gel) of 1’ antibody mix in 1% (w/v) BSA in PBS onto 
parafilm.  Place gel upside down on the drop, trying to avoid bubbles 
9. If also staining for actin, incubate samples in a humidified chamber overnight at 
4°C (phalloidin will attenuate the immunofluorescent signal).  If not staining for 
actin, incubate for 1 hour at RT.  To create a humidified chamber, place 
samples in a large Petri dish that contains wet kimwipes.   
10. Wash 3x with 1% (w/v) BSA in 0.02% (v/v) Tween in PBS for 5 min each 
11. Prepare 2’ antibodies in 1% (w/v) BSA in PBS (dilute according to the 
manufacturer’s specification—usually 1:200-1:1000.  Spin 2’ antibody at 14k 
xg for 2 min at 4ºC before use  
12. Add drops (100 L/gel) of 2’ antibody mix in 1% (w/v) BSA in PBS onto 
parafilm.  Place gel upside down on the drop, trying to avoid bubbles 
13. Incubate in a humidified chamber for 1 hour at RT 
 
Note: If using more that 2 antibodies, repeat antibody and wash steps as often  
    as needed 
14. Wash 3x with 0.02% (v/v) Tween 20 in PBS for 5 min each 
15. Wash 3x with PBS for 5 minutes each 
16. To mount, place a drop of Vectashield mounting media on a coverslip (larger 
than the one the gel was cast on).  Use a kimwipe to dry the glass on back of the 
gel sample, and invert the gel onto the drop 
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17. Image through the larger coverslip to obtain the best image, i.e. the coverslip 
without the bound gel should be the one closest to the objective lens 
 
Additional Notes and Tips: 
 
Staining for F-actin 
 To colocalize F-actin, incubate inverted samples on a drop (100 L/gel) of 
phalloidin (1:40 in PBS) on parafilm for 1-2 hours after Step 15.  Wash 3x 
with PBS and mount.  
 To stain for F-actin alone, incubate samples on a drop of phalloidin after 
blocking (Step 6) for 1-2 hours and proceed to Step 14.  
Staining for nuclei 
 Incubate inverted samples on a drop (100 L/gel) of DAPI (0.1 mg/mL in 
MilliQ water) on parafilm for 10 min.  Wash 3x with PBS and mount.  
Staining for paxillin/vinculin 
 Fix samples in 3.7% (v/v) formaldehyde in PBS for 5 min (Step 2).  Block 
samples with 40% (v/v) heat-denatured FBS in PBS (Step 6).  
Staining for mitochondria 
 Incubate live cells with 200 nM MitoTracker in 2 mL media for 30 min in 
incubator.  Image immediately.  If staining fixed samples, proceed to Step 1.  
Staining for trans-Golgi 
 Complete Steps 1-3.  Before permeabilization (Step 4), add 5 g/mL wheat 
germ agglutinin in 2 mL PBS for 10 min.  Proceed to Step 4.  
If background signal is significant, try 
 Fixing with 70% (v/v) ethanol in water, or 100% methanol for 5-30 min  
 Blocking with 5-10% (w/v) BSA in PBS, or 10% (v/v) goat serum in PBS, or 
10-40% (v/v) heat-denatured FBS in PBS for 1-2 hours 
 Washing with 0.05-0.10% (v/v) Tween 20 in PBS during washing steps 
 Increasing duration of washing steps 
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APPENDIX G 
Protocol for BrdU Incorporation for Cells on Polyacrylamide Gels 
Developed with Kelly McBride 
 
Plate and BrdU Incorporation  
1. Grow cells to 90% confluence in T25 culture flask 
2. Add serum free media and incubate overnight 
3. Passage cells onto the gels in a six-well dish 
a. 50k cells/well for 0.2 kPa gels 
b. 30k cells/well for other stiffnesses 
4. 4 hours later, add BrdU 1:100 in 2 mL of fresh media per well 
5. Incubate at 37ºC for 2 hours-overnight 
 
Fix and Stain  
1. Aspirate media and wash 3x with PBS 
2. Fix with 3.7% (v/v) formaldehyde in PBS for 5 min at RT 
3. Wash 3x with PBS for 5 min each 
a. Samples can be stored at 4ºC for a few days if necessary 
4. To permeabilize, add 1% (v/v) Triton (octyl phenol ethoxylate) in PBS for 5 
min at RT  
5. To denature DNA (and allow BrdU to bind), add 2N HCl for 1 hour at 37ºC 
a. Remove acid to waste container 
6. Wash 3x with PBS for 5 minutes each 
7. Wash 3x with 0.02% (v/v) Tween 20 (polyoxyethylene 20 sorbitan 
monolaurate) in PBS for 5 min each 
8. To block, wash 1x with 0.1% (v/v) in 0.02% (v/v) Tween 20 in PBS for 1 hour 
9. Incubate with 1’ antibody (anti-BrdU) 1:100 in 1% (w/v) BSA in PBS for 1 
hour at room temperature 
a. Invert samples onto 100 µL drop per gel on parafilm 
10. Wash 3x with 0.1% (v/v) in 0.02% (v/v) Tween 20 in PBS for 5 minutes each 
11. Incubate with 2’ antibody (anti-BrdU) 1:200 in 0.1% (v/v) FBS in PBS for 1 
hour at RT 
a. Spin 2’ antibody at 14k xg for 2 min at 4ºC before use 
b. Invert samples onto 100 µL drop per gel on parafilm 
12. Wash 3x with 0.02% (v/v) Tween 20 in PBS for 5 minutes 
13. Image immediately 
a. Dry the back of the gel glass, and invert the sample onto a drop of 
Vectashield on a large coverslip  
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APPENDIX H 
Protocol for Harvesting Cells from Polyacrylamide Gels for SDS-PAGE/Western Blot 
or qPCR Analysis 
 
For SDS-PAGE/Western Blot 
 
Materials 
 Cells grown on 45x50 mm gels (2x per condition) 
 1X TBS 
 Ice bucket 
 100 mm Petri dishes 
 Lysis buffer 
 Cotton-tipped applicators 
 Razor blade 
 Cell scrapers 
Procedure 
1. Prepare a lysis chamber, one per gel  
a. Add a 100 L drop of lysis buffer to a 100 mm diameter Petri dish on 
ice 
2. Remove samples from incubator and rinse cells 4-5x with ice-cold  TBS 
3. Carefully remove cells from any exposed glass with a cotton-tipped applicator, 
and remove the sample with a razor blade 
4. Carefully dry the back of the sample to remove excess TBS 
5. Invert the sample onto the drop of lysis buffer and incubate 5-10 min 
6. Carefully agitate the sample with a cell scraper. Lift the sample from the dish 
and carefully scrape the contents of the gel surface into the dish   
7. Collect the sample with the cell scraper, and collect in sterile 1.7 mL centrifuge 
tubes.  Combine lysate from 2x gels per condition. 
8. Spin 5 min at 14k xg at 4 C 
9. Save supernatant in a new tube 
10. Proceed with conventional SDS-PAGE/Western blot, or snap freeze in liquid 
nitrogen and store at -80 C  
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For qPCR 
 
Materials 
 Cells grown on 45x50 mm gels (1x per sample is usually sufficient) 
 500 mL 0.25% TE/gel 
 1X PBS 
 Media 
 100 mm Petri dishes 
 15 mL tubes 
 Cotton-tipped applicators 
 Razor blade 
 Cell scrapers 
Procedure 
1. Prepare a lysis chamber, one per gel 
a. Add a 100 L drop of TE to a 100 mm diameter Petri dish on ice 
2. Remove samples from incubator, and rinse carefully 4-5x with PBS  
3. Carefully remove cells from any exposed glass with a cotton-tipped applicator, 
and remove the sample with a razor blade 
4. Invert the sample onto the drop of TE and return to the incubator for 10 min 
a. Check cells under scope until balled up/detached from substrate 
5. Flip sample back over with razor blade and rinse the gel gently with 1 mL 
complete media 
a. Gently squirt media over the surface of the cell to detach any balled up 
cells 
6. Use cell scraper to pool media and collect in 15 mL centrifuge tube 
7. Repeat steps 1-6 for all samples 
8. Pellet cells (spin 5 min @ 400 xg; pellet may not be visible!) 
a. Wash very gently with PBS to remove all traces of media/trypsin 
b. Carefully pipette out excess PBS 
9. Proceed with conventional RNA harvest and purification immediately 
a. Less ideal but still works: cell pellets (remove all PBS) may be snap 
frozen in liquid nitrogen and stored at -80 C 
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APPENDIX I 
Protocol for Transfection of Endothelial Cells 
 
This procedure can be used for plasmid DNA and siRNA transfection of endothelial 
cells (bovine aortic or human umbilical vein) 
 
Timeline 
 
Day -1: Plate cells in a vessel 
Day 0:  Transfect cells 
Day 1:  Transfer cells to gels 
Day 2:  Begin imaging 
 
Materials 
 Cells 
 For plasmids: cells in a 6-well dish 90% confluent 
 For siRNA: cells in a 6-well dish 60-80% confluent 
 Lipofectamine 2000 
 Optimem 
 plasmid DNA 
 Sterile 1.7 mL centrifuge tubes 
Procedure 
1. The day before transfection, seed 
 For plasmids: 300k cells/well in a 6-well dish 
 For siRNA: 200k cells/well in a 6-well dish 
The day of transfection (Day 0) 
1. Add 500 L Optimem to a 1.7 mL centrifuge tube (6x, one for each well) 
2. Add  
 For plasmids: 2 g DNA—mix and sit 5 min RT 
 For siRNA: 2 L stock siRNA solution—mix and sit 5 min RT 
3. Add  
 For plasmids: 5 L Lipofectamine—mix and sit 20 min RT 
 For siRNA: 6 L Lipofectamine and sit 20 min RT 
4. Was cells gently 2x with Optimem 
5. Add 1.5 mL Optimem to well 
6. Add the ~500 L DNA/siRNA/Lipofectamine/Optimem mix to each well (2 
mL final volume per well) 
 -swirl/rock to mix, avoid bubbles 
7. Put in incubator 4-6 h. Check cells every few hours for significant debris or 
vacuole formation 
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8. Remove mix, wash 2x with sterile PBS 
9. Replenish fresh media 
10. Plate the next day (Day 1) 
11. Assay the next day (Day 2) 
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APPENDIX J 
GK12 Module Teaching Materials 
 
 
J.1a "Introduction to Polymers" Notes Handout 
 
 
Polymer Notes 
Polymers are all around us!  Materials like plastic and wood are made up of polymers.  
 
Kinds of Polymers 
Many polymers are found in nature (natural), and others are made by people 
(synthetic).  Fill in the blanks with 3 items that contain natural or synthetic polymers: 
 
Natural:       Synthetic: 
1) DNA       1) Plastic  
2) Wood       2) Toys 
3) Rubber       3) Contact lenses 
 
What is a Polymer? 
A polymer is a large molecule made up of repeating parts. 
 
An Example: Polyester 
Let’s take a closer look at what a polymer is. Maybe you have heard of a polymer 
called polyester.  Polyester is a fabric used to make clothing like raincoats, pants, and 
shirts.  This fabric is made of long chains of a compound called an ester.  These ester 
compounds are made of elements on the periodic table, mostly carbon, oxygen, and 
hydrogen. 
 
 
Polyester fibers   are used to make fabrics for clothing 
 
If we look closely at the polyester fibers, we would see chains of ester compounds tied 
together: 
…—ester—ester—ester—ester—ester—ester—ester—… 
 
These repeating units are held together by covalent bonds. 
A covalent bond is formed when atoms in a compound share electrons.  
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Each chain is made of thousands of esters tied together like beads on a string: 
 
 
     
    Ester compound 
Naming Polymers 
Polymer names come from the repeating unit found in the polymer. 
For example, raincoats are made from the polymer called polyester.  This polymer is 
made from thousands of repeating ester compounds. 
 
As you can see, the name of the polymer is taken by combining “poly” with the name 
of the repeating unit, “ester”, to form “polyester”. 
 
Exercise: Fill in the blanks by completing the polymer name or repeat unit. 
I’ve done the first one for you: 
 
Repeating unit   Polymer name 
ester      Polyester 
ether     Polyether 
ethylene    Polyethylene 
styrene    Polystyrene (Styrofoam) 
amine     Polyamine 
 
 
Polymer crosslinkers 
A crosslinker is a compound that is used to chemically bond polymer chains together.  
This gives the polymer stability and helps to determine the physical properties of the 
polymer. 
 
The diagram below is a close-up of some polymer chains in a polymer fiber. 
Draw crosslinkers between the polymer chains: 
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Circle one: 
The  (chemical | physical) make-up of polymers and their crosslinkers determine the  
(chemical | physical) properties of polymers. 
 
List 2 physical properties of polymers: 
1) Density 
2) Stiffness 
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J.1b "Introduction to Polymers" Quiz 
 
 
1) What is a polymer? 
 A. A collection of negatively charged ions 
 B. A small compound made of hydrogen and oxygen 
 C. A large molecule made of repeating units 
 D. An element in the periodic table 
 
2) Which is an example of a synthetic polymer? 
 A. Metal 
 B. Plastic 
 C. Protein 
 D. Glass 
 
3) Which is an example of a natural polymer? 
 A. Plastic 
 B. Sand 
 C. Rock 
 D. Wood 
 
4) Which of the following may be made of polymers? 
  A. Food and beverage containers 
  B. Sports Equipment 
  C. Medical devices 
  D. All of the above 
5) What is the repeating unit in the polymer called polyurethane 
  A. propylene 
  B. saccharide 
  C. amine 
  D. urethane 
 
6) What is the name of the polymer shown below: 
 —ethylene—ethylene—ethylene—ethylene—ethylene— 
  A. Polyether 
  B. Polyester 
  C. Polyethylene 
  D. Polyethyleneimine 
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7) What kind of chemical bond holds polymer repeat units together? 
  A. Ionic 
  B. Covalent 
  C. Metallic 
  D. Hydrogen 
 
8) What is a crosslinker? 
  A. A compound that bonds polymer chains together 
  B. An element in the Lanthanide series  
  C. An atom that spins in a magnetic field 
  D. The repeating mer unit in a polymer 
 
9) What properties of polymers are altered by crosslinkers? 
  A. Density 
  B. Stiffness 
  C. Transparency 
  D. All of the above 
 
10) Rank the following types of matter from smallest to largest  
  A. element, atom, compound, polymer  
 B. atom, element, compound, polymer 
 C. atom, element, polymer, compound 
 D. compound, atom, element, polymer 
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J.2a "Mechanical Testing of Polymers " Notes Handout 
 
Mechanical Testing Notes 
Forces 
-A force is a push or a pull 
 
-The SI unit of force is the  Newton. It has units of  N = kgm/s
2
  
 
-Draw 2 forces acting on the block below: 
 
 
  
 
Newton 2 
-Newton's 2nd Law states that force equals mass times acceleration, or, F=ma 
 
-The SI unit of force is Newton 
 
-The SI unit of mass is kilogram (kg) 
 
-The SI unit of acceleration is m/s
2
 
 
On Earth, the value of acceleration due to gravity is  9.81 m/s
2
 
 
A natural form of Newton 2 is the formula for weight: Weight = (mass)(acc. due to 
gravity), or, W=mg 
 
 Example -Use Newton 2 to calculate your mass 
  F=ma  1 lb = 4.45 N 
  W=mg  
 
1) Convert your weight in lb to N 
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2) Solve W=mg for m 
 m=W/g 
 
 
3) Plug in the values and solve 
 
 
My mass is 68 kg. This value is the same regardless of what planet you're on! 
 
 Example -Use Newton 2 to calculate your weight on    
 Mars 
 F=ma  aMars=gMars=3.71 m/s
2
  1lb = 4.45 N 
 W=mg  m=______kg (from above) 
 
1) Solve W=mg for W 
 
 
 
My weight is 252 N. This value would change if you traveled to the moon! 
 
2) Convert your weight in N to lb 
 
 
 
Stress 
-Stress is a measure of force divided by the cross-sectional area that the force acts on. 
-Stress = Force/Area 
-The Greek letter sigma () is used to represent stress 
 
-The SI unit of force is Newton 
 
-The SI unit of Area is m
2
 
 
-The SI unit of stress is N/m
2
 = Pascals (Pa) 
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 Example -Find the stress acting in the cylinder   
 
 stress = Force / Area 
  = F/A 
 
 F=3.14 N 
 
 
 
 A=(1m)2 = 3.14m2 
 
 
 
  = F/A=3.14N/3.14m2 = 1Pa 
  
 
Strain 
-Strain is a measure how much a material elongates under an applied force. 
-Strain = (Lf-Li)/Li 
-The Greek letter epsilon () is used to represent strain 
 
-The SI unit of length is meter (m) 
 
-The SI unit of strain is unitless or (length/length) 
 
 
 Example -Find the strain in the block  
 
 strain = (Lf-Li)/Li 
 = (Lf-Li)/Li
 
 Li = 1mm 
 
 
 Lf = 5mm 
 
 
 = (5mm-1mm)/1mm 
  =4 mm/mm 
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Stress vs. Strain Curves and Young's Modulus 
-For nearly all materials, we can measure stress and strain in the same sample and plot 
the results. 
-If we calculate the slope of the line of the plot of stress vs. strain, we can find an 
important material parameter called Young's Modulus 
-Young’s Modulus is a measure of material stiffness 
 
 
 
 
 
 Example -Identify the stiffest material.  
 
 
How do you know this material is the stiffest? 
Material 3--it has the greatest slope 
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J.2b "Mechanical Testing of Polymers " Activity 
 
Introduction 
You are an engineer working at HappyTooth Inc., the newest biomedical company 
that specializes in making replacement teeth.  Your job is to determine if new 
materials are mechanically suitable for use as replacement teeth.  One day, your 
supervisor tells you that HappyTooth Inc. recently purchased the RubberTree 
Corporation, a small company that specializes in rubber production.  Since you now 
have access to large amounts of free rubber, your supervisor asks you if rubber is a 
suitable material for making replacement teeth. 
 
In this lab, you will investigate the mechanical properties of rubber, a common natural 
polymer.  The goal of this lab is to determine the Young's Modulus of rubber, and to 
determine whether rubber is a mechanically suitable material for making replacement 
teeth. 
 
Background 
Rubber is a natural polymer made by Hevea brasiliensis, or rubber tree.  These trees 
contain special sap called latex that is used to make rubber.    
 
 Hevea brasiliensis plant    rubber bands 
 
 
The special latex sap is a natural polymer of isoprene.  In a process known as 
vulcanization, isoprene monomers are heated with sulfer (the crosslinker) to form 
rubber. 
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Rubber Polymer Chemistry 
Note the sulfur atoms that crosslink the monomers: 
 
 
 
Materials 
Rubber bands 
Weights 
Metric ruler 
Marker 
Calculator 
Ring stand 
 
Procedure and Questions 
1) Choose three weights from the set and place them in ascending order.  Start with the 
smallest mass. 
 
2) Record the mass used in kilograms in the column labeled “m (kg)” in the 
Experimental Data Table. 
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3) For the mass chosen, calculate the amount of force the mass exerts due to gravity. 
Record the force in Newtons in the column labeled “F (N)” 
 
a. Write the equation you will use: F=ma 
 
b. This famous equation is also known as Newton’s Second Law of Motion 
 
4) Measure the dimensions of the cross-sectional area of the rubber band you’re using. 
Record the area in square meters the column labeled “A (m2)” 
 
5) Calculate the stress that the mass chosen in (2) will exert on the cross sectional area 
determined in (4). Record the stress in Pascals in the column labeled “ (Pa)” 
 
a. Write the equation you will use: F/A 
 
6) Make 2 marks on the rubber band with a marker. Measure the distance between the 
marks and record this initial length in meters in the column labeled “Li (m)” 
 
7) Hang the mass from the rubber band.  While suspended, carefully measure the 
distance between the 2 marks.  Record this final length in meters in the column 
labeled “Lf (m)” 
 
8) Calculate the amount of strain produced in the rubber band by the mass. Record the 
strain in the column labeled “” 
 
a. Write the equation you will use: 
 
b. What are the units of strain? Why? unitless or length/length 
Strain may be reported as a percent for comparison among materials 
 
 
9) Copy the values for stress and strain into the smaller table on p. 4 
 
10) Use the values from (9) to make a plot of stress vs. strain 
 
11) Calculate the Young’s Modulus of the rubber band 
 
 
a. Write the equation you will use: 
 
b. What is the Young’s Modulus of the rubber band? 
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12) The Young's Modulus of a typical human tooth is approximately 100 GPa.  Is rubber a 
suitable material for making replacement teeth?  
 
 
Experiment Data Table 
 
# m (kg) F (N) A (m
2
) σ (Pa) Li (m) Lf (m) ε 
        
1        
        
        
2        
        
        
3        
        
 
 
Copy the values of σ and ε to the table below: 
 
ε σ (Pa) 
ε1=__________ σ1=__________ 
ε2=__________ σ2=__________ 
ε3=__________ σ3=__________ 
 
Scratch work: 
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Plot of stress (σ) vs. strain (ε) 
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Reference Table 
 
Variables Units  Pronunciation of Units 
m = mass  kg   kilogram 
  
F = Force N = kg    Newton = kilogram meter per 
    second squared 
 
a = acceleration due to gravity    =__________ meters per second 
    squared 
 
A = Area m
2
   square meter 
 
Li = initial length m   meter 
 
Lf = final length m   meter 
 
σ = stress [Greek sigma] Pa =   Pascal = Newton per meter  
     squared    
ε = strain [Greek epsilon] unitless 
 
Δ = change [Greek Delta] unitless 
 
E = Young's Modulus Pa =   Pascal = Newton per meter  
    squared    
 
Note: Do not confuse mass (m, a variable representing the amount of matter in an 
object) with meter (m, a unit of length)  
 
Formulas Pronunciation of Formulas 
 
F = ma Force equals mass times acceleration 
 -or informally: Force is mass times acceleration 
 
 Stress equals Force divided by Area  
 -or informally: Stress is Force over Area 
 
 Strain equals final length minus initial length divided 
 by initial length 
 
 Young's Modulus equals change in stress divided by 
 change in strain 
 -or informally: Delta stress over Delta strain  
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J.2c "Mechanical Testing of Polymers " Quiz 
 
1) What is the value of acceleration due to gravity? 
a) 101.3 Nm2 
b) 9.81 m/s2 
c) 8.34 N/m2 
d) 32.1 m/s 
 
2) Weight is defined as a measure of: 
a) Force times acceleration due to gravity 
b) Mass times acceleration due to gravity 
c) Stress per unit area 
d) Stress per unit length 
 
3) Stress is defined as a measure of: 
a) Force times area 
b) Force divided by area 
c) Elongation divided by time 
d) Elongation times force 
 
4) Strain is defined as a measure of: 
a) Force times area squared 
b) Force divided by area squared 
c) Elongation per unit length 
d) Elongation divided by force 
 
5) Which of the following physical parameters would change if you were on the 
surface of the moon? 
a) Weight 
b) Acceleration due to gravity 
c) Mass 
d) Density 
e) a & b 
f) All of the Above 
 
6) “Young’s Modulus” is a measure of which material property? 
a) Temperature 
b) Density 
c) Stiffness 
d) Porosity 
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7) Shown below is a plot of stress vs. strain. Which material has the greatest 
Young’s Modulus? 
 
 
a) A 
b) B 
c) C 
d) D 
 
8) Given the plot of stress vs. strain, what is the Young’s Modulus of the 
material? 
 
 
a) 3 Pa 
b) 0.5 Pa 
c) 6 Pa 
d) 2 Pa 
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9) What monomer is contained in natural rubber? 
a) Styrene 
b) Butadiene 
c) Neoprene 
d) Isoprene 
 
10) Which element is commonly used as a crosslinker in natural rubber 
production? 
a) Sulfur 
b) Phosphorous 
c) Boron 
d) Nitrogen 
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J.3a "Polymer Stiffness and Cell Proliferation " Notes Handout 
 
Cell Biology Notes 
 
Body System Hierarchy 
-The major systems in the body are organized in a hierarchy of structure and function.  
From the largest to smallest, they are system > organ > tissue > cell 
 
-The functional part of organs are cells AND matrix 
 
-The matrix are proteins (biological polymers) that give cells mechanical integrity 
 
 
Cells 
-There are many types of cells in the body. 
-Cells are capable of a variety of behaviors including: 
1. AdhesionSpreading 
2. Migration 
3. Communication 
 
The Study of Biology 
Biological research is usually performed in one of two ways: 
 
1) in vitro (in glass) 
 
2) in vivo (in the living) 
 
We study biology to understand cell function.  This knowledge helps us to 
understand and treat disease. 
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Case Study: Matrix stiffness and cell responses 
 
 
 
-Cell spreading (cell size) is altered by the stiffness of the matrix the cells are grown 
on. 
-Cells were grown on matrices of increasing stiffness (200 - 10,000 Pa).  The bar plot 
of cell area vs. stiffness indicates that area increases with increasing matrix stiffness. 
 
What other cell behaviors are sensitive to matrix stiffness? 
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